The Effect of Interleukin 4 on Protein Kinase Activities Associated With B Lymphocyte Plasma Membranes by McGarvie, Gail McLean
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
THE EFFECT OF INTERLEUKIN 4 ON PROTEIN KINASE 
ACTIVITIES ASSOCIATED WITH B LYMPHOCYTE PLASMA
MEMBRANES
A Thesis Presented for the 
Degree of 
DOCTOR OF PHILOSOPHY
by
GAIL MCLEAN MCGARVIE
Department of Biochemistry 
University of Glasgow
May 1989
ProQuest Number: 10970909
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10970909
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
ACKNOWLEDGEMENTS
I would like to express my sincere thanks to Dr W. Cushley for his 
excellent advice and encouragement throughout this project
I would also like to thank Professor M.D. Houslay and the late 
Professor R.M.S. Smellie for making available the facilities of the 
Department of Biochemistry to undertake this research and to the Medical 
Research Council for a research studentship.
Thanks must go to all my friends and colleagues in the department 
especially in Lab B4b for their advice, friendship and making the work so 
enjoyable. Thank you to Dr Anna Jaques for helpful advice on the writing 
of this thesis, Alison Wood for excellent technical advice and Valerie Beattie 
for her help in laying the ground work for this project
Last but by no means least I would like to thank my husband, 
Andrew and my parents for the continual support and encouragement they 
have given to me throughout this research.
ABBREVIATIONS
The abbreviations used in this thesis are those recommended in the 
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SUMMARY
A variety of ligands bind to unique cell surface receptors and cause 
rapid changes in cell metabolism. In many systems this has been acheived 
by the functional modification of existing proteins, most notably through 
phosphorylation. Phosphorylation of proteins has been observed in B 
lymphocytes on activation with antigen, lipolysaccharide and several 
lymphokines. Although many of the biological functions of the lymphokine 
IL-4 are well known, the signals transduced when IL-4 binds to its receptor 
are poorly understood. In the murine system it has been reported that IL-4 
fails to induce the hydrolysis of inositol lipids, mobilisation of intracellular 
calcium or the activation of protein kinase C. However, the addition of IL-4 
to isolated B cell membranes in the presence of y-[^P]-ATP leads to the 
phosphorylation of a 42 kDa protein. In the human system recent 
experiments suggest that the addition of IL-4 to resting human B cells results 
in the activation of a complex second messenger cascade involving the 
hydrolysis of inositol lipids, elevation of intracellular calcium and an 
increase in the level of cAMP.
Studies in this project have indicated that exposure of plasma 
membranes isolated from high density resting murine B lymphocytes to 
either purified .or recombinant IL-4 in the presence of y-[32p]-ATP promotes 
the phosphorylation of a 42 kDa protein. The use of recombinant material 
negates the possibility that residual PMA in the purified IL-4 is responsible 
for the observed phosphorylation. Linear laser densitometric analysis of the 
autoradiographs suggested that IL-4 was enhancing the phosphorylation of 
this protein some two-fold. The 42 kDa protein could be detected in plasma
membranes from low density B cells that had been exposed to 
lipopolysaccharide for 24 hours, but not in membranes prepared from B 
cells exposed to the mitogen for 48 hours, or in cell lines possesing high 
numbers of IL-4 receptors. This suggests that the 42 kDa phosphoprotein is 
present only in membranes from resting B cells or B cells at early stages of 
activation but not in membranes from cells which are commited to the 
proliferative stages of the cell cycle. Experiments using 8 - a z i d o - y - [ 3 2 p ] -  
ATP as a photoaffinity label indicated that the 42 kDa phosphprotein did not 
bind ATP and was therefore a protein kinase substrate rather than a protein 
kinase itself. There was no evidence of the 42 kDa phosphoprotein in 
identical experiments with human B cells using human IL-4 as a stimulatory 
ligand.
It has been shown that culturing B cells with IL-4 increases the 
expression of IL-4 receptors without driving the B cells into the cell cycle. 
Plasma membranes prepared from murine B cells cultured for 24 hours with 
IL-4 were exposed to y-[^2p]-ATP in the presence of IL-4.
Phosphorylation of the 42 kDa protein was evident, but the profiles also 
illustrated the presence of a major autoradiographic signal of molecular 
weight 75 kDa. This phosphoprotein was unique to cells exposed to IL-4 
and could not be detected in membranes from resting B cells, B cells 
exposed to lipopolysaccharide for 24 or 48 hours or B cells cultured in 
medium alone for 24 hours. The 75 kDa autoradiographic signal was 
resistant to treatment with alkali which suggested that it may be 
phosphorylated on tyrosine residues. Preliminary experiments with 8- 
azido-y-2p] ATP indicated that the 75 kDa phosphoprotein may be able to 
bind ATP. Culturing high density resting B cells with IL-4 in the presence 
of 1 IB 11, an anti-IL-4 monoclonal antibody, prevented the appearance of
xix
the 75 kDa phosphoprotein indicating that binding of IL-4 to its receptor was 
required for the induction of the 75 kDa phosphoprotein. Interferon-y 
inhibits many of the biological effects of IL-4 but it does not prevent the 
binding of IL-4 to its receptor. Exposure of membranes, prepared from 
resting B cells cultured in the presence of Ifn-y, to y-[32p]-ATP resulted in 
phosphoprotein profiles essentially identical to that obtained with 
membranes from cells cultured with IL-4. Phosphoprotein profiles of 
membranes prepared from B cells cultured with both IL-4 and Ifn-y were 
very similar to membranes prepared from cells cultured in medium alone, ie. 
there was no evidence of the 75 kDa phosphoprotein.
Phosphoprotein profiles of membranes from human tonsillar B cells 
cultured with IL-4 for 24 hours showed the presence of an alkali resistant 72 
kDa signal. In membrane phosphoprotein profiles from human tonsillar B 
cells there is also an indication of the disappearence of a 94 kDa protein 
when the cells were cultured in the presence of IL-4. Membrane 
phosphoprotein profiles from human B cells cultured with phorbol ester and 
calcium ionophore, also show the presence of a 72 kDa alkali-resistant 
phosphoprotein signal. Human B cells isolated from peripheral blood were 
cultured with IL-4 and the membranes from these cells exposed to y-[32p]- 
ATP. In this case there was some evidence of a 72 kDa protein but this was 
not definitive.
These data are consistent with the activation of a protein kinase 
activity when IL-4 binds to its receptor. Two phosphoproteins have been 
identified, 42 kDa, unique to the murine B cell model, and 75 kDa, 
apparently present in both murine and human B cells. The molecular 
identities and biochemical functions of these phosphoproteins remains 
undefined.
xx
1. INTRODUCTION.
1.1. The Immune System
The immune system exists as a protection against foreign antigens. It 
is highly complex, discriminating between self and non self, and involves 
multiple cellular interactions in addition to cellular communication mediated by 
soluble growth and differentiation factors. The principal cells involved in the 
humoral immune response are B lymphocytes, which produce antibody, and 
accessory cells from the myeloid lineage and T lymphocytes, which do not 
produce antibody themselves, but assist in antibody production. All three 
types of cell are derived from haematopoetic stem cells.
The immune system is capable of mounting a highly specific response 
against any foreign body. This specificity is determined by T and B 
lymphocytes. Antigen receptors on B lymphocytes have been well 
characterised and found to be identical to secreted immunoglobulin (Ig) except 
for an extra transmembrane portion (Rogers et al., 1980). The recognition 
molecule on T cells is the membrane bound T cell antigen receptor which 
exists as a complex of several proteins (for a review see Davis & Bjorkman, 
1988). The T cell antigen receptor recognises antigen peptides in combination 
with a molecule of the major histocompatibility complex (MHC). The antigen 
receptors on both T and B cells are clonally distributed.
1.1.1. B Cell Development
The development of B cells into mature antibody secreting cells can 
be divided into two stages (Figure 1). Pluripotential stem cells, which 
originate in the blood islands of all embryonic tissue, undergo a programmed 
proliferation and differentiation. This development occurs within primary 
lymphoid organs and is dependent on the microenvironment and independent 
of antigen.
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Figure 1 B Cell Developement
Pluripotential stem cells undergo a programmed proliferation and 
differentiation to develop into mature B cells expressing membrane IgM 
and IgD.' When antigen binds to a mature B cell the cell is stimulated to 
proliferate and differentiate into a high rate antibody secreting cell or a 
memory cell. The specificity of the immune response is based on 
clonal selection. Each B cell undergoes a unique set of V gene 
rearrangements to express only one structure of Immunoglobulin on its 
membrane (Burnet, 1959)
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Each immunoglobulin molecule consists of heavy and light chains. 
Both the heavy and light chains consist of a constant region and a variable 
region, which is the antibody combining site. It is the combining of the heavy 
and light chains that generates antibody diversity. Heavy chains are 
composed of V (variable), D (diversity), J (joining) and C (constant) exons. 
Three segments combine, V, D and J, to code for the Vjj  domain. One of 
several hundred V genes recombines with one of twelve D genes and one of 
four J genes to produce a functional VDJ gene. The VDJ gene then combines 
with a C gene, which determines isotype specificity, forming a complete 
heavy chain. Light chains possess V,J, and C exons, which combine in a 
similar manner to heavy chain genes producing a wide range of functional 
light chains. In the development of B cells each potential B cell undergoes a 
unique set of imunoglobulin V gene rearrangements. This means that each B 
cell produces only one particular structure of the V region of heavy and light 
chains (Burnet, 1959).
Pre B cells are characterised by the expression of |i heavy chains in 
the cytoplasm. On synthesis of light chains, either K or X, the immature B cell 
can express surface Ig. Mature B cells express both IgM and IgD and 
although quiescent are capable of responding to antigen.
1.1.2. Clonal Selection
Hie specificity of the immune response is based on clonal selection 
(Burnet, 1959). Each B cell is programmed to make one immunoglobulin 
molecule which is expressed on its surface as an antigen receptor. When 
antigen binds to the receptor the B cells are stimulated to proliferate and 
differentiate into antibody secreting cells and memory cells (Figure 1).
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Differentiation to memory cells involves a change of Immunoglobulin 
isotype. As the B cell matures class switching can occur eg. B cells 
expressing IgM can switch to IgG, IgA or IgE. Class switching occurs at the 
genomic level. The somatically recombined VDJ gene moves from a position 
5* of C\i and C5 to a location 5' to another constant region gene (Shizimu & 
Honjo, 1984). Memory B cells are quiescent until they encounter antigen 
again when they have a choice to differentiate into antibody secreting cells or 
remain as memory cells.
1.1.3. Proliferation and Differentiation
Antibody production by B cells involves clonal expansion and 
differentiation into high rate antibody secreting cells. In the mouse 80-90% of 
B cells are in a resting or quiescent (Go) state (Monroe & Cambier, 1983a) 
and require the presence of growth factors in order to proliferate. The B cell 
response to antigen can be defined in three stages; activation, proliferation and 
differentiation. Each stage of the cell cycle of B cells is under the control of a 
variety of molecules, the properties of which have been elucidated in recent 
years. These factors are neither tissue, target or stage specific for their action 
on B lymphocytes (Gordon & Guy, 1987). Activation of quiescent (Go) B 
cells into the G1 phase of the cell cycle involves several changes in the B cell 
(Walker et al, 1986) including enlargement of the cell, RNA synthesis and an 
increase in expression of proteins including several surface molecules eg. 
CD23 in humans. In mice entry into G1 is characterised by an increase in 
expression of major histocompatibility (MHC) class II antigens (Mond et al, 
1981). Although an increase in MHC class II antigens is also observed in 
human B cells, the increase is not as pronounced (Godal et al, 1985). Entry 
to G1 phase is completed within 24 hours, and then progression factors move 
the cells into S phase and DNA synthesis (Gordon & Guy, 1987). The cell 
cycle has several sites where cells can potentially arrest or, depending on
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external factors, proceed. Although these arrest points exist throughout the 
cell cycle the most important appear to be in the G1 phase. Figure 2 depicts a 
summary of the cell cycle.
Differentiation takes several days and results in the production of 
antibody (Melchers and Anderson, 1984). Several factors can induce 
differentiation directly from resting cells and in fact maturation appears 
antagonistic to replication (Melchers and Andersson, 1984). Pike and Nossal 
(1985a) have developed a system which selects single antigen specific B cells. 
These cells can be stimulated to proliferate and differentiate when they are 
cultured with antigen and B cell growth and differentiation factors. This 
system has allowed the actions of several growth factors to be identified. IL-1 
and IL-2 have been shown to be both growth and differentiation factors for B 
cells in the presence of antigen and in combination result in an additive effect 
(Pike & Nossal, 1985b). This suggests that the action of individual factors is 
not confined to one stage.
1.2. Activation Through Membrane Immunoglobulin
The initial signal for B cell activation is the binding of antigen to 
membrane immunoglobulin (Ig) which is of two classes, IgM and IgD on 
virgin B cells. Most of the work done in this area makes use of anti Ig, which 
acts polyclonally, rather than using specific antigens. Crosslinking of 
membrane immunoglobulin by anti-immunoglobulin reagents results in 
signals being transduced across the membrane to the B cell (Parker, 1975). 
One of the consequences of anti Ig binding is a 5-10 fold increase in 
expression of surface MHC class II antigens (Mond et al., 1981; Monroe & 
Cambier, 1983a). On antigen binding to membrane immunoglobulin the 
antigen is internalised, processed, and the processed antigen is then expressed
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on the B cell surface in conjunction with MHC class II antigens (Chesnut & 
Grey, 1986). The increase in expression of MHC class II antigens (la) could 
be detected 6-8 hours after stimulation. Induction can be inhibited by 
actinomycin D (Monroe et al., 1982) and cycloheximide (Mond et al.,
1981). Messenger RNA encoding the MHC antigens could be detected within 
2 hours of stimulation (Cambier et al., 1985). The increase in MHC class II 
antigen expression is significant as they are involved in the collaboration of T 
and B cells needed for final proliferation. Some data have suggested that an 
increase in MHC class II antigens allows a more efficient interaction with 
MHC restricted helper T cells (Bottomly et al., 1983; Henry et al., 1977) 
and increased ability to present antigens to them (Roehm et al., 1984). 
Although anti Ig is required for activation of B cells this signal alone is not 
enough to drive the resting B cell to proliferate (Bretscher, 1975) or to make 
the B cell responsive to growth and differentiation factors (Snow et al.,
1983).
1.3. T-B Cell Interaction
When antigen binds to membrane immunoglobulin, signals are 
transduced to the B cell which, although not enough to drive the B cell into the 
cell cycle, leave the cell in an activated state poised to receive a major growth 
stimulus (Snow & Noelle, 1987) which will drive the B cell into the cell 
cycle. Early experiments by Mitchison (1971) demonstrated that T dependent 
antigens required an antigen mediated recognition between B and T cells.
Since then the T-B interaction has been shown to be MHC class II restricted 
both in vitro (Andersson et al., 1980; Jones & Janeway, 1981) and in vivo 
(Sprent, 1978). The receptors on T cells recognise the processed antigen and 
MHC class II antigens expressed on B cells. B cells therefore present antigen 
to T cells in a manner similar to antigen presenting cells (Lanzavecchia, 1985).
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This cognate interaction of T and B cells results in the production of 
lymphokines from T cells and the B cells becoming responsive to the 
lymphokines and subsequently expanding and differentiating (Singer & 
Hodes, 1983).
The signals that are transduced when T and B cells interact are 
unknown and part of the signal may be through molecules that are in close 
proximity to the site of interaction. Baluyut & Subbaro (1986) using anti-la 
and anti-IgM antibodies have observed a synergistic effect on proliferation 
suggesting that some signals may be transduced via MHC class II antigens. 
This has been substantiated by reports that anti-la antibodies induced a rapid 
rise in cAMP levels in B lymphocytes within 60 seconds (Cambier & 
Ransom, 1987) and also induced the rapid translocation of protein kinase C 
from the cytosol to the nucleus (Chen et al., 1986). The exact nature of the 
signals transduced when T and B cells interact are at present unclear but the 
main outcome of the interaction is the activation of B cells through the 
production of lymphokines.
1.4. Macrophage - T cell Interactions
When looking at T and B cell interactions many researchers have 
made use of the availability of T cell hybridomas, cloned T cell lines or in 
vivo primed T cells. This has meant that the question of whether resting B 
cells can initiate an immune response by providing the signals to activate 
resting T cells has not been answered. Cells of the myeloid lineage, such as 
macrophages, can internalise antigen, degrade it and re-express the processed 
antigen on the cell surface in conjunction with MHC class II antigens 
(Rosenthal & Shevach, 1973). These cells, known as antigen presenting cells 
(APC), interact in an MHC restricted manner with T cells. This interaction 
results in the activation of T cells and the production of lymphokines, IL-1
from APC and TL-2 from T cells (Melchers & Andersson, 1984).
Recently, Lassila et al (1988) performed an experiment in chickens 
studying the ability of resting B cells to activate resting T cells. In chickens it 
is possible to create a A-B chimerea consisting of T cells and APC's from host 
B type strain and B cells from an allogeneic donor A strain. Treating chickens 
neonatally with cyclophosphamide destroys B cell precursors but leaves T 
cells and APC's intact B cell precursors from another neonatal chicken (type 
A) were then introduced to the B cell depleted chicken, type B. The T cell 
independent response was normal in these chickens, but the T dependent 
response was deficient although the donor B cells were functional. The donor 
B cells differ in the class II region of MHC antigens from the T cells and 
APC's and, therefore, MHC T-B cell interactions will be difficult as there will 
be few helper T cells capable of recognising the antigen and MHC molecules 
expressed on the B cells. However it was found that the number of MHC 
specific interactions of T and B cells was sufficient for a normal response and 
it was the introduction of APC's expressing the same MHC as the donor B 
cells that restored the T cell dependent antibody response to normal. The 
explanation derived from this result was that antigen presenting cells other 
than B cells are required to activate resting T cells before the T cells can 
interact with the same antigen and MHC molecules expressed on B cells.
1.5. Excitation of B Cells by Other Modes
Although the most specific way to activate a B cell is by MHC 
restricted interaction with helper T cells there are other less specific ways to 
effect this stimulation. B cell populations are not homogeneous and therefore 
the signals required to activate a B cell may depend on the nature of the B cell 
population (Melchers & Andersson, 1984).
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1.5.1. AlloreactiveT Cells
Two classes of alloreactive T cells exist,
i) those that will excite a resting B cell expressing the appropriate class II 
MHC antigen only when specific antigen is also bound to that cell (Schreier 
era/,1980).
ii) those that polyclonally excite a large proportion of B cells even in the 
absence of any antigen binding to surface immunoglobulin (Waterfield et 
a/.,1979, Augustin & Coutinho, 1980)
1.5.2. T Independent Antigens
T independent antigens as their name suggests can activate B cells 
independently of T cells ie. they are non antigen specific and non MHC 
restricted. Originally two types of T independent antigen was identified, TI-l 
and TI-2, based on the ability of the antigen to elicit an antibody response 
from B cells from three sources. B cells from normal adult mice, suckling 
mice and CBA/N mice with X-linked immunodeficiency syndrome (Mosier et 
al., 1977).TI-1 antigens eg. haptenated lipopolysaccharide and Brucella 
abortus, have the ability to stimulate an antibody response in all three mice. 
TI-2 antigens eg. haptenated ficoll and dextran can only stimulate an antibody 
response in mature type B cells ie. from adult mice.
Pike and Nossal (1984) using single hapten specific B cells 
demonstrated that some T independent antigens may be partially dependent on 
T cells, although in a non MHC restricted manner. Individual antigens had 
different extents of requirement of T cell help and this was not related to TI-1 
and TI-2 classifications. The antigens LPS and ficoll did not require any T 
cell help, whereas the polymerised flagellin of salmonella adelaide was
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dependent on the presence of T cells and Brucella abortus was only partially 
dependent on T cell help. These results suggest that the original subclasses of 
T independent antigens may need further classification.
1.5.3. Polyclonal Activators
Polyclonal activators such as lipopolysaccharide (LPS), which excites 
mouse B cells, excite resting B cells irrespective of antigen specificity or 
MHC haplotype (Andersson et al., 1972). LPS drives about 60% of B cells 
into S phase although this can be increased to 80% in the presence of dextran 
sulphate showing synergy in the action of the two mitogens (Wetzel & 
Kettman, 1981). Agents such as LPS may act by crosslinking putative 
receptors on the B cell surface as they are known to exist as large polymeric 
structures in solution (Galanos & Luderitz, 1975). No such receptors have 
been identified and the report that LPS can insert itself directly into the 
membrane suggests that it may not require surface receptors (Raetz et al.,
1983).
1.6. Control of B Cells by Lymphokines
One mechanism by which helper T cells help B cells is by the 
production of soluble molecules which deliver essential signals to the B cells 
by interaction with complementary cell surface receptors. These T cell 
products were first described in 1972 when it was shown that the supernatants 
from T cells could substitute for the cells themselves in T cell dependent B cell 
responses (Schimpl & Wecker, 1972). These lymphokines have now been 
shown to be pleiotropic (O'Garra et al., 1988). Lymphokines act on a wide 
variety of cell types and have multiple effects on a single target cell. The 
availability of monoclonal antibodies, which have facilitated purification of the 
lymphokines and the availability of recombinant forms of the molecules, has 
to some extent helped to define the action of specific lymphokines. There has
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been some problem with the nomenclature of lymphokines which has now 
been made clearer by the use of the term interleukin. The criteria for a 
molecule being termed interleukin is that the molecule has been cloned and the 
expressed molecule has been observed to have the same biological activities as 
the molecule purified from cell supernatants (Paul, 1988).
The molecules that were first identified by their effects on B cells 
were IL-4, EL-5 and IL-6 . IL-4 will be discussed in detail later in this chapter. 
IL-5 has been shown to act as both a growth and differentiation factor on B 
cells. It induces the proliferation of activated normal murine B cells and 
BCL1 cells (Dutton et al, 1984). IL-5 promotes IgM and IgG secretion by 
preactivated murine B cells and BCL1 cells (O'Garra et a l, 1986) and 
enhances the production of IgA by LPS stimulated B cells (Yokota et al.,
1987; Coffman et al., 1987). In the human system it has been demonstrated 
that IL-5 induces IgM (Azuma et al, 1986) and IgA (Yokota et a l, 1987) 
secretion in staphylococcus aureus cowan 1 (Sac) activated B cells from 
peripheral blood. There does, however, seem to be some controversy over 
the proliferative effects of EL-5 in the human system, as it has recently been 
reported that recombinant human IL-5 does not have activity in many of the 
conventional B cell proliferation assays (Gordon & Guy, 1987). The effects 
of IL-5 are not confined to B cells as IL-5 has been shown to act as an 
eosinophil differentiation factor in both the murine and the human system 
(Yokota et al., 1987). IL-5, in combination with IL-2, can induce cytotoxic 
T lymphocytes from thymocytes (Takatsu et a l, 1987).
IL-6  (BSF-2) was described as a B cell differentiation factor by its 
ability to induce antibody secretion in pre-activated normal and Epstein Barr 
virus transformed human B cells (Hirano et a l, 1987). It has also been
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shown to support the growth of B cell hybridomas and plasmacytomas (Bazin 
& Lemieux, 1987; Van Damme et al., 1987) and is identical to hybridoma 
growth factor (Van Damme et al., 1987).
Other molecules that have been identified to have growth factor 
activity on B cells include a 12 kDa T cell product, described as low molecular 
weight BCGF and a high molecular weight factor (50-60 kDa) derived from 
human T cells and the Namalwa B cell line (Ambrus & Fauci, 1985).
There are several molecules that were originally described as having 
effects on cells other that B cells but have now been found to have effects on 
B cells. IL-1 can act on both pre B cells and activated mature B cells. Thus a 
murine pre B cell line expresses membrane immunoglobulin in response to 
IL-1 (Giri etal.y 1984). The addition of IL-1 to B cells treated with IL-4 and 
anti-Ig has been shown to induce proliferation (Howard et al, 1983). In 
studies with single antigen specific B cells IL-1 induced prolifereration and 
differentiation in these cells (Pike and Nossal, 1985b).
It has now been reported that IL-2 has a role in B cell proliferation 
and differentiation. Receptors for IL-2, recognised by the anti-Tac antibody, 
are expressed on activated human B cells (Mingari et al., 1984; Jung et al.,
1984). IL-2 can induce proliferation of B cells in the presence of LPS and 
anti-Ig (Zubler et al., 1984). Studies on antigen stimulated single B cells 
showed that IL-2 could induce proliferation and differentiation of B cells (Pike 
and Nossal, 1985b). IL-2 can also induce differentiation of B cells in the 
presence of anti-Ig and IL-4 (Nakanishi et al., 1984). In the human system 
IL-2 induces proliferation (Jelinek et al., 1986) and differentiation (Bich- 
Thuy and Fauci, 1985) of SAC activated B cells. The addition of EL-2 to
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murine B cells, which express high affinity receptors for IL-2, results in the 
induction of NF-Jg. NF-Jg is a DNA binding protein which promotes the 
expression of J chains. IL-2, therefore, promotes high rate secretion of IgM 
from B cells.
Ifn-y appears to exert both stimulatory and inhibitory effects on the 
response of B cells to antigen. The proliferative effects of IL-4 on B cells are 
inhibited by Ifn-y (discussed later in this chapter, section 1.9.). Although 
some reports show that human B cells can proliferate in response to anti-Ig 
and Ifn-y (Defrance et al., 1986; Romagnani et al., 1986; Defrance et al., 
1987b). In the murine system, Ifn-y has been shown to enhance antibody 
production specifically of the IgG2a class in LPS activated B cells (Snapper & 
Paul, 1987).
As well as soluble molecules contributing to the growth and 
differentiation of B cells, antibodies to several surface antigens on B cells 
have been described as delivering stimulatory or inhibitory signals to the cells 
although the ligands for these surface molecules have not been identified. It is 
also now apparent that the B cell itself can regulate the immune response. An 
autostimulatory B cell growth factor (BCGF) has been detected which has a 
molecular weight of 25-35 kDa (Jurgensen et al., 1986). Human CD23, and 
its mouse equivalent FcRe, is expressed on B cell membranes as a 45 kDa 
protein (Defrance et al., 1987a). This protein can bind IgE and has been 
identified as the low affinity receptor for IgE (Walker et al., 1986).
Expression of CD23/FcRe is increased in the presence of IL-4 (discussed in 
detail later). The binding of CD23 antibody to the 45 kDa membrane protein 
results in its cleavage to a 35 kDa soluble protein (Gordon & Guy, 1987). 
This soluble protein acts as a growth factor for B cells stimulating G1 cells to 
enter S phase and G2 phase of the cell cycle (Gordon et al., 1986). It has
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been suggested that the CD23 molecule and the autocrine BCGF are the same 
molecule (Gordon and Guy, 1987). Binding of a T cell derived BCGF results 
in the release of soluble CD23 and it is possible that the BCGF has a protease 
activity which cleaves the CD23 molecule (Gordon and Guy, 1987).
It is clear that there are several soluble factors and surface molecules 
that effect the proliferation and differentiation of B cells. Figure 2 is an 
attempt to summarise the stages at which these different factors exert their 
effect There are several differences in the action of some molecules in the 
mouse and human system. This could be accounted for to some extent by the 
different sources of B cells used. Experiments on human B cells have tended 
to concentrate on cells obtained from peripheral blood or tonsils whereas the 
spleen has been the main source of B cells in the mouse. The work defining 
the biological effects of lymphokines have so far been performed mostly in 
vitro and the relevance of most of these effects still have to be determined in 
vivo. In vivo the lymphokines have a short half life (minutes) and the 
actions of many of the lymphokines are dependent on the state of 
responsiveness of the B cell.
1.7. Interleukin 4
Interleukin 4 (IL-4) is a glycoprotein with a molecular weight of 20 
kDa. It is synthesised by some activated T cells and exerts its effects on 
several different cells including B lymphocytes, T lymphocytes, mast cells 
(Mosmann et al., 1986) and haematopoetic cells (Zlotnick et al., 1986). 
Murine interleukin 4 was initially identified in the supernatants of EL-4, a 
thymoma cell line, that had been stimulated with phorbol myristate acetate 
(PMA) (Howard et a l , 1982) and has since been purified from this source 
(Farrar et al., 1983; Ohara et al., 1985). cDNA sequences for both murine 
(Noma et al., 1986; Lee et al., 1986a) and human (Yokota et al., 1986) IL-
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Figure 2 Proposed Sites of Action of B Cell Growth and 
Differentiation Factors
Antigen and IL-4 can act on resting B cells to allow entry into the G1 
phase of the cell cycle (Howard et al., 1982). This is characterised by 
cell enlargement and an increase in expression of MHC class II 
antigens and FcRe/CD23 (Walker et al., 1986; Mond et al., 1981). 
Activation to G1 is complete within 24 hours and can be inhibited by 
Ifn-y (Rabin et al., 1986; Mond et al., 1986) and intact 
immunoglobulin (Sinclair, 1983). Progression factors, low molecular 
weight BCGF, IL-1, IL-5 and sCD23 have been reported to assist in 
driving the B cells into S phase and DNA synthesis (Gordon and Guy, 
1987).
Differentiation of B cells to antibody secreting cells takes several days 
and several factors have been identified in playing a role in this, IL-2, 
IL-6  and Ifn-y.
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4 have now been derived.
The nucleotide sequence derived for murine IL-4 encodes for a 
protein of 140 amino acids. The first 20 amino acids are highly hydrophobic 
and represent the signal peptide which allows the protein to be secreted. The 
secreted IL-4 consisted of 120 amino acids and has a molecular weight of 20 
kDa which is consistent with that determined from EL-4 supernatants (Noma 
et al., 1986). Treatment with endoglycosidase F reduces the molecular 
weight of the IL-4 fom 20 kDa to 15 kDa (Ohara et al., 1987). From the 
sequence three potential sites for the attachment of N-linked sugars could be 
identified and the decrease in molecular weight observed with 
endoglycosidase F suggested that at least one of these sites must be 
glycosylated. Glycosylation of IL-4 does not appear to be necessary for the 
biological activity of the molecule (Ohara et al., 1987). IL-4 also has six 
cysteine residues but the intact molecule cannot be labelled with ^C - 
iodoacetamide which indicates that all the residues are involved in disulphide 
bonds. The disulphide bonds need to be intact for IL-4 to be biologically 
active (Ohara etal., 1987).
Regions of the sequence determined for murine IL-4 contained 
significant homology to two other lymphokines, granulocyte-macrophage 
colony stimulating factor (GM-CSF) and y-interferon. Noma et al (1986) 
suggested that these lymphokines may be distantly related which is particuarly 
interesting as y-interferon inhibits many of the biological effects of IL-4.
The nucleotide sequence derived for human IL-4 coded for a protein 
with 153 amino acids, with 24 amino acids being part of the signal peptide, 
leaving 129 amino acids as the secreted protein (Yokota et al., 1986). There 
are seven cysteine residues in the human IL-4 compared to six in the mouse. 
The molecular weight of the protein was estimated to be 15 kDa although this 
does not take account two potential N glycosylation sites. From the amino
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acid sequence human and murine EL-4 have approximately 50% homology but 
EL-4 exhibits complete species specificity (Mosmann et al., 1986).
1.8. Biological Activities of EL-4 on B Lymphocytes
1.8.1. IL-4 acts as a costimulant with anti-Ig
Murine IL-4 was first described by its ability to act as a costimulator 
with anti-IgM to stimulate resting B cells to enter DNA synthesis (Howard et 
al., 1982). As has been described previously (section 1.2.), anti-IgM 
binding to resting B cells primarily results in increased expression of MHC 
class II antigens. The action of anti-IgM alone moves the B cell from a 
resting Go state to G1 but is insufficient to drive the B cell into DNA 
synthesis (Bretscher, 1975). Howard cr al (1982), using supernatant from 
PMA stimulated EL-4 cells, first discovered that IL-4 could act as the factor 
that drove the anti-IgM stimulated B cells into DNA synthesis. IL-4 has now 
also been shown to act as a costimulant with antigen in the proliferation of 
antigen specific B cells using TNP specific B cells (Stein et al., 1986) . I t  
has, however, been reported that human IL-4 displays little or no growth 
promoting activity with human tonsillar cells in the anti-IgM costimulatory 
assay (Defrance et al., 1987b). Human IL-4 could induce proliferation of B 
lymphocytes that had been pre-activated for one day with insolubilised anti- 
IgM or for three days with staphylococcus aureus strain Cowan 1. The 
differences observed between murine and human EL-4 may be due to 
differences in species, sources of the cells or the procedures used for 
activation. This factor was originally called B cell growth factor (BCGF) and 
was initially thought of as a progression factor acting in the late G1 stage of 
the cell cycle. This was proved to be wrong as further work with EL-4 
showed that it had several effects on small, resting B ceUs in the absence of 
anti-IgM (Rabin et al., 1985; Rabin et al., 1986a).
The first indication that IL-4 may not only act in late G1 came from 
experiments that demonstrated that a delay in the addition of IL-4 resulted in a
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delayed entry into S phase and delays of 12 hours completely inhibited entry 
into DNA synthesis (Howard & Paul, 1983). Rabin et al (1985) further 
substantiated that IL-4 has effects on resting B cells by showing that culturing 
cells for 24 hours with IL-4 alone increases the cell volume. Treatment of B 
cells with IL-4 also appeared to induce a state of activation, as cells that had 
been precultured with IL-4 responded more promptly to subsequent culture 
with IL-4 and anti-IgM to enter S phase (Rabin et al., 1985). B cells 
stimulated with IL-4 and anti-IgM normally do not begin to enter S phase until 
about 30 hours after stimulation, some not until 45 hours (Rabin et al.,
1986a; Defranco et al., 1982) but 24 hours preculture with IL-4 accelerates 
this response by 12 hours. The presence of IL-4 would, therefore, recruit B 
cells quickly in response to an antigenic challenge. EL-4 is required to be 
present over a long period (24 hours) to induce the maximum response from 
B cells (Rabin et al., 1986a). This suggests that when IL-4 is bound to its 
receptor it produces a cellular signal that is required over a long period of 
time. Resting B cells do possess receptors for IL-4 and part of the prompter 
response could be explained by the fact that culturing with IL-4 upregulates 
the expression of its own receptors (Park et al., 1987a). From these 
experiments it appears that IL-4 plays a more complex role in B cell activation 
than first imagined. EL-4 has actions on both resting cells and also later in 
Gl.
1.8.2. IL-4 increases the expression of MHC classllantigens
Murine IL-4 enhances the expression of MHC class II antigens (la) 
on normal B lymphocytes (Roehm et al.,1984; Noelle et al., 1984). Human 
IL-4 had a similar effect on Burkitt lymphoma cell lines, but increased MHC 
class II expression was not observed on normal human B cells (Rousset et 
al., 1988). It may be because human B cells endogenously express high 
levels of MHC class II antigens and, therefore, it would be more difficult to 
unequivocally demonstrate an increase (O’Garra et al., 1988). On mouse B
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cells there is a selective and dramatic 10-15 fold increase in MHC class II 
antigen expression as detected by radioiodination and immunoprecipitation 
(Roehm et al., 1984; Noelle et al., 1984). This increase can be detected 8- 
12 hours after stimulation with IL-4 (Noelle et al., 1986; Oliver et al.,
1985). IL-4 induced MHC class IT antigen expression is dependent on new 
transcription and a two fold increase in MHC class II antigen mRNA can be 
detected within 4-6 hours (Noelle et al., 1986). The increase in transcription 
could be mediated by gene regulatory elements which are controlled directly 
or indirectly by IL-4 binding to its receptor. In two murine pre B cell lines 
IL-4 induced rapid transcription of MHC class II antigen mRNA within 1 
hour independently of protein synthesis (Polla et al., 1986). A nuclear 
protein which binds to two sites in the region of the MHC class II genes has 
now been identified (Boothby et al., 1988). This protein is specific to B 
cells and the addition of IL-4 to normal mouse spleen cells increases the 
binding of this protein. The increased binding was concomitant with the 
increase in MHC class II gene transcription. Therefore, B cells contain a 
sequence specific DNA binding activity whose level is influenced by IL-4. 
Noelle et al (1986) reported that the observed increase in transcription of 
MHC class II antigen genes was not enough to account for the dramatic 
increase in the expression of MHC class II antigen on the membrane. IL-4 
may not only affect transcription but other events may also be involved 
perhaps including post translational modifications.
The increase in MHC class II antigen expression by IL-4 could have 
significant effects on the B cell especially in the context of T-B interaction. 
Increased MHC class II antigen expression may enhance the capacity of B 
cells to act as antigen presenting cells and, therefore, increase the 
responsiveness of the interacting T and B cell.
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1.8.3. IL-4 reverses the inhibition ofFc receptors on B cell
activation
B cell activation is under the control of several molecules, one of 
which is the antibody secreted in response to antigen. The secreted IgG can 
bind to Fc receptors which are present on B cells (Didder, 1976). This 
binding to Fc receptors produces signals that inhibit further proliferation of 
the B cell, thus acting in the manner of feedback inhibition (Sinclair, 1983). 
As has been discussed previously, anti-Ig F(ab)'2 fragments act as polyclonal 
activators for almost all B cells and at high concentrations can drive the B cell 
into DNA synthesis (Defranco et al., 1985). Intact anti-IgG, which mimic 
the secreted antibody, are not mitogenic and can inhibit entry into DNA 
synthesis (Phillips & Parker, 1984). The intact anti-IgG crosslinks surface Ig 
and FcRII resulting in a strong negative signal which prevents activation of 
the B cell (Klaus et al., 1984). It has been shown by OGarra et al (1987) 
that this negative signalling can be overcome by IL-4 allowing some B cells to 
enter S phase, although not as many as in the presence of both IL-4 and anti- 
Ig F(ab)'2. The mechanism by which IL-4 overcomes the inhibition by IgG 
is unclear. Intact IgG, although preventing B cell activation, still induces the 
B cell to enter a transitional state which is characterised by an increase in 
expression of MHC class II antigens (Klaus et al., 1984). A short lived 
breakdown of phosphatidylinositol polyphosphates (PtdInsP3) has been 
reported which is sufficient to increase the concentration of calcium in the cell 
and may be enough to allow IL-4 to act as a costimulant (OGarra et al.,
1987). Ligand binding to antigen activates phosphoinositide hydrolysis 
which results in the generation of two second messengers, inositol 
trisphosphate (IP3) and diacylglycerol (DAG). Coupling of the receptor to 
PtdInsP2  hydrolysis is via a guanine nucleotide binding (G) protein. It has 
recently emerged that the co-crosslinking of slg and FcRII on B cells 
uncouples the antigen receptor from the G protein (Harnett & Klaus, 1988; 
Rigley et al., 1989). Uncoupling of the receptor from the G protein means
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that there is no enhancement of PtdInsP2  hydrolysis and, therefore, no 
second messenger or signal transduction. This results in abortive activation. 
To overcome this inhibition, IL-4 must be substituting for this loss perhaps 
by acting through a different mechanism or by stimulating the same or a 
different G protein from that associated with the antigen receptor.
1.8.4. IL-4 Induces Expression of the Low Affinity Receptor 
for IgE
On activation of B cells several new molecules are expressed on the B 
cell surface. One of the earliest is a 45 kDa protein which has been identified 
as the low affinity receptor for IgE (FcRe or CD23) (Walker et al., 1986). 
Hudak et al (1987) demonstrated that murine rIL-4 increased the expression 
of FcRe on splenic B cells 2-3 fold and 6  fold on a B cell hybridoma. 
Induction of FcRe (CD23) on human B cells by human IL-4 has also been 
shown (Defrance et al., 1987a). In both cases IL-4 induced expression of 
FcRe/CD23 was inhibited by Ifn-y (Bonnefoy et al., 1988; Hudak et al.,
1987). IgE itself has been shown to upregulate FcRe by binding to the 
receptor and preventing turnover of the receptor and so allowing newly 
synthesised receptor to accumulate on the surface of the B cell (Lee et al., 
1986b). IL-4 appears to enhance receptor expression by increasing 
transcription (Cairns etal., 1988).
Cloning of the human cDNA encoding CD23 has revealed that the N 
terminus of the receptor is found in the cytoplasm and the C terminus outside 
the cell (Yokota et al., 1988). CD23 appears to have two different functions. 
CD23 acts as a differentiation antigen which is expressed on mature B cells 
but is lost after isotype switching. This suggested that CD23 plays a role in 
growth and differentiation of B cells and reports of sCD23 acting as an 
autocrine growth factor for B cells have confirmed this (Gordon et al.,
1988). Membrane FcRe/CD23 can be cleaved, possibly by proteolytic 
hydrolysis, to release a soluble molecule of 35 kDa which is subsequently
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further cleaved to 25 kDa. Soluble FcRe (sFcRe) can bind IgE. Bonnefoy et 
cd (1988), using monoclonal antibodies that could bind to soluble FcRe, 
developed a radioimmunoassay that demonstrated that as well as enhancing 
membrane FcRe expression IL-4 could also induce the release of sFcRe from 
normal B cells. This action was strongly inhibited by Ifn-y which suggests 
that the action is specific to IL-4.
The second function of FcRe is its role in IgE production and 
importance in parasitic infections. Studies in both murine and human systems 
have indicated that B cells with low affinity receptors for IgE release factors 
that modulate IgE production, and sCD23 has been shown to act with sub- 
optimal concentrations of IL-4 to increase IgE synthesis (Pene et al., 1988a). 
FcRe are found on eosinophils, monocytes and B cells which are all cells 
involved in the IgE response to parasitic infection. Secondly IL-4, which 
regulates IgE production, enhances the expression of FcRe on B cells and 
monocytes (DeFrance et al., 1987a).
Yokota et al (1988) have recently addressed the question as to 
whether the two different functions of FcRe are exerted by the same molecule 
or different molecules. Comparison of antigenicity and the mRNA structure 
of FcRe in B cells, monocytes and eosinophils showed that two different 
species of FcRe existed which differed only in their N terminal amino acid 
sequence. One form of FcRe is expressed only in B cells and is expressed 
constitutively. Die second molecule is found on B cells and monocytes but 
only in response to IL-4. The second molecule is thought to be responsible 
for IgE production. The observation of the existence of two different FcR e 
helps to some extent to explain how apparently the same molecule can have 
two different functions.
1.8.5. IL-4 Induces Secretion oflgGl and IgE from B Cells
In the mouse the addition of several different lymphokines has been 
shown to induce changes in the Ig isotype secreted (Snapper et al., 1988a).
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Resting B cells express IgM and IgD on their surface and, upon culture with 
LPS, IgM is the predominant isotype secreted. LPS treated B cell blasts that 
express membrane IgG3 and membrane IgG2b, although in the minority, 
secrete significant amounts of IgG3 and IgG2b. IgGl and IgG2a secretion is 
low and IgE is undetectable. The addition of IL-4 to LPS treated B cells 
promotes the secretion of IgGl and IgE and partially supresses IgG3 and IgM 
(Vitetta et al., 1985; Sideras et a l, 1985a/b; Noma et al., 1986; Isakson,
1986). Other lymphokines that selectively stimulate secretion of specific 
isotypes are Ifn-y which promotes IgG2a production (Snapper et al., 1988c) 
and IL-5 which has been reported to stimulate IgA secretion (Mosman & 
Coffman, 1987).
The induction of IgG 1 and IgE are differentially regulated (Snapper 
et al., 1987). IL-4 stimulates IgGl in a bimodal fashion. Addition of 
increasing amounts of IL-4 to LPS treated B cells dramatically increases IgGl 
production peaking at 100 units/ml IL-4. Beyond this concentration, between 
600-1000 units/ml IL-4 there was no induction of IgGl, then above 
concentrations of 1000 units/ml IL-4 IgGl production was again stimulated. 
Enhancement of IgE production by IL-4 required higher concentrations, no 
enhancement of IgE was seen until 100 units/ml of IL-4 was present and 
induction was maximal at 10,000 units/ml. IgGl and IgE secretion are, 
therefore, regulated differently. Studies with IL-4 on resting B cells 
demonstrated that IL-4 had preparatory effects on resting B cells which did 
not involve cellular proliferation. When resting B cells were cultured in the 
presence of IL-4 alone for 48 hours then washed and LPS added IgG 1 
secretion was enhanced but the presence of IL-4 after the 48 hours was 
inhibitory. IgE secretion although requiring the preparatory effects of IL-4 
also required IL-4 after the 48 hours suggesting a two phase regulation 
(Snapper et a l, 1987). These results suggest that IL-4 and LPS are acting 
on the B cells independently of each other perhaps through different 
intracellular pathways.
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Snapper et al (1988b) have reported an increase in the number of B 
cells expressing membrane IgGl and IgE after 4 days of culture with LPS and 
IL-4. Cell sorting analysis indicated that B cells expressing IgGl and IgE on 
the surface secreted these Ig isotypes. Co-expression of membrane IgGl and 
IgE on B cells has also been observed but the B cells do not appear to secrete 
both isotypes simultaneously (Snapper et al., 1988b).
IL-4 can act on IgGl" B cells to induce secretion of IgGl. Therefore, 
IL-4 promotes Ig class switching rather that promoting the proliferation and 
differentiation of B cells expressing membrane IgGl (Isakson et al., 1982). 
The concentration of IL-4 needed to promote isotype switching is greater than 
that observed for the other effects on B cells. It may be possible to obtain the 
high concentrations of IL-4 that are needed at the site of T-B cell interactions 
where the local concentration of IL-4 could be high and may be directionally 
secreted from the T cell to the B cell (Kupfer et al., 1986). IL-4 induced 
isotype switching has been shown to be relevant in vivo. The IgE response 
was demonstrated invivo by Finkelman et al (1986). Mice that were 
infected with the larvae of the helminth Nippostrongylus brasiliensis had a 
100 fold increase in serum IgE which could be inhibited in the presence of 
anti-IL-4 antibody. This suggests that IL-4 plays a role in the biosynthesis of 
IgE in vivo.
It has been reported that IL-4 induces IgE secretion in normal human 
B cells fom peripheral blood and tonsils and a low induction of IgG is also 
observed (Pene et al., 1988a). Although no polyclonal activator was present 
in these experiments the presence of monocytes and T cells was required 
which suggests that factors other than IL-4 were needed. IL-5 enhanced IL-4 
induced IgE production particuarly at sub optimal levels of IL-4 (Pene et al, 
1988b). IL-5 alone was ineffective and IL-4 inhibited the induction of IgA by 
IL-5. These results are consistent with reports in murine systems of murine
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IL-5 augmenting IL-4 stimulation of IgE in LPS activated B cells (Coffman 
et al., 1987). The IL-4 induced IgE response was inhibited by Ifn-y and by 
F(ab) 2 fragments of anti-CD23 antibody (Pene et al., 1988a). This 
observation is particuarly interesting as IL-4 has been reported to enhance the 
expression of membrane CD23 on B cells and induce its release as a soluble 
25 kDa molecule. The sCD23 has been demonstrated to enhance IL-4 
induced IgE synthesis at sub-optimal concentrations of IL-4 although sCD23 
alone is ineffective. Safarti et al (1984) reported that sCD23 augments 
ongoing IgE synthesis by B cells from atopic individuals. There is a 
relationship between CD23 expression, release and the production of IgE but 
the mechanism at present is unclear.
1.9. Interferon-y: A Potent Inhibitor of IL-4 Action on B
Cells
Interferon-y (Ifn-y) inhibits the majority of the biological effects of 
IL-4 on B cells in both mouse and human systems (Rabin et al., 1986b;
Mond et al, 1986). It does not appear to affect the action of IL-4 on other 
cell types but is specific to B cells. The proliferation of B cells in response to 
LPS is not affected by Ifn-y and neither is the increase in cell volume and 
increase in expression of MHC classll antigens induced by anti-Ig. Ifn-y is, 
therefore, exerting its effect directly on IL-4 responses. Ifn-y is most 
effective when added simultaneously with IL-4 and has been shown to inhibit 
IL-4 induced increase in MHC class II expression, increase in cell volume, 
FcRe/CD23 expression, the costimulatoiy effect with anti-Ig and promotion 
of IgGl in the mouse and IgE secretion in both mouse and human (Mond et 
al., 1986; Rabin et al., 1986b; Rousset et al., 1988). Although Ifn-y has a 
number of inhibitory effects on antibody production it also has some 
stimulatory responses. Ifn-y can induce MHC antigen expression on 
macrophages and B cell tumours (Mond et al., 1986). It has been reported 
that IL-2 can synergise with Ifn-y to enhance B cell differentiation (Sidman et 
al, 1984; Nakagawa et al., 1985). Romagani et al (1986b) have observed
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Ifn-y acting as a costimulator with anti-IgM to drive human tonsillar cells to 
DNA synthesis although this could be explained if the cells were not resting. 
There has also been reports of Ifn-y acting on resting B cells. Culturing 
resting B cells with Ifn-y enhances the secretion of IgG2a on subsequent 
culture with LPS (Snapper et al., 1988c). The enhancement of IgG2a 
appears to work in a similar manner to IL-4 inducing IgGl secretion. IL-4 is 
inhibitory to the induction of IgG2a by Ifn-y. It therefore appears that there is 
a reciprocal regulation between IL-4 and Ifn-y. Lowenthal et al (1988) have 
demonstrated that there is no decrease in binding of IL-4 to its receptor in the 
presence of Ifn-y. Ifn-y does not act by binding to the IL-4 receptor or by 
preventing binding of IL-4 itself. Perhaps it is the intracellular signals 
produced by IL-4 on binding to its receptor that are disrupted by Ifn-y, 
although the signal transduction of both pathways are unclear. The mutually 
exclusive effect of IL-4 and Ifn-y may have a functional significance in that 
together they can regulate the B cell immune response.
Recently, proposals have been made that murine helper T cells can be 
subdivided into two classes, Thl and Th2 (Mosman & Coffman, 1987). 
Looking at a wide range of T cell clones it was observed that they could be 
subdivided on the basis of the lymphokines that they produced. Thl cells 
produce IL-2, Ifn-y and lymphotoxin, whereas Th2 cells produce IL-4 and 
IL-5. Both types of cells can secrete IL-3 and GM-CSF. The two types of 
helper T cell proliferate in response to antigen and T cell growth factors in the 
same manner and no difference in surface markers has been identified. 
Therefore the interaction of a T cell subset (Thl or Ih2) would determine 
whether IL-4 or Ifn-y was produced and hence determine the response 
elicited A cellular basis for this hypothesis would be in the regulation of 
isotype switch (Stevens et al., 1988). Stimulation of Th2 cells would release 
IL-4 which promotes IgGl and IgE secretion which are both needed to 
respond against parasitic infections. Stimulation of Thl cells on the other 
hand, would result in Ifn-y production which enhances IgG2a secretion.
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IgG2a is particuarly effective in responses against viral infections and is 
highly effective at complement fixation, opsonisation and antibody mediated 
cellular cytotoxicity by macrophages (Snapper et al., 1988c). This means 
that the sub division of helper T cells may be relevant in what type of infection 
the immune response is elicited against. The division of helper T cells into 
sub classes is not confirmed as some T cell clones do not fall into either class 
but secrete both IL-4 and Ifn-y. In vitro experiments with human T cells has 
so far failed to identify different sub classes of helper T cells such as those 
demonstrated in the mouse (Maggi et al., 1988) and these sub classes have 
also not been identified in vivo. It is therefore some what controversial as to 
whether the divisions of helper T cells exist or are relevant in vivo.
1.10. Receptors for Interleukin 4
Receptors for IL-4 have been identified by the binding of 
radiolabelled [^^I]-IL-4 to IL-4 responsive cells (Lowenthal et al., 1988; 
Park et al .,1987a; Park et al., 1987b; Ohara & Paul, 1987). EL-4 receptors 
have been identified on several haematopoetic cells including B and T 
lymphocytes, mast cells and macrophages (Ohara & Paul, 1987) and also on 
cells from non haematopoetic lineage (Lowenthal et al., 1988). The finding 
of IL-4 receptors on a wide range of cell types is consistent with the wide 
range of biological activities reported for IL-4. Resting B cells express low 
levels of receptor. Binding experiments on high density resting B cells from 
DBA/2 and C57BL/6J have reported numbers of 65 (Park et al., 1987a) and 
311 (Ohara & Paul, 1987) IL-4 receptors per cell, respectively. The number 
of receptors is increased 5-10 fold on activation of the cells with LPS (320 
IL-4 receptors/cell in C57BL/6J mice and 1511 receptors/cell in DBA/2 mice), 
and also with anti-IgM (1560 receptors/cell in DBA/2 mice). The same was 
found on human cells, where resting B cells from peripheral blood expressed 
140 receptors/cell which was increased to 710 receptors/cell on treatment with 
PHA (Park et al., 1987b). IL-4 receptors are also increased on culturing 
with IL-4 itself. Upregulation of the receptors is detectable within six hours
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and is maximal at eighteen hours (Ohara and Paul, 1987). This observation 
helps to explain the fact that IL-4 has effects on resting B cells. Continuously 
proliferating cell lines in both mouse and human express high numbers of IL- 
4 receptors.
Binding of [12^1]-IL-4  to its receptor was specific and only excess 
unlabelled IL-4 and 1 IB 11, an antibody to IL-4, could prevent IL-4 binding 
to its receptor. Human IL-4 could not inhibit the binding of murine IL-4 to 
the murine IL-4 receptor and vice versa, which is consistent with the finding 
that no murine IL-4 receptors were found on human cells and no human 
receptors on mouse cells. IL-1, IL-2, IL-3, Ifn-y, anti-LFA-1, anti-Lyb2 and 
several other growth factors did not compete with IL-4 for binding to the 
receptor. Ifn-y, although it inhibits many of the biological effects of IL-4, 
does not bind to the IL-4 receptor, nor does it prevent the binding of IL-4 
and, therefore, must exert its effect after receptor binding. It has been 
reported that anti-LFA-1 (Mishra et al., 1986) and anti-Lyb2 (Subbarao and 
Mosier, 1983) could substitute for IL-4 in some of its biological functions and 
it was proposed that these molecules may be the receptor for IL-4.
Arguments against this are that IL-4 has effects on both LFA-1" and Lyb2" 
cells and neither monoclonal antibodies can inhibit the binding of IL-4. It is, 
however, still possible that these molecules are indirectly involved in IL-4 
binding to its receptor.
Kinetic studies indicated that the IL-4 receptor exists as a single class 
of high affinity receptor (Park et al., 1987a; Park et al., 1987b; Ohara and 
Paul, 1987). The existence of a lower affinity receptor cannot be excluded 
due to the concentration of ligand used in these experiments. The binding of 
IL-4 to its receptor was rapid and saturable at 4°C and 37°C. Maximum 
binding of was achieved within 20  minutes with a t j /2  of 1-2
minutes in the mouse (Park et al., 1987a) and less than 30 minutes in the 
human (Park et al., 1987b). The dissociation was slow with a i\/2 of 4
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hours (Lowenthal et al., 1988) exhibiting a biphasic pattern corresponding to 
a fast and slow dissociating component. Lowenthal et al (1988) have 
demonstrated in HT-2 cells, a T helper cell line, that the receptor and ligand 
are rapidly internalised which is thought to be an initial step in signalling. It 
was found that the cells could internalise and accumulate more molecules of 
[125j]_iL-4 than the number of receptors expressed on the surface of the cell 
at any one time. This suggested that the internalised IL-4 receptors were 
either re-cycled, new receptors were synthesised, or a pool of pre-synthesised 
receptors existed which were not at the cell surface. Which of these 
possibilities is correct still remains to be elucidated.
Affinity crosslinking experiments where [*2^1]-IL-4  bound to 
receptors was crosslinked using bifunctional agents have identified the IL-4 
binding components of the receptor. In the mouse, using DBA/2 mice, Ohara 
and Paul (1987) have identified a component with a molecular weight of 80 
kDa which, when the molecular weight of IL-4 (20 kDa), was deducted gave 
a molecular weight of 60 kDa. Park et al (1987a), using five different cell 
lines which expressed IL-4 receptors, identified a crosslinked species of 
molecular weight 124 kDa. The IL-4 was hyperglycosylated and had a 
molecular weight of 49 kDa which left an IL-4 binding component of 75 kDa. 
Crosslinking studies have been performed on two human cell lines, Raji and 
gingival fibroblasts (Park et al., 1987b). Both cell types showed a 
crosslinked component of 154 kDa, which represented a binding component 
of 139 kDa. Recently Galizzi etal (1988) performed affinity crosslinking 
experiments using [125]]-IL-4 on a human burkitt lymphoma cell line, Jijoye, 
and identified two IL-4 binding components; 140 kDa equivalent to that found 
by Park et al (1987b) and a 70 kDa component The murine IL-4 receptor 
from B cells has now been cloned and the nucleotide sequence determined and 
the estimated molecular weight for the receptor is 140 kDa (Drs D. Cosman 
and S. Gillis, Immunex Group, USA. personnal communication). As the IL- 
4 binding component in human cells has been estimated to be 139 kDa (Park
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et al., 1987b) it may be therefore, that the receptors for IL-4 are of similar 
size in the murine and human system. At present the human IL-4 receptor has 
not been isolated and therefore, it is unclear whether the IL-4 binding 
components represent the whole IL-4 receptor or only a subunit which binds 
IL-4. The IL-4 binding component in the mouse was found to be 75 kDa, but 
this may have been a result of protease action as a 70 kDa component was 
also identified in human cells under certain conditions. It was not determined 
whether this 70 kDa protein was related to the 139 kDa IL-4 binding protein 
(Galizzi et al., 1988). IL-4 shows species specificity and, since IL-4 itself 
appears to have significant homology between species, differences may exist 
in the murine and human receptors. It may be that the receptor is composed 
of more than one protein and the overall structure could be similar between 
species with differences existing in the IL-4 specific binding protein.
1.11. Signal Transduction
A variety of molecules can participate in the activation of resting B 
cells. Each molecule has different biological effects on the B cell and a unique 
receptor through which it acts. This suggests that each molecule may have a 
distinct mechanism of intracellular signalling and the overall activation of a B 
cell may require the initiation of several of these pathways in a particular 
combination. There have been numerous reports detailing mechanisms of 
signal transduction in non lymphoid tissue. It appears from these studies that 
a variety of ligands binding to unique receptors and eliciting a wide variety of 
biological responses have common pathways of signal transduction.
Sutherland and Rail (1958) were the first to propose the concept of second 
messengers. This allows the rapid changes in cell metabolism, that are 
observed on ligand binding to receptor, by the functional modification of 
existing proteins. These functional modifications have been most notably 
acheived through phosphorylation of existing proteins which can either up or
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down regulate the activity of these proteins. Several pathways of 
transmembrane signalling have now been identified and these are now being 
investigated in lymphocytes.
4
There are three points in T dependent B cell activation where signals 
can be transduced; at the initial binding of antigen to membrane 
immunoglobulin; at the MHC restricted T-B cell interaction and at the 
interaction of the many lymphokines with their receptors (Snow and Noelle,
1987).
1.12. Antigen Binding To Membrane Immunoglobulin Activates
The PI Cyde
The first indication of the mechanism of transmembrane signalling 
involved when antigen binds to membrane immunoglobulin was the report by 
Maino et al (1975) that an increase in incorporation of [32 p] into 
phosphatidylinositol (PI) was observed in porcine B lymphocytes on 
activation with anti-Ig. Grupp et al (1987) have since reported an increase in 
PI metabolism using hapten-specific B cells. This suggested that the 
phosphatidyl inositol cycle may be involved in membrane Ig signalling. The 
PI response has been demonstrated in transmembrane signalling in a number 
of systems (Michell, 1982a; Michell, 1982b) including T lymphocytes (Fisher 
and Muller, 1968).
Further evidence for the involvement of the PI cycle in Ig signalling 
in B lymphocytes came from the observation that the tumour promoting 
phorbol diesters, eg. phorbol myristate acetate (PMA), could also increase the 
expression of MHC class II antigens on B cells (Monroe et al., 1984; 
Lindsten et al., 1984). Phorbol esters are known to activate protein kinase C
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(PKC) directly, replacing diacylglycerol and, indeed the receptor for PMA has 
been found to be PKC itself (Parker et al., 1984; Castagna et al., 1982). 
Further evidence for the involvment of PKC came from two reports; 
Coggeshall & Cambier (1984) reported a rapid rise, within 30 seconds to 1 
minute, in [32p] incorporation into PtdOH, a phosphorylated product of 
DAG, on stimulation with anti-Ig, and Bjisterbosch et al (1985) observed the 
rapid formation of diacylglycerol (DAG). Based on this it was hypothesised 
that signalling by membrane Ig involved the hydrolysis of Ptdlns, PtdlnsP 
and PtdInsP2  by phospholipase C (PLC) which results in the formation of 
diacylglycerol (DAG), the physiological activator of PKC, to stimulate PKC 
(Cambier & Ransom, 1987). Ransom et al (1986) and Bjisterbosch et al 
(1985) reported that release of L1SP3 is rapid while InsP2  and InsP is slower 
indicating that of all the polyphosphatidylinositol phosphates, PtdInsP2 is 
preferentially hydrolysed and this is consistent with observations made in non 
lymphoid systems.
In nearly all cases where ligand binding to receptor induced an 
increase in polyphosphoinositide hydrolysis, a rapid increase in intracellular 
free calcium has also been reported. Experiments loading cells with labelled 
calcium, [^C a^+], showed that anti-Ig induced a rapid increase in 
intracellular free calcium within minutes of stimulation. This was 
substantiated by the use of calcium indicator dyes (Braun et al., 1979,
Pozzan et a l , 1982). The release of calcium was not induced by PMA which 
suggested that PKC was not involved (Ransom & Cambier, 1986) but it was 
induced by PtdInsP2  hydrolysis. Again using permeabilised cells loaded with 
[45ca2+] it was shown that L1SP3  induced significant mobilisation of calcium 
from intracellular stores (Ransom et al., 1986).
Stimulation of B lymphocytes with anti-Ig was shown to induce a
32
rapid translocation of PKC, within 2 minutes, in both human (Nel et al.,
1986) and mouse (Chen et al., 1986) cells. DAG exerts its second 
messenger function by directly binding to and activating PKC. The binding 
of DAG to PKC increases the affinity of PKC for calcium and this mediates 
the redistribution of PKC to the plasma membrane. The activation of protein 
kinase C results in the phosphorylation of several cytosolic and membrane 
associated proteins on serine and threonine residues (Nishizuka, 1984). 
Phosphorylation of these proteins can influence cellular metabolism by 
altering the functional activities of the proteins which can result in a 
stimulatory or an inhibitory effect Enhanced or unique phosphorylation of 
several proteins associated with B cell plasma membranes has been 
demonstrated. Studies by several groups (Nel et al., 1986; Hombeck and 
Paul, 1986) showed that phosphorylation patterns of B cells were similar on 
treatment with either PMA or anti-IgM. This provides further evidence for the 
activation of PKC by anti-IgM. Burke et al (1989) have substantiated this by 
demonstrating that phosphorylation of the proteins was inhibited in the 
presence of PKC inhibitors. The molecular weights of these proteins range 
from 170 kDa to 15 kDa (Nel et al., 1986; Burke et al., 1989). The 
functions of the phosphorylated protein are unknown but they may play a role 
in B cell activation. Hombeck & Paul (1986) identified four of the seven 
phosphorylated proteins that they observed to be associated with the 
cytoskeleton. These results suggested that phosphorylation may play a role in 
the initial cytoskeletal reorganistaion which induces crosslinking of membrane 
immunoglobulin. One of the earliest events on treatment with anti-Ig is the 
crosslinking and reorganisation of receptors into patches or caps (Braun & 
Unanue, 1980). The crosslinked receptor is then internalised and degraded 
(Antoine et al., 1974). Aggregation of membrane Ig involves the attachment 
of the immunoglobulin to proteins in the cytoskeleton. Actin has been
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identified as being a protein involved in aggregation (Bourguigon et al.,
1978, Flanagan & Koch, 1978) and also immunoprecipitation of Ig has 
revealed attachment to a 50 kDa protein (Unanaue et al., 1971).
The consequence of anti-IgM stimulation of B lymphocytes is the 
induction of transcription of several genes. Transcription of the gene cfos is 
induced within 15 minutes, c-myc within 60 minutes and la within 120 
minutes (Cambier & Ransom, 1987). The signals that are transduced 
between the activation of protein kinase C and the induction of these genes are 
unknown. Several proteins have been identified as substrates for protein 
kinase C but as yet the function of these proteins has not been determined. 
The only event which occurs is the membrane depolarisation which is 
observed at 3 minutes and is maximal at 60 minutes and can be induced by 
agents which activate PKC (Monroe and Cambier, 1983b). Valinomycin, a 
potassium ionophore, inhibits both the membrane depolarisation and also the 
increase in MHC class II antigens. This suggests that membrane 
depolarisation is involved in the signalling of anti-Ig inducing expression of 
MHC class II antigens but, as yet, the precise mechanism is unclear.
In several signal transduction pathways, G proteins have been found 
to be involved in regulation (for a review see Harnett & Klaus, 1988). The 
proteins exist in an apy heterotrimeric structure. When GTP binds to the a  
subunit the GTP-a dissociates from the p and y and can directly modify the 
activity of its target The activation is terminated by conversion of GTP to 
GDP by the GTPase activity of the a  subunit which allows the reassociation 
of the a  subunit with the p and y. A role for G proteins has been implicated 
in the coupling of receptor to PtdInsP2  hydrolysis in several systems. It has 
been shown in B cells that slgM and slgD receptors are coupled to the
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polyphosphoinositide-specific phosphodiesterase (PPI-PDE) by a pertussis 
toxin insensitive Gp (Gold et al., 1987; Harnett & Klaus, 1988). Therefore 
binding of antigen to membrane Ig activates a PPI-PDE via a G protein. PDE 
then catalyses the hydrolysis of PtdInsP2  to InsP3 and DAG. InsP3 induces 
the release of calcium from internal stores which activates calcium calmodulin 
dependent protein kinase and also acts with DAG to activate PKC. The 
activation of PKC results in the phosphorylation of several proteins which 
leads to membrane depolarisation and the induction of transcription of several 
genes (summarised in figure 3).
1.13. Lipopolysacharide
In a study by Bijsterbosch et al (1985) two polyclonal activators,
LPS and PMA did not induce phosphoinositide hydrolysis or calcium 
mobilisation. Betel et al (1974) had earlier found that LPS did not stimulate 
incorporation of [-^P] orthophosphate into phosphatidylinositol. LPS does, 
however, induce the translocation of PKC (Chen etal., 1986) and also 
membrane depolarisation (Kiefer et al,, 1980). It is possible that LPS 
bypasses phosphatidylinositol degradation and calcium mobilisation and 
directly activates PKC as has been suggested by Wightman & Raetz (1984). 
PMA has been shown to activate PKC directly, substituting for DAG and 
PKC is the cellular receptor for PMA (Parker et al., 1984; Castagna et al.,
1982). It has now been shown that LPS activates a GTP binding protein 
(Jakeway & Defranco, 1986). The LPS response in WEHI-231, a B cell 
lymphoma, was inhibited by pertussis toxin, which inactivates a subset of G 
proteins. This result, combined with LPS inhibiting adenylate cyclase in 
P388D} cells, strongly suggests a role for a Gi receptor coupling protein. 
LPS, therefore by binding to a putative receptor activates a protein, Gi, 
which inhibits adenylate cyclase resulting in a decrease in cAMP levels. One 
of the consequences of decreased cAMP levels is an increase in the existing
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Figure 3 The Signals Transduced Upon Antigen Binding
Ligand binding to the antigen receptor activates phospholipase C (PLC) 
via a G protein. Phospholipase C catalyses the hydrolysis of 
phosphatidylinositol 4,5 bisphosphate (PtdInsP2 ) to yield two second 
messengers, diacylglycerol (DAG) and inositol 1,4,5 triphosphate 
(IP3). IP3 diffuses to the endoplasmic reticulum where it mediates the 
release of calcium (Ca++) from intracellular stores. Calcium may act 
through calmodulin to activate calcium/calmodulin dependent protein 
kinases but it also acts in concert with DAG to mediate the translocation 
of protein kinase C (PKC) to the plasma membrane. Protein kinase C 
via phosphorylation can alter the functions of several proteins.
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PtdInsP2  hydrolysis as cAMP is an inhibitor of this pathway.
1.14. Signals Transduced upon Ifn-y Binding to its Receptor
Interferon-y (Ifn-y) is a potent inhibitor of the majority of the 
biological effects of IL-4 on B lymphocytes. This inhibition is not a result of 
binding to the IL-4 receptor or preventing binding of IL-4. It is therefore 
interesting to consider the signal transduction pathways activated by IL-4 and 
Ifn-y.
Experiments using bifunctional reagents to crosslink [125l]-Ifn-y t0  
several human cell types have identified a binding component of 105-130 kDa 
(Pestka et al., 1987; Rubinstein et a l , 1987), although, a larger component 
of 160-180 kDa was found on monocytes (Fischer et al., 1989). On murine 
cells a slightly smaller Ifn-y binding component of 90-110 kDa was 
determined (Wietzerbin et al., 1986; Mariano et a l , 1987). Little is known 
of the initial events of cellular activation by Ifn-y, although in human U937 
cells, a monocyte cell line, rapid changes in intracellular calcium and 
membrane potential was reported (Klein et a l , 1987a; Klein et a l, 1987b). 
Ifn-y also caused redistribution of PKC in these cells within 10 minutes, and 
the transcription of several Ifn-y induced genes was blocked by inhibitors of 
PKC (Fan et a l, 1988). A role for intracellular calcium mobilisation and 
PKC has been inferred in the activation of murine macrophages with Ifn-y 
(Celada and Schreiber, 1986). Binding of Ifh-y to the human Ifn-y receptor 
has been demonstrated by immunoprecipitation to result in the 
phosphoiylation of the receptor (Mao et a l, 1987). Cambier & Ransom 
(1987) reported that Ifn-y and anti la antibodies, which have similar biological 
effects to Ifn-y, did not induce phosphatidylinositol hydrolysis or calcium 
mobilisation in B cells. It was noted, however, that the biological effects of
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anti-la and Ifn-y were similar to agents such as dibutyrl cAMP (dbcAMP), 
forskolin and cholera toxin. These agents are all known to elevate cAMP 
levels and it was hypothesised that anti-la and Ifn-y may act in this manner ie. 
a p adrenergic like mechanism. Further evidence for this hypothesis came 
from the observation that anti-la antibodies induced a three fold increase in 
cAMP within 60 seconds in B cells. It was also reported that both anti-la and 
dbcAMP induce translocation of PKC to the nuclear envelope (Chen et al.,
1986). Recently Ostrowski et al (1988) observed that Ifn-y induced the 
translocation of PKC from the cytosol to the membrane in a pre B cell 
line,70Z/3. This activity was observed 20 minutes after stimulation and was 
not required for the enhanced Na+/H+ exchange demonstrated in these cells 
on treatment with Ifn-y. The redistribution of PKC observed in other systems 
after stimulation of phosphatidylinositol hydrolysis is rapid (within two 
minutes).
The signals transduced when Ifn-y binds to its complementary 
receptor appear to involve an increase in cAMP levels and a translocation of 
PKC but how these two events are connected is unclear. It may also be that 
different pathways of activation are used by different cell types.
1.15. Phosphotyrosine
Until recently, the only acid stable phosphoamino acids known were 
phosphoserine and phosphothreonine, but phosphorylation on tyrosine 
residues is now emerging as an important protein modification. 
Phosphotyrosine only accounts for 0.05% of the total acid stable phosphate in 
proteins while phosphothreonine and phosphoserine account for 
approximately 10% and 90% respectively (Sefton et al., 1980). Despite this, 
protein tyrosine kinases are emerging as important regulatory enzymes.
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Phosphotyrosine was first discovered as the product of a kinase activity that 
was associated with the retroviral transforming proteins (Eckhart et al., 1979; 
Hunter & Sefton, 1980). This was substantiated when it was discovered that 
cells infected with certain retroviruses contained ten times the amount of 
phosphotyrosine of uninfected cells (Sefton et al., 1980). Due to the 
discoveiy that tyrosine phosphoiylation was associated with the transforming 
proteins of several RNA tumour viruses, it was hypothesised that it might be 
essential for transformation. Cells that were infected with virus mutants that 
were temperature sensitive for transformation showed that the increase in 
phosphotyrosine was correlated to transformation (Sefton et al., 1980). 
Phosphotyrosine is not unique to retroviruses, but has also been detected in 
some cellular proteins and the receptors for several growth factors possess a 
tyrosine specific kinase activity. In many cases where cells are infected with 
retroviruses or treated with growth factors, tyrosine phosphorylation is the 
first detectable event. The fact that tyrosine phosphorylation plays a role both 
in viral transformation, which leads to unrestricted growth, and in the action 
of several growth factors suggests that it has a function in growth control.
1.15.1 Association o f Phosphotyrosine with RNA Tumour
Viruses
Genetic evidence indicates that the protein product of a single gene is 
sufficient to induce transformation of a virally infected cell to a malignant state 
(Bishop, 1983). This suggests that a single protein can induce a number of 
alterations to a cell. Rous sarcoma virus (RSV) is a sarcoma-causing virus of 
chickens. The virus has four genes, three which code for viral structural 
proteins and the other gene, v-src, which is responsible for transformation of 
the host cell (Copeland et al., 1980). V-src codes for a phosphoprotein of 
60 kDa, pp60v'5rc. This protein was found to be tightly associated with a 
protein kinase activity in vitro which was specific for tyrosine residues
(Collett & Erikson, 1978; Levinson et al., 1978). It has now been shown 
that pp60v“jrc itself possess the ability to transfer phosphate from ATP to 
tyrosine residues on proteins (Gilmer & Erikson, 1981; McGrath & 
Levinson, 1982). This was the first evidence that tyrosine phosphorylation 
was associated with the transforming gene product of RNA tumour viruses.
The major substrate of the pp60v'5rc protein tyrosine kinase was 
pp60v'src itself (Erikson et al., 1979; Collett et al., 1983). The 
autophosphoiylation appeared to enhance the activity of the tyrosine kinase. 
The major site of phosphorylation in vivo was on tyrosine 416 in the carboxy 
terminal region (Smart et al., 1981) although some phosphorylation has been 
observed on serine 17. This latter phosphorylation is believed to be due to 
cAMP dependent protein kinase (Collett et al., 1979; Cross & Hanafusa,
1983). Early studies suggested that phosphorylation at tyrosine 416 may be 
responsible for transformation. This was disputed by studies using site 
directed mutagenesis to replace tyrosine 416 with either phenylalanine 
(Snyder et al., 1983) or a short linker sequence (Cross & Hanafusa, 1983). 
This demonstrated that even without phosphorylation on tyrosine 416 the 
kinase was still active and the cells transformed. This does not mean that 
tyrosine phosphorylation plays no role in transformation as tyrosine 
phosphate, although reduced, was not totally absent due to phosphorylation 
of other tyrosine residues in pp60v_,yrc.
Pp60v‘*s'rc was identified as an integral plasma membrane protein 
exposed at the inner membrane surface (Levinson et al., 1981). Despite this, 
•pp60v'src is synthesised on free ribosomes (Lee et al., 1979; Levinson et 
al., 1981) and released as a cytoplasmic protein. In the cytoplasm pp60v'  
src is associated with two proteins p89 and p50 (Hunter and Sefton, 1980).
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It is then transported to the plasma membrane where it dissociates from the 
proteins and associates with the plasma membrane (Hunter and Sefton, 
1980). The cytoplasmic form of pp60v"5rc has little tyrosine kinase activity 
(Courtneidge & Bishop, 1982).
The transforming proteins of several other retroviruses have since 
been shown to possess protein tyrosine kinase activity. The transforming 
protein of Abelson murine leukemia virus (A-MuLV) is a 120 kDa integral 
plasma membrane protein spanning the lipid bilayer (Witte et al., 1979). In 
cells transformed with A-MuLV there is a ten fold increase in total cell 
phosphotyrosine and in vivo p i208a8~a^  was phosphorylated on serine, 
threonine and tyrosine residues. Immunoprecipitation of pl20£a£‘fl^  has 
revealed a tyrosine specific protein kinase activity of which the major 
substrate was pl20£fl£ 'fl^  (Witte et al., 1980).
V-fps (an oncogene of chicken sarcoma viruses) and v-fes (an 
oncogene of feline sarcoma viruses) are proteins which are structurally, 
functionally and immunologically related (Beemon, 1981). Transformation 
by these proteins results in an increased phosphotyrosine content in cells 
(Cooper & Hunter, 1981a/b) and the proteins themselves possess a protein 
tyrosine kinase activity which results in autophosphorylation. These 
retroviral tyrosine kinases, like other retroviral transforming proteins, have 
been found to be associated with the plasma membrane.
V-yes from chicken sarcoma viruses has properties which are similar 
to pp60v-,src. It phosphorylates tyrosine and serine residues in vivo and 
tyrosine residues in vitro (Kawai et al., 1980; Ghysdael et al., 1981).
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The only non retroviral transforming protein which was reported to 
be associated with tyrosine kinase activity in vitro is the middle T antigen of 
polyoma virus (Smith et al., 1979; Eckhart et al., 1979; Schaffhausen & 
Benjamin, 1979). Results now suggests that this tyrosine kinase activity is 
unlikely to be intrinsic to the middle T antigen as transformed cells contain no 
more phosphotyrosine than untransformed cells (Sefton et al., 1980) and 
middle T antigen prepared by in vitro translation of polyoma specific mRNA 
has no protein kinase activity. The discovery that pp60c'src is stably 
associated with the middle T antigen in cell lysates suggests that this may have 
been the kinase responsible for the phosphorylation of middle T antigen 
observed in vitro (Courtneidge & Smith, 1984).
If protein tyrosine kinases play a role in viral transformation which 
leads to unrestricted growth they may play a role in the control of normal cell 
growth. This was substantiated by the fact that retroviral transforming genes, 
oncogenes, are derived from host sequences during the life cycle of the 
retrovirus. The cellular genes are termed proto oncogenes. A relationship 
between viral and cellular genes has been substantiated by the finding that the 
cellular homologue of pp60v-5rc, ppbO*7"5^ ,  is structurally similar to the 
viral protein (Takeya & Hanafusa, 1983). Pp60c",src has been conserved 
through evolution and was found to be expressed in every vertebrate species 
examined, suggesting that it may have an essential function in cellular 
metabolism (Bishop & Varmus, 1982). pp60c‘5rc was identified as having a 
protein tyrosine kinase activity in vivo and is itself phosphoiylated on serine 
and tyrosine residues (Collett et al., 1979; Hunter & Sefton, 1980) which 
suggests that tyrosine phosphorylation may be involved in the control of 
normal cell growth. Transformation does not result from an overexpression 
of pp60c_,S7r as cells that had ten times the amount of pp60c'src had a 
normal morphology (Parker et al., 1984; Iba et al., 1984). Therefore,
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differences must exist between pp60v-5rc and pp60c",src, perhaps in enzyme 
activity or substrate specificity.
1.16. Phosphotyrosine in Normal Cell growth
Further evidence for the involvment of tyrosine kinases in cell growth 
has come from the finding that several receptors for mitogenic hormones 
possess intrinsic protein tyrosine kinase activity.
1.16.1 Platelet Derived Growth Factor
Platelet derived growth factor (PDGF) is the major growth factor in 
serum for cells of connective tissue origin and cultured glial cells (Deuel & 
Huang, 1983). Binding of PDGF to its receptor induces membrane ruffling, 
reduction in cell adhesion, changes in the actin cytoskeleton structure and an 
overall increase in mitotic activity (Deuel & Huang, 1983; Ek et al., 1982). 
Cooper et al (1982) demonstrated that stimulation of cells with PDGF caused 
a two fold increase in total cell phosphotyrosine. Evidence from both in vitro 
and in vivo studies have shown that a protein tyrosine kinase activity is 
activated upon PDGF binding to its receptor (Frackelton et al., 1983). 
Phosphorylation is rapid, occuring within five minutes, and the major protein 
phosphorylated has a molecular weight of 170-180 kDa which corresponds to 
the PDGF receptor itself (Ek & Heldin, 1982; Ek et al., 1982; Nishimura et 
al., 1982). Further evidence for the phosphorylation of the PDGF receptor 
has come from in vivo studies labelling PDGF stimulated fibroblasts with 
[32p]-phosphate. Immunoprecipitation of proteins with anti phosphotyrosine 
antibodies revealed several tyrosine kinase substrates, but the major 
phosphorylated protein corresponded to the PDGF receptor. The protein 
tyrosine kinase appears to be its own substrate and this is consistent with 
other systems where protein tyrosine kinases are involved.
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In the case of PDGF there is a strong correlation between PDGF 
binding, phosphorylation and the biological response induced by PDGF. The 
time for maximum phosphoiylation to be reached and maximum binding are 
similar as are the concentrations of PDGF required for half maximum binding 
and tyrosine phosphorylation (Cooper et al., 1982; Frackelton et al., 1984). 
DNA synthesis has also been shown to correlate well to PDGF binding and 
phosphorylation (Huang et al., 1982). The data are consistent with PDGF 
receptor kinase being the mediator of PDGF induced mitogenesis.
1.16.2Epidermal Growth Factor
Epidermal growth factor (EGF) elicits a wide variety of cellular 
responses some occuring rapidly and others taking several hours, all of which 
culminate in the cell entering mitosis (Staros et al., 1985). The most rapid 
response to EGF is the stimulation of a protein tyrosine kinase intrinsic to the 
EGF receptor itself (Cohen et al., 1982). Two domains exist on a single 
polypeptide of the EGF receptor, one corresponding to the EGF binding site 
and the other to the EGF stimulated tyrosine kinase. In vitro studies 
following the incorporation of [32p] from y-[^P]-ATP into A431, a cell line 
derived from a human epidermoid carcinoma, membrane proteins stimulated 
with EGF revealed the major substrates of the EGF stimulated tyrosine kinase 
to be proteins of molecular weight 150 kDa and 170 kDa (Carpenter et al., 
1978). The 170 kDa protein has been identified as the EGF receptor and the 
150 kDa protein is a product of receptor degradation (Cohen et al., 1982). 
Receptor autophosphorylation occurs on tyrosine residues 1068,1148 and 
1173 at the carboxy terminus of the protein ( Downward et al., 1984a/b). 
Other substrates have been identified for the EGF stimulated tyrosine kinase 
which include several cytoplasmic proteins but their functions have not yet
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been elucidated. The EGF tyrosine kinase is also capable of phosphorylating 
exogenous substrates.
A relationship between the EGF receptor kinase and mitogenesis is 
unclear and no direct correlation exists between receptor phosphorylation and 
DNA synthesis (Hunter & Cooper, 1981). One consequence of 
autophosphoiylation of the receptor might be the enhancement of the EGF 
kinase activity (Staros et al., 1985) which is consistent with the insulin 
receptor (Rosen et al., 1983). Autophosphoiylation may play a role in 
regulating the affinity of the receptor for hormone. It was observed that 
addition of tumour promoters to several cell types resulted in a loss of EGF 
binding and this was due to a decrease in the affinity of the receptor for EGF 
(King and Cuatrecausas, 1982; Friedman et a l , 1984). The loss of binding 
was accompanied by an increase in phosphothreonine and phosphoserine 
content of the receptor and a decrease in phosphotyrosine. It has been 
reported that tumour promoters replace diacylglycerol to activate the calcium- 
phospholipid dependent protein kinase C which phosphorylates proteins on 
serine and threonine residues (Nishizuka, 1984). Further evidence for the 
involvement of protein kinase C came from in vitro studies which 
demonstrated that PKC could phosphorylate the EGF receptor on the same 
threonine residue that was found to be phosphorylated in intact cells, 
threonine 654 (Hunter et a l, 1984). It was suggested from these studies that 
PKC might be a regulator of EGF receptor tyrosine kinase, acting in a 
negative feedback manner. These results are consistent with the observation 
that EGF stimulates phosphatidylinositol turnover which results in the 
activation of PKC (Moolenaar et a l , 1984). p adrenergic agonists that 
elevate cAMP levels, resulting in the activation of cAMP dependent protein 
kinase have also been shown to inhibit EGF binding (Pessin et al., 1983).
In vitro studies have demonstrated that cAMP dependent protein kinase can
phosphorylate the EGF receptor on serine in the presence of EGF but these 
results have not been confirmed in vivo (Ghosh-Dastidar and Fox, 1984).
1.16.3Insulin and Insulin Like Growth Factor
Insulin initiates a series of biochemical events (Czech, 1977) 
involving phosphorylation and dephosphoiylation of several enzymes 
(Cohen, 1982). The insulin receptor consists of two a , 135 kDa, subunits 
and two p, 95 kDa, subunits linked by disulphide bonds. The a  subunit 
binds insulin and the p subunit has been shown to bind ATP acting as an 
insulin stimulated tyrosine specific protein kinase (Kasuga et al., 1983). The 
kinase domain of the insulin receptor has similarities to the EGF receptor and 
the src family of protein kinases (Houslay, 1981). The major substrate of the 
kinase activity of the P subunit is the 95 kDa P subunit itself (Kasuga et al.,
1983). The autophosphoiylation of the receptor has been reported to enhance 
the tyrosine kinase activity and this may overcome the need for the continuous 
presence of insulin (Yu & Czech, 1984). In vivo the P subunit is 
phosphorylated on serine in the basal state and treatment with insulin 
enhances phosphorylation of serine and induces tyrosine phosphorylation 
(Kasuga et al., 1982).
Evidence for a role for tyrosine phosphorylation in insulin action 
comes from a mutant cell line which shows no receptor phosphorylation and 
fails to respond to insulin (Haring et al., 1984). Involvement of 
phosphotyrosine in insulin action is substantiated by the observation that 
tumour promoters which inhibit the insulin stimulated tyrosine kinase also 
inhibit a number of insulin mediated effects (Takayama et al., 1984). 
Consistent with the EGF receptor only a low level of phosphorylation is 
required to induce maximal biological effects (Haring et al., 1982). In vitro
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phosphoiylation is exclusively on tyrosine (Czech, 1985). Phosphorylation 
is on tyrosine 1150 and 1316 although other tyrosine residues may be 
involved (Herrera & Rosen, 1986).
Control of the insulin tyrosine kinase activity appears to be modulated 
in the same way as the EGF tyrosine kinase. Tumour promoters and p 
adrenergic agents are antagonistic acting by inducing phosphorylation on 
serine residues of the p subunit resulting in decreased affinity of the insulin 
receptor for insulin and a reduced protein tyrosine kinase activity.
Insulin like growth factor (IGF1) can mimic some of the actions of 
insulin. IGF1 stimulates a tyrosine kinase activity which phosphoiylates the 
p subunits of the IGF1 receptor and the structurally related insulin receptor 
(Rubin et al., 1983).
1.17. Substrates for Protein Tyrosine Kinases
To identify the functions of tyrosine kinases it is important to identify 
the substrates and their functions. The major targets for many protein 
tyrosine kinases are themselves often resulting in an enhancement of the 
tyrosine kinase activity. Other phosphotyrosine containing proteins have been 
identified but their functions are unclear.
Several approaches have been made to identify targets for pp60v-,src. 
The two proteins that are associated with pp60v_,src in the cytoplasm, pp89 
and pp50 may be candidates. Pp89 is phosphorylated only on serine residues 
(Oppermann et al., 1981). Pp50 although phosphorylated at serine in 
untransformed cells, is phosphorylated at both serine and tyrosine in RSV 
transformed cells (Hunter & Sefton, 1980). Pp50 would, therefore, be a
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possible substrate but further studies have shown that its role in 
transformation is obscure.
Comparison of proteins in transformed and untransformed cells by 
2D electrophoresis of [32p] labelled cell extracts has identified several 
potential substrates. A protein, pp36 was identified in this manner (Radke & 
Martin, 1979). Pp36 exists in an unphosphorylated form in both chicken and 
mammalian cells, but transformation by RSV results in the phosphorylation of 
pp36 on both serine and tyrosine residues (Radke et al., 1980; Erikson & 
Erikson, 1980; Cooper & Hunter, 1981b). Pp36 is an abundant peripheral 
membrane protein but its function is unknown (Cooper & Hunter, 1982). 
Some correlation has been described between pp36 phosphorylation and 
transformation (Cooper et a l , 1983a).
Enolase, phosphoglycerate mutase and lactate dehydrogenase, three 
glycolytic enzymes, have been identified as being phosphorylated on tyrosine 
residues in RSV transformed cells (Cooper et a l , 1983b). The relevance of 
tyrosine phosphorylation of these proteins is unclear as they are not thought to 
be important regulatory enzymes in glycolysis. A protein p42 was identified 
as a substrate of pp60v_,src in chick cells, but not in mouse cells. A direct 
role for this protein in transformation is therefore questionable (Cooper et a l ,
1984).
The only cytoskeletal protein found to contain significant amounts of 
phosphotyrosine is vinculin (Sefton et a l, 1981). Vinculin is concentrated in 
focal adhesion plaques and, therefore, tyrosine phosphorylation could be 
responsible for the disruption of the cytoskeleton which occurs rapidly on 
RSV transformation (Hanafusa, 1977).
Detailed analysis of phosphotyrosine containing proteins from several 
cell lines transformed by a variety of transforming agents have identified few
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positive correlations between protein phosphorylation and any transformation 
parameter.
Phosphotyrosine containing proteins that are substrates for protein 
tyrosine kinases associated with normal cell growth have also been identified. 
Interestingly pp36 was shown to be phosphorylated on tyrosine in EGF 
stimulated A431 cells (Hunter & Cooper, 1981). Phosphorylation was on the 
same tryptic peptide as that defined in RSV transformed cells. 
Phosphorylation of pp36 has also been observed in some mouse 3T3 cells 
(Cooper et al., 1982) but no correlation between pp36 phosphorylation and 
mitogenesis has been defined.
Other proteins identified as substrates for the EGF stimulated protein 
tyrosine kinase in a variety of 3T3 cell lines include at least five proteins in the 
molecular weight range 40-45 kDa (Cooper et al., 1982). In chick embryo 
fibroblasts a variety of mitogens eg. TPA, PDGF, EGF and IGF-1 induced 
phosphorylation of a family of proteins in the range 40-42 kDa, now termed 
p42 (Nakamura et al., 1983). P42 constitutes only 0.001% of total cell 
protein but it is highly conserved among vertebrates (Hunter & Cooper,
1985).
Phosphotyrosine containing proteins have been difficult to detect due 
to the low percentage of protein involved. The use of 2D electrophoresis can 
separate many phosphoproteins but minor proteins remain unresolved. 
Phosphotyrosine antibodies have identified several proteins as tyrosine kinase 
substrates but up to 40% of phosphotyrosine proteins are not identified. 
Protein tyrosine kinase substates have been difficult to detect due to the 
relative paucity of phosphotyrosine containing proteins and added to this is
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the fact that tyrosine kinases have a tendency to be promiscuous in their 
activity.
1.18. Evidence for Phosphotyrosine in Cell Growth
The finding that the transforming proteins of several retroviruses, 
which lead to unrestricted growth, and the receptors for some growth factors 
possess tyrosine kinase activity has led to the idea that tyrosine 
phosphorylation may play a role in cell growth. Retroviral tyrosine kinases 
could be analagous to permanently activated receptors which neither respond 
to external signals or to down regulation. This hypothesis is substantiated by 
the observation that the transforming protein of RSV pp60v_,src is similar to 
its cellular homologue (Takeya & Hanafusa, 1983). Since then several 
transforming gene products have been shown to be homologous to cellular 
proteins. Considerable homology has been observed between the EGF 
receptor and v-erb-B, a transforming gene product of erythroblastosis virus. 
It has been suggested that the gene for the EGF receptor is the cellular gene 
from which the oncogene was derived (Downward et al., 1984b). The 
region of the EGF receptor between Leu 694 and Phe 937 has homology with 
several transforming proteins most of which have been found to express 
protein tyrosine kinase activity (Staros et al., 1985). The oncogene of simian 
sarcoma virus, sis shows homology with the cellular gene encoding the 
PDGF receptor, although a direct relationship has not yet been identified 
(Waterfield et a l, 1983). The insulin receptor has some limited homology 
with the transforming protein, v-ros, from vr-2  sarcoma virus.
In vitro, purified protein tyrosine kinases are phosphorylated 
exclusively on tyrosine but it is emerging that, in vivo, phosphorylation takes 
place on serine and threonine residues as well as tyrosine. There have been
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reports that EGF and insulin can enhance phosphatidylinositol turnover which 
leads to the activation of protein kinase C (Moolenaar et al., 1984). There is 
also evidence in vitro that the tyrosine kinase encoded by src, pp60v_,yrc 
(Sugimoto et al., 1984) and ros, pp6 8v' ro,s (Macara et al., 1984) can 
phosphoiylate phosphatidyl inositol, phosphatidyl inositol 4 phosphate and 
1,2 diacylglycerol. This increases PI turnover and results in activation of 
PKC which phosphorylates proteins on serine and threonine residues. These 
reports are supported by the observation that PI turnover is dramatically 
increased in cells transformed by RSV (Diringer & Friis, 1977) and UR2 
sarcoma virus (Macara et al., 1984). Phosphorylation of tyrosine kinases on 
serine and threonine appears to reduce the activity of the kinase; thus, PKC is 
acting as a negative control. PKC is known to have a role in cell growth and, 
therefore, the association of the two kinases may be important. As yet there 
has been no demonstration of the direct association of the two protein kinases 
and the report that the abl kinase from E.coli cannot stimulate PtdInsP2  
turnover either in vitro or in vivo would argue against a direct association 
(Foulkes &Rosner, 1985).
1.19. A Role for Tyrosine Phosphorylation in Lymphocytes
There is considerable support for the involvment of protein tyrosine 
kinases in the control of cell growth and recently several reports have 
supported a function for tyrosine phosphorylation in lymphocytes. Campbell 
&Parkhouse (1989) demonstrated by using anti-phosphotyrosine antibodies 
that mitogen activated murine B cells possessed tyrosine phosphorylated 
proteins that were not present in resting B cells.
Membranes from T and B lymphocytes have distinct patterns of 
tyrosine phosphorylation (Earp et al., 1984; Earp et al., 1985). In 
membranes from normal B cells two two tyrosine kinase substrates have been
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identified, p61 and p55. These proteins have been found in membranes from 
human Raji cells, mouse spleen and rat spleen. Comparison of tryptic 
phosphopeptides of these proteins has revealed identical phosphotyrosine 
domains (Eaip et al., 1985). Two tyrosine kinase substrates have also been 
identified in T lymphocyte membranes, p64 and p58 (Earp et al., 1984) these 
proteins have similar tryptic phosphopeptides but are distinct from the B cell 
proteins (Earp et al., 1985). The T cell protein p58 has also been described 
by Casnellie et al (1983). Antibodies raised against the putative substrate site 
have been shown to inhibit tyrosine phosphorylation of exogenous substrates, 
suggesting that p58 may be be a tyrosine specific protein kinase. Casnellie et 
al (1982) have reported a protein tyrosine kinase activity in a lymphoma cell 
line, LSTRA, whose major substrate is a protein of molecular weight 58 kDa, 
later defined as p p 5 6 ^ ^ A . Marth et al (1985) characterised a gene coding 
for a tyrosine kinase activity, IskT, expressed in lymphoid cells and 
overexpressed in LSTRA. The IskT protein is closely related to pp60c,src 
and was found to be analagous to the phosphoprotein, p58, described by Earp 
et al (1985). The gene for this protein was rearranged and expressed at high 
levels in LSTRA cells and it was thought, therefore, that it maybe this 
alteration that led to the transformation of the cells.
Reports of other phosphotyrosine containing proteins have included 
two proteins identified in human peripheral blood B lymphocytes (Nel et al.,
1984). These two proteins, p56 and p60 are phosphoiylated after stimulation 
of the B cells with anti-Ig. A protein TPP-6 6  in human T lymphocytes 
showed enhanced phosphorylation on tyrosine in response to two mitogenic 
lectins, phytohemagglutinin (PHA) and concanavalin A (Con A) (Wedner & 
Bass, 1986). Phosphorylation was first observed two minutes after 
stimulation and increased over 120 minutes. Phorbol esters, which are
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known activators of PKC, have recently been found to stimulate tyrosine 
phosphorylation in some cell types. Nel et al (1985) performed a study of 
tyrosine kinase activity in normal and chronic lymphocytic leukemia 
peripheral blood B lymphocytes stimulated with phorbol ester. They 
observed several tyrosine kinase substrates. In the triton soluble material two 
proteins with molecular weight 56 and 61 kDa, which is similar to the 
proteins identified before (Earp et al., 1985, Nel et al., 1984). Four 
phosphotyrosine proteins were also found in the soluble material, molecular 
weight, 75,6 6 ,43 and 28 kDa. The phosphoprotein profiles were similar in 
normal and leukemic cells. Phosphorylation was an early event and was 
followed by a mitogenic response within 24 hours.
Tyrosine phosphoiylation has also been reported in association with 
the T cell antigen receptor (Klausner et a l, 1987, Samelson et al., 1986).
The antigen receptor complex on murine T cells consists of disulphide linked 
a  and (5 chains which are non covalently associated with four polypeptides, 
gp26, gp21, p25 and p i6 . Stimulation of a murine T cell hybridoma with 
PMA induced phosphorylation of two proteins, p25 and gp21 on serine 
residues. Stimulation with antigen induced phosphorylation of gp21 on 
serine and a 21 kDa protein on tyrosine residues. The 21 kDa protein, 
previously unidentified was found to immunoprecipitate with the antigen 
receptor complex (Samelson et al., 1986). These results show that two 
different protein kinases are being activated by antigen binding. T cells can 
also be activated by antibodies to the antigen receptor complex or Thy 1, a 
molecule which is structurally independent of the antigen receptor.
Antibodies to either these molecules activates both kinases (Klausner et al,
1987). An induction of polyphosphoinositide hydrolysis, which leads to 
PKC activation, has already been implicated in the activation of T cells via the
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T cell antigen receptor (Patel et al., 1987). It is now evident that another 
kinase activity is also involved, a tyrosine specific protein kinase. The 
activation of two protein kinases has been observed before in the insulin and 
EGF receptors.
The ability of IL-2 to induce tyrosine phosphorylation has been 
determined in two IL-2 dependent T cell lines and in normal human T cells 
(Salzman et al., 1988). The existence of phosphotyrosine containing 
proteins was assessed by using antibodies to phosphotyrosine in conjunction 
with immunoblotting. An increase in phosphorylation was observed in four 
proteins with molecular weight 100, 84,57 and 38 kDa. The increases are 
detectable within 2.5 minutes and maximal between 5 and 15 minutes. A 
correlation between protein phosphorylation and incorporation of [^H]- 
thymidine has been suggested. This suggests that IL-2 like many other 
polypeptide growth factors exerts its effect through activation of a protein 
tyrosine kinase. Whether the activity is intrinsic to the IL-2 receptor remains 
to be detemined.
1.20. Signal Transduction upon IL-4 Binding to its Receptor
Justement et al (1986) and Mizuguchi et al (1986) investigating the 
signals transduced when IL-4 binds to its receptor found that there was no 
evidence of enhanced phosphoinositide metabolism, calcium mobilisation, 
translocation of PKC and no membrane depolarisation in murine B cells. It 
has also been observed that IL-4 does not significantly increase protein 
phosphorylation in whole cells (Cambier & Ransom, 1987).
The only insight into the mechanism of action of IL-4 is its ability to 
induce phosphorylation of endogenous membrane proteins (Justement et al.,
1986). IL-4 specifically enhances phosphorylation of a 44 kDa (now 42 kDa)
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protein in membranes from resting murine B cells. There may also have been 
some evidence of phosphoiylation in the 60 kDa molecular weight range but 
this is thought to be an artefact These experiments indicate that IL-4 binding 
to its receptor in murine B cells activates a protein kinase which is associated 
with the plasma membrane. Based on previous findings it is probably not 
PKC.
In contrast to this it has been demonstrated that binding of human IL- 
4 to its receptor on resting human tonsillar B cells initiates a complex second 
messenger cascade (Finney et al., 1989). The signals involve a rapid 
transient generation of IP3 which is mirrored by an increase in intracellular 
Ca^+ and followed by a large increase in c AMP. The increase in IP3 induced 
by anti-ji is similar but more sustained than that induced by IL-4. The 
increase in calcium was transient returning to a basal level within 60 seconds 
after stimulation. Stimulation with IL-4 also showed an increase in cAMP 
levels but had no effect on cGMP. Phorbol diester and calcium ionophore 
which mimic the increase in hydrolysis of PtdInsP2  could not increase cAMP 
levels or mimic the induction of CD23 by IL-4. This suggested that IL-4 
although possibly acting by enhancing PtdInsP2  hydrolysis may also involve 
another second messenger outwith this system. The involvement of two 
signal transduction pathways is not uncommon eg. EGF and insulin systems.
The data presented suggest that differences may exist in the signals 
transduced by IL-4 in the human and murine system. This is supported by 
the fact that human and murine IL-4 differ in their effects on target cells and 
exhibit species specificity (Park et al., 1987a; Park et al., 1987b; Coffey & 
Hadden, 1981).
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1.21. Objectives
The sole clue to date on the signals transduced when IL-4 binds to its 
complementary receptor is the activation of a membrane associated protein 
kinase which phosphorylates a 42 kDa protein on resting murine B cells.
PKC is thought not to be the kinase responsible which according to our 
current knowledge suggests two other possibilities, a cAMP or cGMP 
dependent protein kinase and a tyrosine specific protein kinase. As 
previously mentioned the products of several retroviruses and receptors of 
several growth factors have been associated with intrinsic tyrosine kinase 
activity. It is emerging that phosphotyrosine plays an important role in the 
control of cell growth.
The aim of this study was to assess the role of membrane associated 
protein kinases in the signals transduced when IL-4 interacts with its plasma 
membrane receptor on B lymphocytes. This work involved the analysis of 
any phosphoproteins induced by IL-4 on B cells at various stages of 
activation. The mitogen lipopolysaccharide was used to stimulate the B cells 
and B cell lines were also used. The ability of these phosphoproteins to bind 
ATP was also assessed to determine whether they possessed an intrinsic 
protein kinase activity or were protein kinase substrates. Attempts were made 
to identify the phosphoamino acids of these proteins and also the identity of 
these phosphoproteins.
Ifn-y inhibits many of the biological effects of IL-4 and therefore the 
effect of Ifn-y on the ability of IL-4 to induce protein kinase activity was 
determined.
These studies were performed on murine B lymphocytes from
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BALB/c mouse spleen and human B lymphocytes from tonsils and peripheral 
blood. The ability of human and murine IL-4 to stimulate protein kinase 
activities was assessed and compared in murine and human B cells.
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2. MATERIALS AND METHODS.
2.1.MATERIALS.
All routine chemicals were of the highest grade available and were 
supplied by Sigma Chemical Company or BDH Chemicals, both of 
Poole, Dorset, England except for the following.
2.1.1. Animals.
Mice Male and female 8-12 week old B ALB/c.
Rabbits Male New Zealand Whites.
Mice and rabbits were supplied by the University of Glasgow 
Biochemistry department breeding colonies.
2.1.2. Human Tissue.
Peripheral blood Male and female volunteers between 20 - 45
patients at Yorkhill Sick Childrens Hospital, 
Glasgow. (Courtesy of Mr Chandrachaud).
2.13. Cell Culture Materials.
years old.
Tonsils 5-10 year old male and female tonsillectomy
Glutamine
Penicillin/streptomycin 
Foetal calf serum
RPMX-1640 medium Gibco Ltd., Paisley, Scotland. 
Gibco Ltd., Paisley, Scotland. 
Gibco Ltd., Paisley, Scotland. 
Northumbria Biologicals.
Trypan blue Sigma Chemical Co., St Louis,
2-mercaptoethanol
USA.
BDH Chemicals Ltd, Poole.
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2.1.4. B Cell Separation Materials.
Percoll Sigma Chemical Co., St. Louis, USA.
Ficoll-Hypaque Pharmacia Fine Chemicals, Uppsala,
Sweden.
Sheep red blood cells SAPU, Lanarkshire, Scotland.
2-aminoethylisothiouronium Sigma Chemical Co., 
bromide (AET) St. Louis, USA.
T cell depletion kit Seralab, Crawley Down, Sussex,
(comprises four rat monoclonal IgG2b antibodies directed against T 
cell surface antigens, Thyl on all mouse peripheral T cells, Lytl on 
helper T cells, L3T4 on helper T cells, Lyt2 on cytotoxic and 
suppressor T cells).
Guinea pig complement Seralab, Crawley Down, Sussex.
Plasticware Sterilin Ltd., Feltham, England.
2.1.5. Radiochemicals.
The following radiochemicals were obtained from Amersham International 
pic, Aylesbury, Bucks, UK.
2-[^H]-Adenosine 5-monophosphate 14 Ci/mmol
Uridine diphospho-D-[U-^C]-Galactose 303 mCi/mmol 
(Methyl-[^H])-Thymidine 44 Ci/mmol
y- [32p]-Adenosine triphosphate 5000 Ci/mmol
[125j] Na (Carrier Free) 100 mCi/ml
8-Azido-y-[^^P]-ATP 8.6  Ci/mmol
(From ICN Radiochemicals, Irvine, CA).
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2.1.6. Photographic Materials.
X-Omat-S X-ray film
Developer
Fixer
Kodak (U.K.) Ltd., London. 
Kodak (U.K.) Ltd., London. 
Kodak (U.K.) Ltd., London.
2.1.7. Enzymes and Substrates.
All fine chemicals listed below were obtained from Sigma Chemical Co., 
Poole, Dorset, England.
Lactate dehydrogenase EC 1.1.1.27 (rabbit muscle 
type 11).
Pyruvate (sodium salt).
NADH (disodium salt).
Catalase EC 1.11.1.6 (bovine liver).
Fumarase EC4.2.1.2 (pig heart).
Malic acid (monosodium salt). 
Leucylaminopeptidase EC3.4.11.2 (porcine kidney 
microsomes).
Leucyl-2-napthylamide.
4-methylumbelliferone (sodium salt).
1-methyl-2 -pyrollidone.
2 -amino-2 -methyl-propan-l-ol (free base).
P galactosidase E.C. 3.2.1.23 (jack beans). 
p-N-acetyl glucosaminidase E.C. 3.2.1.30 (bovine 
kidney).
4-methylumbellifeiyl-P-galactoside.
4-methylumbelliferyl-P-N-acetyl-glucosaminide.
5' nucleotidase E.C. 3.1.3.5 (snake venom). 
Triethanolamine.
Adenosine 5' monophosphate. 
Galactosytransferase E.C. 2.4.1.22 (bovine milk). 
Uridine 5' diphosphogalactose (sodium salt). 
Cytochrome C.
NADPH.
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2.1.8. Ligands and Mitogens.
BSF-1 (IL-4 purified from EL4 supernatant) a 
generous gift from Dr R. J. Noelle, 
Dartmouth Medical School, Hanover, 
USA.
Recombinant mouse IL-4 Genzyme (Via A & J 
Beveridge, Edinburgh). 
Genzyme.
Holland Biotechnology 
bv, Lieden, The 
Netherlands.
Recombinant human IL-4 
Recombinant mouse interferon y
11B11 (Rat monoclonal antibody to murine EL- 
4) A generous gift from Dr E.C. Snow, 
University of Kentucky, Lexington, 
USA).
The following were obtained from Sigma Chemical Company, Poole, 
Dorset.
Concanavalin A.
E.coli lipopolysaccharide 0127:B8.
Goat anti-mouse IgM.
Phorbol 12-myristate 13-acetate.
Ionomycin (Colimycin, Calcium ionophore A23187).
2.1.9. Gel Electrophoresis Materials.
Acrylamide, N,N'-methylene bis acrylamide, N,N,N',N'- 
tetramethylethylenediamine (TEMED), ammonium persulphate and 
sodium dodecyl sulphate (SDS) were obtained from BDH Chemicals, 
Poole, Dorset, U.K.
Low molecular weight marker proteins were purchased from Pharmacia 
Fine Chemicals, Hounslow, Middlesex, U.K. Coomassie brilliant blue R 
stain was from Sigma, and silver nitrate was purchased from Johnson 
Matthey Chemicals Ltd., London.
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2.1.10. Antibodies.
Monoclonal anti rat IgG2b FTTC. Seralab, Crawley Down, Sussex. 
Simultest T and B cell test Becton Dickinson.
(Anti-CD3 M I C and anti-CD 19 PE).
Anti-CD23 (MHM6) mouse ascites. A generous gift from Dr
J. Gordon, University 
of Birmingham, UK. 
Anti-mouse Fc-FTTC. ICN Immunobiologicals, Irivine,
CA.
Monoclonal anti-mouse B cells (I-A). Seralab, Crawley
Down, Sussex.
Anti-mouse IgG-FITC. ICN Immunobiologicals, Irvine,
CA.
Anti-human IgM-Ml’C. Sigma Chemical Co. Ltd.
Transferrin-FITC. "
Insulin-FITC. "
Anti-rat IgG-FITC. "
2.1.11. Thin Layer Electrophoresis Materials.
All of the undemoted chemicals were from Sigma Chemical Company, 
Poole, with the exception of xylene cyanol which was purchased from 
Geo. T. Gurr Ltd.
O-phospho-L-tyrosine.
O-phospho-L-serine.
O-phospho-L-threonine.
Xylene cyanol. 
e-DNP lysine.
Ninhydrin.
Thin layer chromatography plates (type 100 
cellulose).
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2.1.12. Immunological Reagents.
Horse radish peroxidase conjugated anti rabbit immunoglobulin was 
supplied by ICN Biomedicals Inc. Normal rabbit and goat sera were 
obtained from the Scottish Antibody Production Unit, Carluke, Scotland, 
and the following reagents were from Sigma Chemical Company.
Bovine serum albumin.
Keyhole limpet haemocyanin (KLH).
Ovalbumin (OVA).
4-aminobenzylphosphonic acid, 
o-phenylenediamine.
2.1.13. Substrate Peptides.
RR-SRC, Phosphate acceptor peptide and [Val^] -angiotensin II were 
supplied by Peninsula Laboratories or Biomac Ltd., Glasgow.
2.1.14. Miscellaneous.
Ecoscint liquid scintillant was supplied by National Diagnostics, and 
Iodogen (l,3,4,6-tetrachloro-3a, 6 a-diphenylglycouril) was purchased 
from Pierce-Warriner Ltd., Chester, U.K.
2.2. BUFFERS
Phosphate Buffer Saline (PBS)
170 mMNaCl
3.4 mM KC1 
10 mM Na2HP04
1.8 mM KH2PO4
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METHODS
2.3. Preparation of B Lymphocytes
2.7>.Preparation ofB  Cells from BALB/c Mice.
BALB/c mice were sacrificed by ether inhalation followed by cervical 
dislocation. The spleens were removed and teased into a single cell 
suspension in RPMI-1640 medium. Cells were then washed twice in RPMI- 
1640 medium at room temperature. Erythrocytes were removed by 
suspending cells in 5 ml of erythrocyte lysis buffer (17 mM Tris HC1, pH 
7.2,0.144 M ammonium chloride) at room temperature for 5 minutes. An 
equal volume of RPMI-1640 medium was added to the cells and they were 
carefully layered onto a 5 ml cushion of foetal calf serum and centrifuged for 
5 minutes at 1000 rpm. Erythrocyte-depleted cells were then washed twice in 
RPMI-1640 medium. T cells were depleted by incubating cells for 40 
minutes at 37°C with a cocktail of four rat IgG2b monoclonal antibodies with 
specificities for T cell markers (anti-Thy-1, anti-Lyt-1, anti-Lyt-2, anti- 
L3T4), each diluted 1:500 in PBS, in the presence of guinea pig complement 
(diluted 1:40 with PBS). After T cell depletion the cells were washed and 
resuspended in 2 ml of a percoll solution of density 1.08 g/ml.
2.3.2. Preparation ofB  Lymphoctes from Human Peripheral
Blood and Tonsils
AET Treatment of Sheep Red Blood Cells
Sheep erythrocytes were coated with 2-aminoethylisthiouronium 
bromide (AET). 5 ml of sheep erythrocytes were centrifuged and washed 
twice in RPMI-1640 medium. At the same time 102 mg of AET was 
dissolved in 10 ml distilled H2O and adjusted to pH 9.0 with 5 M NaOH and 
then filter sterilised. 4 ml of the AET was added to the sheep erythrocytes 
and the suspension was incubated at 37°C for 20 minutes. After 20 minutes 
the cells were washed 5 times with RPMI-1640 medium and then a final 
volume of 9 ml of RPMI-1640 medium was added. The AET treated sheep 
red blood cells were stored at 4°C for up to a week. The cells were diluted
1: 5 before use.
Separation ofB and T Lymphocytes
20  ml of human peripheral blood was removed by venipuncture and 
diluted 1:2 with RPMI-1640 medium. The diluted blood was layered onto an 
equal volume of Ficoll-hypaque and centrifuged for 15 minutes at 2500 ipm. 
Tonsillar cells were teased from the tonsils and then washed in incomplete 
medium, resuspended in 20 ml per tonsil and layered onto Ficoll-hypaque. 
Lymphocytes were removed from the interface and washed twice with RPMI- 
1640 medium. The cells were counted and resuspended in RPMI-1640 
medium at 10^ cells /ml and equal volumes of 2% AET treated sheep 
erythrocytes and FCS were added. This suspension was centrifuged at 800 
rpm for 5 minutes and then left on ice for one and a half hours. After the 
incubation the pellet was gently resuspended by rocking. The sample was 
layered onto Ficoll-hypaque and centrifuged at 2500 rpm for 15 minutes. B 
lymphocytes were removed from the interface and washed twice in RPMI- 
1640 medium. The T lymphocytes which were rosetted by the sheep 
erythrocytes can be obtained by lysing the sheep erythrocytes with the 
addition of a few drops of sterile H2O.
2.3.3. Separation ofB  Cell Populations by Percoll Gradient
Centrifugation
Percoll gradients were prepared as described by Ratcliffe and Julius 
(1982). Percoll densities of 1.09, 1.08,1.075, 1.065, andl.055 g/ml were 
prepared from an iso-osmotic stock (9 parts percoll: lpart 10 x PBS) using 
the formula:-
v y = v i rp j^pj.
(p - py)
where pi = density of stock iso-osmotic percoll
p = density of diluted solution produced
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py = density of diluting medium 
Vy = volume of diluting medium 
Vi = volume of stock iso-osmotic percoll
2 ml of each density of percoll solution were layered into a 15 ml 
nitrocellulose tube starting with 1.09 g/ml and decreasing in density to 1.055 
g/ml with 1 ml of RPMI-1640 medium on top, the 1.08 g/ml contained the B 
cells to be separated. The gradients were centrifuged in a SW27 Beckman 
rotor at 1400g for 30 minutes. Separation on discontinuous percoll gradients 
depends on the size and density of the cells . The cells move until their 
density is equivalent to the percoll density. Resting B cells are small, high 
density cells and were collected at the 1.09/1.08 g/ml interface. On activation 
B cells increase in size and therefore their bouyant density falls (Rabin et al 
1985). The larger, less dense B cells were collected at the 1.065/1.055 g/ml 
interface. After removing the B cells from the appropriate percoll interface the 
cells were washed three times in RPMI-1640 medium.
2.4. Cell Viability
Cell viability was determined by mixing 4 volumes of cell suspension 
diluted 1:100 to 1 volume of 0.05% (W/V) tiypan blue. Viability was 
determined on the basis that dead cells take up tiypan blue. Numbers of live 
and dead cells could be estimated by counting in a Neubauer haemocytometer. 
The average number of cells per 16 square grid was multiplied by 10^ then 
the dilution factor taken into account to give the number of cells per ml of 
culture.
% viability = number of live cells x ioo 
total number of cells
2.5. Cell Culture of Murine and Human B Lymphocytes from
Spleen, Tonsils and Peripheral Blood
Cells were maintained in complete medium (RPMI-1640 (as described 
in table 1) supplemented with 10% (v/v) foetal calf serum, heat inactivated at
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Table L Composition of RPMI-1640 Medium
Amino Acids mg/ml Amino Acids mg/ml
L-Arginine 2 0 0 .0 L-Lysine HCL 40.0
L-Asparagine 65.0 L-Methionine 15.0
L-Aspartic acid 2 0 .0 L-Phenylalanine 15.0
L-Cystine (2HCL) 65.0 L-Proline 2 0 .0
L-Glutamic acid 2 0 .0 (hydroxy-L-proline free)
Glycine 1 0 .0 L-Serine 30.0
L-Histidine (free base) 15.0 L-Threonine 2 0 .0
L-Hydroxyproline 2 0 .0 (alio free)
L-Isoleucine (alio free) 50.0 L-Tryptophan 5.0
L-Leucine 50.0 L-Tyrosine 15.0
(methionine free) L-Valine 2 0 .0
Vitamins Inorganic Salts
Biotin 0 .2 Ca(N03)2.4H20 1 0 0 .0
D-calcium pantothenate 0.25 KCL 400.0
Choline chloride 3.0 MgSC>4 48.84
Folic acid 1.0 NaCl 6000.0
i-Inositol 35.0 Na2HP0 4 800.0
Nicotinamide 1.0 NaHCC>3 2 0 0 0 .0
para-Aminobenzoic acid 1 .0 Other Components
Pyrodoxine hydrochloride 1.0 Glucose 2 0 0 0 .0
Riboflavin 0 .2 Phenol red 5.0
Thiamine hydrochloride 1.0 Reduced Glutathione 1 .0
Vitamin B12 0.005
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56°C for 30 minutes, 2 mM L-glutamine, penicillin (10^ I.U./litre), 
streptomycin (100 mg/litre)) and 50 pM mercaptoethanol (Lemke and Opitz, 
1976). Cells were cultured for the times indicated in the text and in figure 
legends and with the appropriate concentrations of polyclonal activators and 
interleukins. Cells were cultured in 25 cm^ Costar flasks in a 95% 0 2 /5 % 
CO2  humid incubator. Preparation and maintenance of cells was carried out 
in a Laminar-flow hood.
2.6. Cell Lines
Daudi human thyroid lymphoma (Klein, et al., 1968).
Raji human Burkitt lymphoma cell line (Pulvertaft, 1964).
P388Dj mouse DBA/2 lymphoid macrophage-like cell line
(Koren et al., 1975).
Cells were grown in Costar flasks in complete medium in a 95%
O2 /5% CO2 humid incubator at 37°C and sub-cultured every second day.
2.7. Measurement of Murine T Cell Depletion by Using
Polyclonal Activators of T and B Cells
Concanavalin A (Con A) and lipopolysaccharide (LPS) are polyclonal 
activators of lymphocytes, they act by mimicing the in vivo stimulation of 
lymphocytes by specific antigens. Con A is a mitogen T cells and LPS is a 
mitogen for mouse B cells. This difference in lymphocyte specificity was 
used to determine if a population of lymphocytes contained T or B cells by 
their response to LPS or Con A. To determine if a purified population of B 
cells had been obtained aliquots of lymphocytes were taken before and after T 
cell depletion. Cells from these 2 populations were suspended at 5x10^ 
cells/ml in complete medium plus 50 pM mercaptoethanol and 100 pi added 
to each well of a 96 well costar plate. Each population was cultured with 100 
pi containing 0,5,10 and 50 pg/ml of Con A or LPS. The cells were 
cultured for 18 hours then 1 pCi of [^H]-methyl thymidine was added to 
each well and the cells were cultured for a further 6  hours. The cells were 
harvested onto nitrocellulose filters using a Titertek cell harvester and the
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incorporation of [^H]-methyl thymidine into the cells estimated by liquid 
scintillation counting in 3 ml of ecoscint.
2.8. Activation of Murine B Cells by Lipopolysaccharide .
LPS is a polyclonal activator for B cells, it drives B cells into the cell
cycle resulting in proliferation and differentiation. To determine the optimum 
concentration of LPS needed for B cell activation the following assay was 
carried out. Resting B cells were prepared (2.3.1. & 2.3.3.). Cells were 
suspended in complete medium plus 50 jiM 2-mercaptoethanol at 5x10^ 
cells/ml. 100 pi of cell suspension was added to each well of a 96 well costar 
plate. 100 (il of complete medium containing LPS at 0 ,2 .5 ,5 ,10,20 and 50 
pg/ml was added to the appropriate well. Each concentration of LPS was 
tested in triplicate. The cells were incubated at 37°C for 18,42, 6 6  and 90 
hours, then 1 pCi of [^H]-methyl thymidine was added to them. The cells 
were incubated for a further 6  hours and then harvested at 24,48, 72 and 96 
hours onto nitrocellulose filters by a Titertek cell harvester. The filters were 
counted in 3 ml of ecoscint on a Beckman LS 6800 scintillation counter.
2.9. Interleukin 4 Bioassay
The assay to asess the response of the murine B cells to recombinant 
murine IL-4 was performed according to the method of Ohara et al (1985). 
Resting B cells were prepared from BALB/c mice (2.3.1 & 2.3.2.). The cells 
were resuspended at 5x10^ cells/ml in complete medium plus 50 pM 2- 
mercaptoethanol and 100 pi was added to each well of a 96 well Costar 
culture plate. The B cells were incubated in either medium alone, 5 pg/ml 
goat anti mouse IgM, 100 u/ml rmIL-4,5 pg/ml goat anti mouse IgM and 100 
u/ml IL-4 or 10 pg/ml LPS for 48 hours then pulsed with 1 pCi/well [^H] 
methyl thymidine for 6  hours. Cells were harvested by a Titertek cell 
harvester onto nitrocellulose filters and the radioactivity incorporated 
determined by liquid scintillation.
69
2.10. Preparation of Cells for Flow Cytomretry
To analyse cells by flow cytometry aliquots of approximately lx 10^ 
cells were removed from cultures, centrifuged and then washed twice in ice 
cold PBS. The cells were resuspended in PBS to give 1x10^ cells/50 |il 
PBS. The appropriate antibody was then added to the cells as specified in the 
text and figure legends. Samples where antibodies conjugated directly to 
FTTC were used were incubated for 20 minutes on ice. After incubation they 
were centrifuged, washed twice in ice cold PBS and finally resuspended in 
0.5 ml of PBS for analysis by flow cytometry. In the cases where a two step 
reaction was required the first antibody was added to the cells and incubated 
for 20 minutes as before. The cells were then centrifuged, washed twice in 
ice cold PBS and resuspended in PBS containing the second antibody. The 
second incubation was again for 20 minutes on ice . After the incubation the 
cells were washed in PBS and then resuspended in 0.5 ml of PBS for 
analysis by flow cytometry.
In each sample 2.5 pi of propidium iodide (PI) (final concentration 1 
pg/ml) was added to the cells before analysis. Dead cells were gated by their 
ability to take up PI and fluoresce in the red channel.
In each batch of cells analysed a control was included which had no 
antibodies added and this was used to correct for autofluorescence of the 
cells. Where a two step reaction was involved a control with second antibody 
was included to account for non specific binding.
2.11. Preparation of Plasma Membranes
Plasma membrane was prepared according to the method of Earp et al 
(1984). B cells were centrifuged at 1000 rpm for 7 minutes in a MSE 
Centaur centrifuge then washed twice with 10 ml of 0.15 M NaCl. The 
washed cells were gently resuspended in 2.5 ml homogenisation buffer (10 
mM potassium phosphate buffer pH 7.4,1 mM EDTA) and homogenised at 
4°C with 60 strokes of a glass hand pestle. To ensure that the cells had been 
broken a small sample was inspected under the light microscope. 2.5 ml of
homogenisation buffer containing 0.5 M sucrose was added to the broken 
cells and the homogenate centrifuged at 1000 rpm for 5 minutes to remove 
nuclei and unbroken cells. The supernatant was removed and centrifuged for 
1 hour at 105,000 g in a SW65 Beckman rotor. The pellet was resuspended 
in 20 mM PIPES pH 7.0 and the protein concentration was estimated.
2.12. In Vitro Phosphorylation of Plasma Membrane Proteins
A modification of the method of Earp etal (1984) was used to 
phosphorylate plasma membrane proteins. Phosphorylation assays, total 
volume 100 pi, contained 50 pg of plasma membrane, 30 mM MgCl2  or 5 
mM MnCl2 , 10 pM sodium orthovanadate, 0.02% (v/v) Triton-X-100 in 20 
mM PIPES pH 7.0. The reaction was carried out on ice and initiated by the 
addition of 10 pCi [32p-y] ATP (2 pM, specific activity 5000 Ci/mmol). The 
samples for SDS gel electrophoresis were terminated after 5 minutes by 
adding 25 pi of hot (55°C) sample buffer and boiling for 5 minutes. Prior to 
SDS gel electrophoresis NaH2P0 4  was added to a final concentration of 1 
mM. The sample was then loaded onto a 10% polyaciylamide gel. The 
phosphorylation assay was carried out in the absence of ligand or in the 
presence of 10 units IL-4 (mouse) or 100 units (human), either recombinant 
or purified, or 100  units of recombinant Ifn-y where indicated.
2.13. Incorporation of [32p]-Phosphate into Plasma Membrane
Proteins
The amount of radioactivity incorporated into acid insoluble material 
was estimated by taking 3 x 5 pi samples from the terminated reaction above 
(2.12.) and spotting them onto Whatman No.3 filter paper discs. The discs 
were washed 4 times over a period of 40 minutes in 10% TCA, 10 mM 
sodium pyrophosphate, then for 5 minutes in ethanol. The discs were then 
dried and counted in 3 ml ecoscint on a Beckman LS 6800 scintillation 
counter.
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2.14. ATP Binding Capacity of Plasma Membrane Proteins
To determine which, if any, proteins could bind ATP the photoaffinity 
label y-[32p]-8-Azido ATP was used in phosphorylation assays similar to 
those described in 2.12. 8-Azido ATP binds irreversibly to ATP binding 
proteins in the presence of UV light. Phosphorylation assays contained 50 
|ig of membrane, 30 mM MgCl2 , 10 pM Na3V0 4 , 0.02% Triton-X-100 and 
3 pCi [32p_y] g-Azido ATP in 20 mM PIPES. The assays were carried out at 
room temperature on glass slides and the reaction was initiated by UV 
irradiation for one minute. The reaction was terminated by the addition of 25 
pi of hot (55°C) sample buffer and the samples were boiled for 5 minutes. A 
final concentration of ImM NaH2P0 4  was added before loading the sample 
onto a 10% acrylamide gel for electrophoresis. The assays were carried out 
in the presence and absence of 10 units rmIL-4. To ensure labelling was 
specific assays were performed in the absence of UV light and also in the 
presence of excess unlabelled ATP (final concentration 50 mM).
2.15. Phosphorylation of Peptides by Plasma Membrane Protein
Kinases
It has been shown that cAMP dependent protein kinases and casein 
protein kinases recognise substrates at least in part by the primary amino acid 
sequence around target residues. There is also evidence of homology 
between tyosine protein kinase sites. Short peptides (see Fig4.), with one 
potential phosphorylation site surrounded by the amino acids thought to be 
needed for recognition of the site, have been used as exogenous substrates for 
plasma membrane protein kinases in the phosphorylation reactions (2 .12). 
Peptide phosphorylation assays contained 10 pg of membrane, 30 mM 
MgCl2 or 5 mM MnCl2 , 10 jiM Na3VC>4 , 0.02% (v/v) Triton-X-100 and 3 
units IL-4 in 20 mM PIPES pH 7.0 to a total volume of 30 pi. 
Phosphorylation assays were carried out at 30°C in the presence of 2mM 
Substrate Protein Kinase (RRSRC), 0.2 mM Phosphate Acceptor Peptide 
(PAP) or 2 mM [Val^] Angiotensin II and were initiated by addition of 3 |iCi 
[32p_y] ATP (ICi/mMol). The reactions were terminated after 3 minutes by 
the addition of 50 pi of 5% TCA. The samples were spun in a microfuge and
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Figure 4 Amino Add Sequence of Peptide Substrates
Figure 4 shows the amino acid sequence of the three peptides used as 
exogenous substrates in the phosphorylation assays (section 2.15). 
Each peptide as one potential phosphate acceptor site (in bold) and 
positively charged amino acids (in italics) at the N terminal to allow 
binding to the negatively charged paper.
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three 2 0  pi aliquots of supernatant were spotted onto 2  x 2cm squares of 
Whatman P81 ion exchange chromatography paper. The peptides can bind to 
this negatively charged paper by virtue of two positively charged terminal 
amino acids. The papers are washed at room temperature for 40 minutes with 
four changes of 30% acetic acid, which removes excess [^^P-y]ATP. The 
papers were dried and counted in 3 ml of ecoscint in a Beckman LS 6800 
scintillation counter.
2.16. Analysis of Total Phosphoamino Add Content by Two
Dimensional Thin Layer Electrophoresis
Membrane protein phosphorylation was carried out exactly as in 2.12. 
except the reaction was stopped by adding BSA to a final concentration of 50 
pg/ml. After a few minutes trichloroacetic acid was added to a final 
concentration of 10% (V/V). Samples were left on ice for 1 hour then 
proteins were pelleted in a microfuge for 5 minutes. The pellet was washed 2 
times with ethanol and left to air dry. The pellet was resuspended in 200 pi 
of 5.7 N HC1 and incubated for 1.5 hours at 110°C. Any remaining liquid 
was lyophilised.
2.16.1Analysis o f the Phosphoamino Acid Content o f Proteins
Elutedfrom SDS-PAGE Gels
Proteins identified from autoradiographs were excised from SDS- 
PAGE gels. The paper was removed and the gel ground in 50 pi 50 mM 
NH4 HCO3 , 0.1% SDS and 5% 2 mercaptoethanol. After grinding the 
volume is made up to 500 pi and the sample is shaken continually for 1 hour 
at room temperature. The acrylamide is pelleted by centrifuging for 5 minutes 
in a microfuge. A final concentration of 50 pg/ml BSA and 10% (V/V) TCA 
is added to the supernatant as described in 2.16.
To obtain proteins from gels that have been previously treated with 
KOH the protocol is followed exactly as above except the proteins are not 
precipitated with BSA/TCA since during KOH treatment peptide bonds as 
well as the phosphodiester bonds have been hydrolysed.
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2.17. Two Dimensional Thin Layer Electrophoresis
Buffers
First dimension buffer. pH 1.9
78 ml glacial acetic acid 
25 ml 8 8% (v/v) formic acid 
897 ml H20
Second dimension buffer. pH 3.5
50 ml glacial acetic acid 
5 ml pyridine 
945 ml H2O
Dve
1 mg/ml xylene cyanol 
5 mg/ml e-DNP lysine
Two dimensional thin layer electrophoresis was carried out according 
to the method of Cooper et al (1983a). The samples from 2.16 and 2.16.1. 
were dissolved in 10 |il of pH 1.9 buffer and 10 |il of a standard mix of 
phosphoamino acids (1 mg/ml of each of tyrosine, threonine and serine 
phosphate). 5 |il of the sample was carefully spotted onto 10x10 cm cellulose 
thin layer plates. A small amount of dye was run parallel to the sample to 
allow progress of electrophoresis to be monitored. The cellulose sheet was 
homogeneously wet with pH 1.9 buffer using Whatman 3mm filter paper to 
concentrate the sample. The thin layer plate was placed into an 
electrophoresis tank and electrophoresis was performed at a constant voltage 
of 500 volts. The sample was allowed to migrate halfway across the cellulose 
sheet towards the anode (20 minutes). The cellulose sheet was then dried, 
wet with pH 3.5 buffer, rotated through 90° and again allowed to migrate 
halfway towards the positive pole (20 minutes). When the cellulose sheet 
was removed from the tank it was dried and sprayed with 0 .1% (w/v) 
ninhydrin in acetone and developed in a 60°C oven until the standard 
phosphoamino acids could be identified. The plate was then subjected to
76
autoradiography to visualise the radioactive phosphoamino acids.
After autoradiography each phosphoamino acid was cut out and 
counted in 3ml of ecoscint to determine [32P] -phosphate incorporation into 
each phosphoamino acid.
2.18. Polyacrylamide Gel Electrophoresis
SDS-polyaciylamide gel electrophoresis was performed according to 
method of Laemmli (1970).
Stock Solutions
Unless otherwise indicated all solutions were stored at 4^C.
Solution A
45% (W/V) Aciylamide
1.2% CWIV) N-N'-methvlene bis acrvlamide
Solution was deionized with amberlite monobed resin (MB-3), 
filtered and stored in the dark.
Solution B
1.5 M Tris-HCl, pH 8.8  
0.13% (V/V) TEMED
Solution C
12% (W/V) SDS
Stored at room temperature.
Solution D
10% (W/V) Ammonium persulphate
Solution E
0.625 M Tris-HCl, pH 6.8
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Reducing Loading Buffer (x5)
65 mM Tris-HCl, pH 6.8  
2% (W/V) SDS 
10% (V/V) Glycerol 
5% (V/V) 2-Mercaptoethanol 
0.001 % (W/V) Bromophenol blue 
Stored at -20^C
Resevoir Buffer (x51 
125 mM Tris 
660 mM Glycine 
1% (W/V) SDS 
Stored at room temperature.
2.18.1 Separating Gel Preparation
10% separating gels were prepared from stock solutions as follows;
Solution A 
Solution B 
Solution C 
Solution D 
Deionized water 
TEMED
The solution was poured into casting apparatus and allowed to 
polymerise.
13.3 ml
15.0 ml 
0.5 ml 
0.5 ml 
30.7 ml
50.0 nl
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2.18.2Stacking Gel Preparation
Stacking gels were prepared from stock solutions as follows;
Solution A 2.64 ml
Solution C 0.20 ml
Solution D 0.20 ml
Solution E 2.40 ml
Deionized water 18.67 ml
TEMED 24 jil
The solution was poured on top of the separating gel and allowed to 
polymerise around a 10 or 2 0  well teflon comb.
2.18.3. Molecular Weight Markers
In each gel 5 filof low molecular weight markers were run parallel 
to the samples.
Subunit molecular weight Source 
Phosphorylase b 94,000 rabbit muscle
Albumin 67,000 bovine serum
Ovalbumin 43,000 egg white
Carbonic anhydrase 30,000 bovine erythrocyte
Tiypsin inhibitor 20,100 soyabean
a-lactalbumin 14,400 bovine milk
2.18 A Electrophoresis
Samples in reducing loading buffer were loaded into individual wells 
in the stacking gel. Electrophoresis was performed at a constant current of 
45 mA for 3-4 hours or 10 mA for 17-18 hours at room temperature or until 
the dye front reached the bottom.
2.18.5.Coomassie Blue Staining
After electrophoresis gels were stained with 0.25% (w/v) coomassie
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blue in destain (4.5 vols. ethanol, 4.5 vols. deionized water and 1 vol. 
glacial acetic acid) for 1 hour then in destain until protein bands were 
revealed. Gels were then dried onto Whatman 3mm chromatography paper 
under vacuum at 80°C and autoradiographed at -70°C.
2.18 .6£ilver Staining
SOLUTIONS
All solutions were freshly prepared and used within 5 minutes of 
preparation.
Solution A
0.8  g of silver nitrate in 4 ml of dH^O.
Solution B
21 ml of 0.36% (w/v) NaOH, 1.4 ml of 14.8 M ammonia.
Solution C
Solution A was added dropwise to solution B while stirring
vigorously and then made to 100 ml with dE^O.
Solution D
2.5 ml 1% (v/v) citric acid mixed with 0.25 ml 38% (v/v)
formaldehyde and made up to 500 ml with dH^O.
Silver staining of gels was carried out according to the method of 
Wray et al (1981). After SDS-PAGE gels were soaked in 50% methanol 
overnight to remove SDS. The gel was stained in solution C for 15 minutes 
with gentle agitation and then washed in deionised water. The gel was 
developed using solution D and proteins appeared within 15 minutes. The 
reaction was terminated by rinsing the gel in deionised water.
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2.18.7 Alkali Treatment of SDS-PAGE Gel
Two identical gels were stained and destained as in 2.18.5. then 
incubated, for 90 minutes at 55°C, in two changes of 5 mM sodium 
dihydrogen phosphate either with or without 1 M potasium hydroxide. Gels 
were rinsed in deionized water then placed in destain for 30 minutes before 
being dried under vacuum at 80°C onto Whatman 3mm filter paper and 
autoradiographed.
2.18.8 Processing of Autoradiographs
X-ray film was sandwiched between dried gels and a Dupont 
"Cronex" intensifier screen in a light proof cassette. Films were stored at - 
70°C until appropriate exposure.
2.1%.9 Development of Films
After exposure, autoradiographic images were visualised by 
processing of films in a Kodak X-OMAT processor.
l.IS.lODensitometiy
Autoradiographs were analysed by linear laser densitometry using a 
Bio-Rad densitometer. Data were collected without electronic boosting or 
enhancement, and the data were analysed on an Ollivetti M24 
microcomputer system.
2.19. Estimation of Purification of Plasma Membranes
To ensure that the method used for preparation of membranes had 
enriched plasma membrane and there was minimal contamination from 
components of other cellular compartments, enzyme activities which could be 
assigned to one, or at most two, sub-cellular compartments were assayed in 
homogenised cells and membranes prepared as described in 2.11. The cells 
used were resting B cells from B ALB/c mouse spleen and cells from a human 
B lymphoma cell line, Daudi. The marker enzymes assayed were 5' 
nucleotidase and leucylaminopeptidase for plasma membrane, fumarase as a 
marker of mitochondrial contamination as well as lactate dehydrogenase,
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which is also a marker of cytosolic contamination. Catalase was used as a 
marker for peroxisomes, acid (3 galactosidase and p N acetylglucosaminidase 
as markers for lysosomes, galactosyl transferase for the golgi and NADPH- 
cytochrome C reductase as a marker for endoplasmic reticulum.
2.19.IJMCtate Dehydrogenase
Lactate dehydrogenase was assayed at 37°C by following the 
decrease in absorbance at 340 nm due to the formation of NAD+ from NADH 
in the reaction (Houslay and Tipton, 1973).
The reaction cocktail, 1 ml, consisted of 0.05 M Tris HC1 pH 7.4, 0.32 M 
sucrose, 0.36 mM pyruvate and 100 mM NADH. 10 fil of 1:1000 dilution of 
commercial lactate dehydrogenase (as a positive control) or 10 jil of whole 
cell homogenate or membrane was added to start the reaction. The reaction 
was carried out in the presence and absence of 0.1% (v/v) Triton-X-100. The 
change in absorbance was followed using a Cecil spectrophotometer coupled 
to an SE 120 BBC chart recorder. The specific activity of the enzyme 
(units/mg protein) was calculated. The molar extinction coefficient for NAD, 
e = 6 .22  x 10^ 1 mol'l cm 'l.
2.19.l.Catalase
Catalase activity was measured by the evolution of oxygen from 
hydrogen peroxide at 240 nm (Darnell et al 1986). The reaction cocktail, 1 
ml, consisted of 0.1% H2 O2  in 100 mM potassium phosphate buffer pH 7.4. 
The reaction was carried out at 37°C in the presence of 0.1% (v/v)Triton-X- 
100 and was initiated by the addition of 10 jil of either commercial catalase 
(1:1000), whole cell homogenate or membrane. Measurements were made as 
in 2.19.1. The molar extinction coefficient for catalase was e = 3121 moH
PYRUVATE ^  LACTATE
NADH NAD+
2.\9.3 Fumarase
Fumarase is a Krebs cycle enzyme responsible for the conversion of 
malate to fiimarate. Fumarase activity was determined by the method of Hill 
and Bradshaw (1969) by following the appearance of fiimarate as detected by 
an increase in absorbance at 240 nm. The reaction was performed at 25°C 
and consisted of 0.05 M malic acid in 0.1 M potassium phosphate buffer pH
7.6 and 10 |il of a 1:1000 dilution of commercial fumarase or 10 }il of whole 
cell homogenate or membrane to initiate the reaction. The reaction was 
carried out in the presence of 0.1% Triton-X-100 to disrupt the mitochondria. 
The assay was recorded on the equipment used in 2.19.1. The molar 
extinction coefficient for fumarase was e = 2 .1 1 1  mmol"! cm"!.
2.\9 ANADPH-Cyto chrome C Reductase
NADPH-cytochrome C reductase was assayed by the method of 
Williams and Kamin (1962). Cytochrome C acts as an electron acceptor 
when NADPH is oxidised to NADP+. The reaction cocktail consisted of 0.9 
ml of 50 mM sodium phosphate buffer pH 7.2,50 pi of a 25 mg/ml solution 
of cytochrome c, 10 (il of 10 mM EDTA and 10 pi of whole cell homogenate 
or membrane. To initiate the reaction 100 ml of a 2 mg/ml solution of 
NADPH was added and the change in absorbance at 552 nm was followed 
using the same equipment as in 2.19.1. The molar extinction coefficient for 
cytochrome C was, e = 27,0001 mol"! cm"!.
2.19.5.5' Nucleotidase
5 ’ nucleotidase was assayed by monitoring the release of ^ H- 
adenosine from ^ H-adenosine 5* monophosphate (AMP) (Newby et al, 
1975). 10 pi of commercial 51 nucleotidase (0-0.2 units) or 10 pi of whole 
cell homogenate or membrane was incubated with 190 pi of a solution 
containing 50 mM triethanolamine hydrochloride pH 7.6,10 mM magniesium 
sulphate, 1 mM AMP and 2-[^H]-AMP (105cpm/190ml) for 10 minutes at 
30°C. The reaction was terminated by the addition of 40 pi of 0.15 M zinc 
sulphate which precipitates unreacted AMP. The solution was kept on ice for 
3 hours when 40 pi of 0.3 N barium hydroxide was added and the samples
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were incubated for a further 15 minutes on ice. After incubation the samples 
were centrifuged for 3 minutes at 14000g and a 150 pi aliquot of supernatant 
was removed and counted in 3ml of ecoscint The activity of 5' nucleotidase 
in the whole cell homogenate and membrane was determined from a standard 
curve of commercial 5' nucleotidase.
2.19.6 JLeucylaminopeptidase
Leucylaminopeptidase was assayed as leucyl-2-napthylamidase using 
leucyl-2-napthylamide as a substrate (Wachsmith et al 1966). For the 
reaction 10 pi of whole cell homogenate or membrane was incubated for 10 
minutes at 37^C in 50 pi of 80 mM sodium phosphate buffer pH 7.25, 0.17 
mM leucyl-2-napthylamide and 0.3% (w/v) Triton-X-100. The reaction was 
terminated by the addition of 3 ml 0.1 M 2-amino-2-methyl propan-l-ol HC1 
buffer pH 10.4. The 2-napthylamide liberated was measured fluorimetrically 
in a LS-5 luminescence spectrophotometer using an excitation wavelength of 
340 nm and monitoring emmision at 410 nm. The fluorimeter was calibrated 
by measuring the flouresence of 4 methylumbelliferone between 0 and 0.5 
nmoles to form a standard curve. 1 nmole of 4 methylumbelliferone is the 
fluorescent equivalent of 36 pmole of 2-napthylamide. 4 
methylumbelliferone (lGmg) was dissolved in 1 ml of l-methyl-2 -pyrollidone 
then diluted to 10 mg/ml in water.
2.19.7. Acid p  Galactosidase and p  N Acetylglucosaminidase
P galactosidase and P N acetylglucosaminidase were assayed by the 
method of Peters et al (1972). In the assay 4-methylumbelliferyl-a-D- 
galactoside and 4-methylumbelliferyl-N-acetyl-P-D-glucosaminide were 
hydrolysed by P galactosidase and p N acetylglucosaminidase respectively to 
leave 4-methylumbelliferone which can be measured fluorimetrically. In the 
reaction 20 pi of whole cell homogenate or membrane was incubated with 40 
ml of buffer pH 4.5, containing 50 mM sodium acetate, 100 mM sodium 
chloride and 0.8% (w/v) Triton-X-100, on ice for 20 minutes to disrupt the 
lysosomes. A further 80 pi of acetate buffer containing 100 mM sodium 
chloride and 1 mM 4 methlyumbellifeiyl p galactoside or 0.4 mM 4
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methylumbellifeiyl (3 N acetylglucosaminidase was added and the reaction 
proceeded at 37®C for 10 minutes (P galactosidase) or 5 minutes (p N 
acetylglucosaminidase). The reaction was terminated by the addition of 3 ml 
of 0.1 M 2-amino-2-methyl propan-l-ol HC1 pH 10.4. The fluoresence of 
the 4 methylumbelliferone liberated was measured at 444 nm with an 
excitation of 364 nm on equipment as in 2.19.6. A standard curve of 4 
methylumbelliferone (0-0.5 nmoles) was constructed as in 2.19.6.
2.19.8 .Galactosyl Transferase
Galactosyl transferase was measured by its ability to transfer galactose 
from UDP-galactose to ovalbumin (Beaufay et al 1974). The assay cocktail, 
final volume 100 pi, consisted of 0.1 M sodium cacodylate pH 6.2,1.25 mM 
UDP [U-l^C] galactose diluted to a specific activity of 0.4 mCi/mmol with 
unlabelled UDP-galactose, 10 mM ATP, 10 mM MnCl2,30 mM 2- 
mercaptoethanol, 5% ovalbumin and 0.2% Triton-X-100. The reaction was 
initiated by the addition of 20  (il of commercial galactosyl transferase (0 -0.02  
units) or 20 pi of cell homogenate or membrane. The reaction proceeded at 
37°C for 60 minutes when 0.2 ml of 8% trichloroacetic acid (TCA) was 
added to terminate the reaction. The samples were centrifuged and the 
supernatant was discarded and the pellet washed three times with 8% TCA. 
After washing the pellet was dissolved in 0.8 ml IN NaOH by heating at 
80°C for 20 minutes. This solution was neutralised with 1 ml of IN acetic 
acid. The C]-galactose bound to ovalbumin was determined by counting
1.5 ml of the neutralised solution in 10 ml of ecoscint in a Beckman LS 6800 
scintillation counter.
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3. RESULTS.
CHARACTERISATION OF B 
LYMPHOCYTES AND PLASMA 
MEMBRANE.
CHAPTER 3
CHARACTERISATION OF B LYMPHOCYTES AND PLASMA 
MEMBRANE.
3.1. T CELL DEPLETION
There are two types of lymphocytes, B lymphocytes, distinguished 
by surface immunoglobulin, and T lymphocytes. This study has centered on 
the B lymphocytes. B lymphocytes were isolated from BALB/c mouse 
spleen, human peripheral blood and tonsils, all secondary lymphoid tissues. 
In the small lymphocyte population, both T and B lymphocytes are similar in 
size and are morphologically identical. T and B lymphocytes can only be 
distinguished phenotypically by the proteins on their cell surface.
3.1.1. Murine T cell Depletion
Murine T cell depletion was accomplished by the use of four 
monoclonal antibodies which are directed against antigens on T cell 
membranes, Thyl, Lytl, Lyt2 and L3T4, and complement.
The number of lymphocytes before T cell depletion was on average 1x108 
cells/spleen and after T cell depletion and percoll separation the number of 
resting lymphocytes was 2x10*7 cells/spleen as determined by simple cell 
counting. To ensure that there was selective depletion of T cells, two 
methods were used; responsiveness to mitogens and flow cytometry.
3.1.2. Determination o f Lymphocyte Population by Response 
to Mitogens
Concanavalin A (Con A) and lipopolysaccharide (LPS) are 
polyclonal activators of T and B cells respectively (Melchers & Anderson 
1984). When Con A and LPS are added to lymphocyte cultures T 
lymphocytes proliferate in response to Con A and B lymphocytes to LPS. 
Aliquots of lymphocytes were taken before and after T cell depletion. Both 
populations of cells were cultured with various concentrations of either Con
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Figure 5 Responsiveness of Purified B Lymphocytes to Concanavalin 
A and Lipopolysaccharide
Aliquots of lymphocytes from BALB/c spleen before and after T cell 
depletion were cultured in complete medium plus 50 pM 
mercaptoethanol in the presence of 0,5,10 and 50 |ig/ml of LPS or 
Con A for 24 hours. 1 pCi per well of [^H]-methyl thymidine was 
added in the last 6 hours of culture before harvesting. Cells were 
harvested onto nitrocellulose filters and cpm were determined by liquid 
scintillation counting (materials & methods 2.7.). Incorporation is 
represented as counts per minute and is the average of three 
determinations (x +/- SD, n=3).
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A or LPS for 24 hours as described in section 2.7. Proliferation of the cells 
in response to the mitogens was determined by measuring the incorporation 
of [^H] methyl thymidine into the cells in the last 6 hours of culture. Figure 
5 shows the results from such an experiment.
Lymphocytes from either population cultured in the absence of either 
mitogen showed veiy little incorporation of thymidine. This would be 
expected as the cells are in a quiescent state with no stimulus to drive them 
into the cell cycle. The cells before T cell depletion, which would consist of a 
mixture of T and B cells, responded to both mitogens at all concentrations 
showing a large increase in thymidine incorporation above the resting cells. 
The cell population present after T cell depletion, which should consist 
mostly of B cells, were stimulated to proliferate in response to LPS, a B cell 
mitogen. Incorporation of thymidine by the 'purified B' cells was similar to 
that seen in lymphocytes before T cell depletion at all the concentrations of 
LPS. The T cell mitogen, Con A, did not stimulate the B cell enriched 
population to proliferate. Incorporation of thymidine into the 'purified B' cell 
poulation in response to Con A was at the level of unstimulated cells at all 
concentrations of Con A.
These results demonstrate that before T cell depletion both T and B 
cells are present but after T cell depletion the cells are mostly B with very few 
T cells present, as demonstrated by their lack of response to Con A.
3.1.3. Estimation o fT  Cell Depletion by Flow Cytometry
The efficiency of T cell depletion was also estimated by the use of 
flow cytometry. Lymphocytes before and after T cell depletion were 
incubated with each of four rat IgG2b monoclonal antibodies specific to T 
cells, Thyl, Lytl, Lyt2 and L3T4. A second antibody conjugated to 
fluorescein isothiocyanate (FITC) was then used to detect the T cell specific 
antibodies. The fluorescence intensity of the cells was then determined by
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flow cytometry, which gave an indication of the number of T cells present in 
each population. Figure 6 shows plots of fluorescence intensity versus cell 
number for both cell populations stained with each of anti-L3T4, anti-Lytl 
and anti-Lyt2.
L3T4 is a protein found on all helper T cells. Figure 6 panel A 
shows the intensity of fluorescence of lymphocytes before and after T cell 
depletion stained for L3T4. The mean fluorescence of cells before T cell 
depletion was 250 and after 100. There has therefore been a reduction in the 
number of L3T4+ cells on T cell depletion. Autofluorescence of the cells has 
been accounted for but the 'purified B' cells are still quite heavily stained. 
Control experiments with second antibody alone showed that there was 
substantial non specific staining due to the second antibody.
Staining for T cells with anti-Lytl, found on all helper T cells, did 
not show a significant decrease in fluorescence on T cell depletion, figure 6 
panel B. This suggests that there has been virtually no depletion of T cells 
but this is contradictory to the experiments with anti-L3T4. Again the 
apparent staining of the 'purified B’ cell population is probably due to the non 
specific binding of the second antibody to the cells.
Lyt2 is a marker for cytotoxic and suppressor T cells. Staining for 
cells with anti-Lyt2, figure 6 panel C, showed a mean fluorescence intensity 
for cells before T cell depletion of 300 and after 100. Therefore there was 
less binding of anti-Lyt2 after T cell depletion suggesting that there has been a 
successful depletion of cytotoxic and suppressor T cells.
The results for the binding of anti-Thyl are displayed differently, 
figure 7, panel B, represents the fluorescence intensity of cells before T cell 
depletion minus the fluorescence due to non specific binding of the second 
antibody. Panel A is a similar representation of the population of cells after T
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Figure 6 Analysis of Murine T Cell Depletion by Flow Cytometry
Aliquots of BALB/c spleen cells were taken before and after T cell 
depletion and analysed for the presence of T cells by the use of T cell 
specific antibodies and flow cytometry. The cells were prepared for 
flow cytometry as described in materials & methods 2.10.
The first antibody was 25 pi of 1:100 dilution of 
A anti-L3T4 
B anti-Lytl 
C anti-Lyt2
The second antibody was 50 pi of a 1:50 dilution of anti-rat IgG F1TC. 
Each figure represents a plot of fluorescence intensity against cell 
number. Panel A, B and C show the traces for cells before and after T 
cell depletion, as indicated in the key beside each panel, minus 
autofluorescence of the cells.
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Figure 7 Analysis of Thyl on Murine Spleen Cells Before and Alter T 
Cell Depletion
Aliquots of B ALB/c spleen cells were taken before and after T cell 
depletion and analysed for the presence of T cells by the anti-Thyl and 
flow cytometry. The cells were prepared for flow cytometry as 
described in materials & methods 2.10.
The first antibody was 25 (il of 1:100 dilution of anti-Thyl and the 
second antibody was 50 pi of a 1:50 dilution of anti-rat IgG FITC. 
Panel B is the trace for anti-Thyl staining of T cells before depletion 
minus autofluorescence and non specific staining due to the second 
antibody. Panel A is in the same format representing cells after T cell 
depletion.
Panel A
Panel B
Thyl on 'purified B cells' - non specific staining 
Thyl on T  & B cells' - non specific staining
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cell depletion. There has been a decrease in the number of cells at the higher 
fluorescence intensity, 300, in the ’purified B' cell population but there is still 
binding of the anti-Thyl to the 'purified B' cells. Recent reports have 
indicated that Thyl is expressed on some murine B cells in response to LPS 
and IL-4 (Snapper et al., 1988a). If this is the case then some fluorescence 
might be expected from purified B cells if any of the cells have previously 
seen antigen. However, similar experiments using NIMR1, which 
recognises the Thy 1.2 determinant, showed a significant decrease in binding 
after T cell depletion suggesting that the T cells had been successfully 
depleted from the cell population (R. Butcher and W. Cushley personal 
communication). This suggests that it is non specific binding of the 
antibodies that is responsible for the observed binding in the 'purified' B cell 
population.
Identification of T cells by antibodies against cell surface proteins 
and analysis by flow cytometry has indicated a decrease in the number of T 
cells in the 'purified B' cell population. This depletion is not conclusive with 
all the antibodies used, mainly due to the non specific binding of the second 
antibody. If these results are taken together with the results from the mitogen 
responsiveness experiments there is evidence that the T cell depletion has 
been successful for murine spleen cells.
3.1.4. Human T cell Depletion
T lymphocytes from human peripheral blood and tonsils were 
separated by their ability to bind sheep red blood cells by a specific receptor, 
the CD2 molecule (section 2.3.1.). The efficiency of this T cell depletion 
was determined by flow cytometry. T and B lymphocytes were identified by 
simultaneous two-colour immunofluorescence using antibodies against CD3 
on T cells (which are FITC conjugated) and against CD 19 on B cells (which 
are PE conjugated).
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Figure 8 Analysis of T and B Lymphocytes from Human Tonsils by 
Flow Cytometry
Aliqouts of lymphocytes from human tonsils were taken before (A &B) 
and after (C &D) T cell depletion and analysed for the presence of T 
and B lymphocytes by simultaneous two colour immunofluorescence 
(CD3-FITC for T cells and CD19-PE for B cells). The cells were 
prepared for flow cytometry as described in materials and methods
2.10. The cells were incubated on ice for 20 minutes with 5 pi of 
simultest T and B cell test from Becton Dickinson. Lymphocytes were 
selected on the basis of forward and side scatter. The T cells are 
represented by green fluorescence on the x axis (FlTC-anti-CD3) and 
the B cells by red fluoresence on the y axis (PE-anti-CD19).
A nonspecific staining of T  and B' cells 
B T  and B' cells
C non specific staining of 'purified B' cells 
D 'purified B' cells
The lymphocytes were gated into quadrants on the basis of 
fluorescence and statistics were performed.
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Figure 9 Analysis of T and B Lymphocytes from Human Peripheral 
Blood by Flow Cytometry
Aliqouts of lymphocytes from human peripheral blood were taken 
before (A &B) and after (C &D) and analysed for the presence of T and 
B lymphocytes by simultaneous two colour immunofluorescence 
(CD3-HTC for T cells and CD19-PE for B cells). The cells were 
prepared for flow cytometry as described in materials and methods
2.10. The cells were incubated on ice for 20 minutes with 5 jil of 
simultest T and B cell test from Becton Dickinson. Lymphocytes were 
selected on the basis of forward and side scatter. The T cells are 
represented by green fluoresence on the x axis (FITC-anti-CD3) and 
the B cells by red fluoresence on the y axis (PE-anti-CD19).
A nonspecific staining of T  and B' cells 
B T  and B' cells
C non specific staining of 'purified B' cells 
D 'purified B’ cells
The lymphocytes were gated into quadrants on the basis of 
fluorescence and statistics performed.
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Figures 8 and 9 show the results obtained for tonsillar and peripheral 
blood lymphocytes respectively. Panels A and C represent non specific 
staining of the cells in each population. Panels B and D show the cells 
stained for T and B cells before and after T cell depletion respectively. 
Controls showed that there was very little non specific staining. In tonsillar 
cells 99% of cells (figure 8, panels A &C) were unstained and in peripheral 
blood greater than 90% of the cells were unstained in controls (figure 9, 
panels A &C). In lymphocytes before T cell depletion, as would be 
expected, both T and B cells could be detected. Peripheral blood comprised 
59% T cells and 7% B cells and 32% neither B or T cells (figure 9, panel B). 
After T cell depletion 27% B cells and 13% T cells could be detected (figure 
9, panel D). A large population of cells was unstained, 58%, which suggests 
that there are cells other than T and B lymphocytes in the preparation.
Cells from tonsils before T cell depletion consisted of 38% B cells 
and 56% T cells (figure 8, panel B). After T cell depletion the percentage of 
B cells was increased to 91% and T cells were reduced to 7% (figure 8, panel 
D). In tonsillar cells there were less than 5% of unstained cells suggesting 
that most of the cells in tonsils are T and B lymphocytes, which is consistent 
with it being a lymphoid tissue. In both tonsils and peripheral blood there 
has been a significant depletion of T cells and enrichment of B cells on T cell 
depletion. The results indicate that a purified B cell population was obtained.
3.2. Response of Resting B Lymphocytes to IL-4
3.2.1. Costimulation assay
In the mouse interleukin 4 has been shown to exert its effect 
primarily on small resting B cells or B cells in the early G] phase of the cell 
cycle. One of the properties of murine EL-4 is to act as a costimulant with anti 
Ig antibodies to cause entry of the B cells into the cell cycle (Howard et al., 
1982). A bioassay has been developed using this costimulator activity of IL-
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Figure 10 Costimulation Assay of Murine B Cells
High density resting B cells from BALB/c spleen (sections 2.3.1. &
2.3.3.) were cultured in complete medium plus 50 pM mercaptoethanol 
for 48 hours in the presence of ligands as indicated in the key. [^H] 
methly thymidine was added in the final 16 hours before harvesting the 
cells onto nitrocellulose filters (materials and methods 2.9.).
Thymidine incorporated into the cells was determined as counts per 
minute (CPM). (x +/- SD, n=6).
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4 on DBA/2 mice (Ohara et al 1985). This assay was used to ensure that the 
resting B cells prepared from BALB/c mice were responding to IL-4. 
Bioassays were performed (as described in 2.9.) where high density resting 
B cells from mouse spleen were cultured in medium alone or in the presence 
of anti IgM, IL-4 or anti IgM + EL-4 for 56 hours and [3H] methyl thymidine 
was added in the last 16 hours. The results from such an experiment are 
displayed in figure 10.
Cells cultured in medium alone exhibit only a low level of [^H] 
methyl thymidine incorporation as would be expected for resting B cells. 
There was little incorporation of [^H] methyl thymidine above control of the 
cells cultured with anti Ig. This observation is consistent with the work of 
Noelle et al (1983) and Cambier eta l (1982), which demonstrate that anti 
IgM alone does not drive B cells into the cell cycle unless at concentrations of 
greater than 50 (ig/ml. B cells cultured with IL-4 alone also exhibited little 
proliferation. When B cells were cultured with both anti IgM and IL-4 there 
was an increase in [3H] methyl thymidine incorporation from 2000 to 7000 
cpm indicating that the cells were being driven into the cell cycle. These 
results demonstrated that the resting B cells prepared from BALB/c mouse 
spleen were responsive to IL-4 in a anti-IgM costimulator assay.
3.2.2. Detection o f MHC Class II  Antigens by Flow Cytometry
One of the most dramatic effects of IL-4 on resting murine B 
lymphocytes is the 10-15 fold increase in expression of MHC class II 
antigens (Roehm et al., 1984; Noelle et al., 1984). Resting B lymphocytes 
and lymphocytes cultured in the presence of IL-4 for 24 hours were analysed 
for their expression of MHC class II antigens. MHC class II antigens were 
detected with an anti-la antibody and a second antibody conjugated to FTTC 
and analysed by flow cytometry (section 2.10.). Figure 11 compares the 
intensity of fluorescence, which is a measure of MHC class II expression, in
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Figure 11 Induction of MHC Class II Antigens by IL-4 on Murine B 
Cells
High density resting B cells and resting B cells cultured for 24 hours 
with IL-4 were prepared for flow cytometry (2.10.). The cells were 
stained with 25 fil of a 1:10 dilution of anti-mouse (I-A) followed by 
50 |il of 1:50 dilution of anti-rat IgG F1TC and then subjected to flow 
cytometry. The results are displayed as fluorescence intensity against 
cell number.
Panel A
. . . .  MHC class II expression in Go B cells
  MHC class II expression in IL-4 cultured B cells
Panel B
. . . .  MHC class II expression in Go B cells
  MHC class II expression in IL-4 cultured B cells
....... MHC class II expression due to IL-4 (by deducting
the fluorescence due to MHC class II expression on 
resting from B cells cultured with IL-4)
Panel C
  MHC class II expression due to IL-4 (by deducting
the fluorescence due to MHC class II expression on 
resting from B cells cultured with IL-4)
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resting cells and cells cultured with IL-4 (panel A). Resting B cells showed 
some expression of MHC class II antigens with a peak fluorescence of 40. 
Cells cultured with IL-4 showed a shift in fluorescence intensity with a peak 
fluorescence of 700. Panel B compares the fluorescence intensity of resting 
B cells and B cells cultured with IL-4 and shows the fluorescence that is due 
to culturing the cells with IL-4. This is more clearly demonstrated in panel C 
where the fluorescence observed represents the increase in MHC class II 
which is due to culturing the B cells with IL-4. Culturing B cells with IL-4 
has led to a 17 fold increase in MHC class II expression which is consistent 
with that observed by others. (Roehm et al., 1984; Noelle et al., 1984).
This provides further evidence that the B cells prepared from BALB/c spleen 
can respond to IL-4.
3.2.3. Response o f Human B Lymphocytes to Human
Interleukin 4
The responsiveness of the human B lymphocytes from peripheral 
blood and tonsils to IL-4 was determined by the increase in expression of 
CD23, the low affinity receptor for IgE. Culturing B lymphocytes with IL-4 
increases the expression of CD23 (Defrance et a l, 1987a). CD23 
expression was detected by using a monoclonal antibody against CD23 
followed by a secondary F1TC conjugated antibody. CD23 expression was 
measured in B cells from both peripheral blood (figure 12) and tonsils (figure 
13).
Figure 12, panel A represents the autofluorescence of B cells from 
peripheral blood cultured for 24 hours in the absence of ligand and the 
equivalent cells stained with second antibody only and stained for CD23 
expression. The autofluorescence of the B cells falls below an intensity of 
10. The was a little non specific staining of the cells with the second 
antibody but fluorescence due to the binding of the monoclonal antibody 
against CD23 could be clearly identified. Figure 12, panel B compares the
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expression of CD23 in B cells cultured for 24 hours in the presence and 
absence of IL-4. In both cases the non specific fluorescence due to the 
second antibody has been deducted. The mean peak fluorescence of B cells 
cultured in the absence of ligand is 11 whereas in the presence of ligand it has 
increased to 200. The fluorescence due to CD23 on IL-4 cultured B cells 
shows a wide spread suggesting that the amount of CD23 expressed per B 
cell is variable. It does demonstrate, however, that B cells isolated fom 
peripheral blood are responding to human IL-4 by increasing the expression 
of CD23.
The expression of CD23 on B cells isolated from tonsils was also 
determined. Figure 13 compares CD23 on B cells cultured in the absence of 
ligand, the presence of IL-4 and the presence of PMA and calcium ionophore 
for 24 hours. The mean peak fluorescence for cells cultured in the absence of 
ligand was 10 in tonsillar B cells. Culturing the B cells in the presence of IL- 
4 caused a shift in the fluorescence intensity to 50 although the peak was 
wide (panel A). B cells that were cultured in the presence of PMA and 
calcium ionophore showed levels of CD23 similar to the cells cultured in the 
absence of ligand (panel B). This indicated that the B cells were responding 
to IL-4 by increasing CD23 expression but this effect was not mimiced by 
PMA and calcium ionophore. PMA and calcium ionophore mimic the effects 
of growth factors that activate the hydrolysis of PtdInsP2 - The results from 
expression of CD23 would suggest that IL-4 does not act through PtdInsP2 
hydrolysis to increase CD23 expression. These results are substantiated by 
Finney et al (1989) who demonstrated that phorbol ester and calcium 
ionophore alone could not mimic the effect of IL-4 in inducing CD23 
expression. Exposure of the B cells to dibutyryl cAMP, which mimics 
cAMP elevation, phorbol ester and calcium ionophore did induce CD23 
expression. This suggests that the action of IL-4 on B cells may involve 
PtdInsP2 hydrolysis leading to the production of DAG and InsP3 but it also 
involves an intracellular messenger that elevates cAMP levels.
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Figure 12 Expression of CD23 on Human B Lymphocytes from 
Peripheral Blood
High density resting B cells separated from peripheral blood were 
cultured in complete medium plus 50 |iM 2 mercaptoethanol for 24 
hours with no additions or with 1000 units/ml rhIL-4. Cells were 
prepared for flow cytometry (section 2.10.) and stained with 25 jil of a 
1:10 dilution of anti-CD23 antibody followed by 50 pi of anti-mouse 
Fc-HTC (1:50). Lymphocytes were selected by their forward and side 
scatter. Dead cells were gated out by counter staining with propidium 
iodide. Non specific staining of the second antibody is shown on 
graph A and is deducted in graph B.
Panel A
  autofluorescence
. . . .  control cells stained with second antibody only
  control cells stained for CD23
Panel B
  autofluorescence
  control cells stained for CD23 - second antibody
  IL-4 treated cells stained for CD23 - second
antibody
r ' h  ih  il  i'i j 
101010
FL1
10
FL  1
101
Figure 13 Expression of CD23 on Human B Lymphocytes from 
Tonsils
High density resting B cells separated from tonsils were cultured in 
complete medium plus 50 pM 2 mercaptoethanol for 24 hours with no 
additions or with 1000 units/ml rhIL-4 or with 10 ng/ml PMA + 1 pM 
colimycin. Cells were prepared for flow cytometry (section 2.10.) and 
stained with 25 pi of a 1:10 dilution of anti-CD23 antibody followed by 
50 pi of anti-mouse Fc-FITC (1:50). Lymphocytes were selected by 
their forward and side scatter. Dead cells were gated out by counter 
staining with propidium iodide. Non specific staining of the second 
antibody was deducted in each case.
Panel A
  autofluorescence
  control cells stained with second antibody only
  IL-4 treated cells stained for CD23 - second
antibody
Panel B
  autofluorescence
  control cells stained for CD23 - second antibody
  PMA + colimycin treated cells stained for CD23 -
second antibody
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The B cells isolated from both peripheral blood and tonsils can 
respond to IL-4 by increasing the expression of CD23.
3.3. Expression of Cell Surface Receptors on B Lymphocytes
as Determined by Flow Cytometry
3.3.1. Expression o f Immunoglobulin on Murine and Human B 
Lymphocytes
B cells are distinguished by their expression of immunoglobulin on 
the membrane which is similar to secreted immunoglobulin except for an 
extra transmembrane portion. B cells initially express IgM and IgD at the cell 
surface. The expression of immunoglobulin on B cells isolated from BALB/c 
spleen was observed by staining the cells with an antibody against IgG 
(H+L) conjugated to FITC and analysis by flow cytometry. Resting cells, 
cells cultured for 24 hours in the absence or presence of IL-4 and cells 
cultured for 24 and 48 hours with LPS were analysed (figurel4, A & B). 
Resting cells had a high level of Ig as determined by fluorescence intensity 
with a mean peak of 250. The mean fluorescence peak was increased on 
culture to 500, which represents a two fold increase in Ig expression. The 
expression of Ig was not altered above 500 in cells cultured with IL-4 or 
LPS.
The expression of IgM was analysed on human tonsillar B cells by 
staining the cells with an antibody against human IgM conjugated to FITC 
and analysed by flow cytometry. Figure 15A shows the traces obtained for 
resting cells and cells cultured for 24 hours in the presence and absence of 
IL-4. Two peaks of fluorescence can be seen with mean peak fluorescence 
intensities of 7 and 100 in each case. Autofluorescence of the cells does not 
interfere with the fluorescence due to the anti-IgM FITC binding. This 
suggests that there might be two populations of cells one expressing more
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Figure 14 Expression of Immunoglobulin on Murine B Lymphocytes
High density resting B lymphocytes from BALB/c spleen were 
uncultured, cultured in the absence of ligand, the presence of 100 
units/ml rmIL-4 or 10 |ig/ml LPS for 24 hours or 10 |ig/ml LPS for 48 
hours. Aliquots of cells from each of these conditions was analysed 
for the expression of Ig. Cells were prepared for flow cytometry 
(section 2.10.) and stained with 5 |il anti-mouse IgG (H+L) FITC.
The cells were then analysed by flow cytometry gating out dead cells 
by counter staining with propidium iodide.
Panel A
- - - - autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured with 100 units/ml rmIL-4
Panel B
autofluorescence
  resting B cells (uncultured)
  B cells cultured for 24 hours with 10 jig/ml LPS
. . . .  B cells cultured for 48 hours with 10 |ig/ml LPS
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Figure 15 Expression of Immunoglobulin on Human B Lymphocytes
High density resting B cells were isolated from tonsils and analysed 
for expression of IgM. Resting B cells were also cultured for 24 hours 
in the absence of ligand, the presence of 1000 units/ml rhIL-4 or with 
10 ng/ml PMA + 1 jiM colimycin and analysed for IgM. The cells 
were prepared for flow cytometry as described in materials and 
methods 2.10. and stained with 5 pi 1:50 dilution of anti human IgM- 
FITC. Lymphocytes were selected by their forward and side scatter 
and dead cells were gated by counter staining with propidium iodide.
Panel A
  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured with 1000 units/ml rhEL-4
Panel B
  autofluorescence
  resting B cells (uncultured)
  B cells cultured with 10 ng/ml PMA + 1 |iM
colimycin
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IgM than the other. Alternatively the less bright peak may be due to non 
specific binding of the antibody. Figure 15B compares expression of IgM in 
resting cells and cells cultured for 24 hours with PMA and calcium 
ionophore. Again the cultured cells show the same pattern of IgM expression 
as the resting B cells.
The fact that all cells analysed in both mouse and human samples 
appear to express immunoglobulin suggests that they are B cells which is 
further evidence of the efficiency of T cell depletion. In both cases the 
expression of immunoglobulin does not appear to increase significantly on 
activation.
3.3.2. Expression o f Insulin Receptors on B Lymphocytes
Resting B lymphocytes from BALB/c spleen, lymphocytes cultured 
in the absence of ligand for 24 hours, the presence of IL-4 for 24 hours, the 
presence of LPS for 24 hours and the presence of LPS for 48 hours were 
analysed for the expression of insulin receptors. The cells were incubated 
with insulin conjugated to FITC and then analysed by flow cytometry.
Figure 16 shows the results obtained from such an analysis. Freshly isolated 
resting B cells demonstrated a peak fluorescence of 40. On culturing the cells 
in the presence or absence of IL-4 two peaks of fluorescence were observed; 
one at 40, equivalent to the uncultured cells, and a new brighter peak at 2000 
(panel A). The increased expression of the insulin receptor was observed on 
all cultured cells even in the absence of ligand, and culturing with LPS (panel 
B) or IL-4 did not increase expression any further. This means that culturing 
the B cells increases the expression of insulin receptors and this is probably 
due to factors that are present in the foetal calf serum. The less bright peak 
may be due to non specific binding of the label as the ligand was used to 
detect the receptor rather than an antibody against the receptor itself. 
Alternatively the two distinct fluorescent peaks observed on culturing may 
represent two different affinities of insulin receptor on B cells.
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Figure 16 Expression of Insulin Receptors on Murine B Lymphocytes
Resting B cells from BALB/c mouse spleen and B cells cultured in the 
absence of ligand, the presence of 100 units/ml rmIL-4, the presence of 
10 jig/ml LPS all for 24 hours or with 10 pg/ml LPS for 48 hours were 
analysed by flow cytometry for the expression of insulin receptors.
The cells were stained with 25 pi of a 1:10 dilution of FITC-insulin 
following the protocol for preparation of cells for flow cytometry 
(section 2.10.). Dead cells were gated by counter staining with 
propidium iodide.
Panel A
  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured in the presence of 100 units/ml
rmIL-4
Panel B
  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured for 24 hours with 10 |!g/ml LPS
  B cells cultured for 48 hours with 10}ig/ml LPS
3 5 0
10 10
FL 1
3 5  0
i u n i—
102 
FL 1
10 1010
107
Figure 17 Expression of Insulin Receptors on Human B Lymphocytes
High density resting B cells were isolated from human tonsils and 
analysed for the expression of insulin receptors. B cells were also 
cultured in the absence of ligand, the presence of 1000 units/ml rhEL-4 
or with 10 ng/ml PMA + ljiM colimycin for 24 hours and similarly 
analysed for expression of insulin receptors. The cells were prepared 
(section 2.10.), stained with 25 pi of insulin-FlTC (1:10) and 
subjected to flow cytometry.
Panel A
  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured in the presence of 1000 units/ml
rhIL-4
Panel B
  autofluorescence
  resting B cells (uncultured)
  B cells cultured with 10 ng/ml PMA + lpM
colimycin
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B lymphocytes from human tonsils showed a similar pattern of 
expression of insulin receptors to the murine B cells, figure 17. The resting 
B cells demonstrated one peak of fluorescence which had a mean value of 10. 
On culturing the cells two distinct peaks were again observed with a mean 
fluorescence intensity of 10 and 1000. Neither the presence of IL-4 or PMA 
and calcium ionophore increased the fluorescence above that observed with 
cells cultured in the absence of ligand.
3.3.3. Expression o f Transferrin Receptors on B Lymphocytes
Both murine and human B cells were analysed for the expression of 
transferrin receptors by the ability of the cells to bind transferrin labelled with 
FITC, figures 18 and 19 respectively. Murine and human B cells showed 
similar results. Freshly prepared resting mouse B cells had a mean peak 
fluorescence of 3 which was increased to 6 on culturing the cells either in the 
absence of ligand or the presence of IL-4 or LPS for 24 hours or LPS for 48 
hours. Resting uncultured human tonsillar B cells had a mean fluorescence 
intensity of 4 and showed no increase in fluorescence intensity on culture 
either in the absence of ligand or the presence of IL-4 or PMA and calcium 
ionophore for 24 hours. In both murine and human cells the level of 
fluorescence detected in the presence of FITC-transferrin was above the 
autofluorescence of the B cells. In cells that have entered the cell cycle, eg. 
LPS treated cells, the expression of transferrin receptors should have 
increased as the cells are synthesising DNA and some of the enzymes eg. 
ribonucleotide reductase require iron which enters the cell via the transferrin 
receptors. The failure to observe this increase in receptor expression may be 
explained by the fact that transferrin itself was used to detect the receptor.
The transferrin was labelled with FITC and this may have altered the 
specificity of the interaction of transferrin with the receptor and hence the 
failure to detect binding.
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Figure 18 Expression of Transferrin Receptors on Murine B 
Lymphocytes
Resting B cells from BALB/c mouse spleen and B cells cultured in the 
absence of ligand, the presence of 100 units/ml rmIL-4, the presence of 
10 pg/ml LPS all for 24 hours or with 10 pg/ml LPS for 48 hours were 
analysed by flow cytometry for the expression of transferrin receptors. 
The cells were stained with 25 pi of a 1:10 dilution of FITC-transferrin 
following the protocol for preparation of cells for flow cytometry 
(section 2.10.). Dead cells were gated by counter staining with 
propidium iodide.
Panel A
- —  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured in the presence of 100 units/ml
rmIL-4
Panel B
  autofluorescence
  resting B cells (uncultured)
  B cells cultured for 24 hours with 10 pg/ml LPS
. . . .  B cells cultured for 48 hours with lOpg/ml LPS
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Figure 19 Expression of Transferrin Receptors on Human B 
Lymphocytes
High density resting B cells were isolated from human tonsils and 
analysed for the expression of transferrin receptors. B cells were also 
cultured in the absence of ligand, the presence of 1000 units/ml rhIL-4 
and with 10 ng/ml PMA + lfiM colimycin for 24 hours and similarly 
analysed for expression of transferrin receptors. The cells were 
prepared (section 2.10.), stained with 25 |il of transferrin-FITC (1:10) 
and subjected to flow cytometry.
Panel A
  autofluorescence
  resting B cells (uncultured)
. . . .  B cells cultured in the absence of ligand
  B cells cultured in the presence of 1000 units/ml
rhIL-4
Panel B
  autofluorescence
  resting B cells (uncultured)
  B cells cultured with 10 ng/ml PMA + l|iM
colimycin
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3.3.4. Expression ofIL-2 Receptors on Human B Lymphocytes
The expression of the receptor for IL-2 on human tonsillar B cells 
was determined in cells cultured in the presence and absence of IL-4 by using 
a FITC labelled antibody against the IL-2 receptor, figure 20, panel A. In 
both cases the fluorescence detected was above the autofluorescence of the B 
cells. The mean fluorescence intensity of B cells cultured for 24 hours in the 
absence of ligand was 3 and in the presence the value was 8. The peak for 
the IL-4 cells showed a increase in fluorescence by the presence of a shoulder 
on the control peak. These results indicate that B cells that are cultured in the 
absence of ligand have some receptors for IL-2 on the surface which is 
increased when the cells are cultured with EL-4. These preliminary results 
have been further substantiated by simultaneous two and three colour 
experiments by others in the laboratory (R. Butcher and W. Cushley, 
personal communication).
3.3.5. Expression o f la  on Human B Lymphocytes
B cells isolated from human tonsils were cultured in the presence 
and absence of EL-4 for 24 hours and analysed for the expression of la. Cells 
were stained with an antibody against la labelled with FITC then subjected to 
flow cytometry, figure 20, panel B. The results show that the B cells express 
high levels of la with a mean peak fluoresence of 1500. The presence of EL-4 
does not appear to affect the expression of la above that of the control cells. 
The possibility that there is non specific binding cannot be ruled out It has 
been reported that human B cells endogenously express high levels of MHC 
class II antigens and therefore an increase is more difficult to detect (O'Gaira 
et al., 1988). Although, human EL-4 was observed to increase MHC class II 
expression on Burkitt lymphoma cell lines this has not been detected on 
normal human B cells (Rousset et al., 1988).
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Figure 20 Analysis of IL-2 Receptors and la Expression on Human B 
Lymphocytes
High density resting B cells were separated from human tonsils and 
cultured for 24 hours either in the absence (control) or presence of 
1000 units/ml rhIL-4. Expression of IL-2 receptors and la on the B 
cells was then determined. B cells were stained with 5 pi anti-IL-2 
receptor (FITC labelled), panel A or 5 pi anti la (FITC labelled), panel 
B and prepared for flow cytometry as described in section 2.10. 
Lymphocytes were selected by forward and side scatter and dead cells 
were gated by counter staining with propidium iodide.
Panel A
. . . .  autofluorescence
  control B cells stained for IL-2 Receptors
  IL-4 B cells stained for EL-2 Receptors
Panel B
. . . .  autofluorescence
  control B cells stained for la
IL-4 B cells stained for la
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3.4. Lipopolysaccharide as a Mitogen for Murine B
Lymphocytes
LPS is a polyclonal activator of murine resting B lymphocytes 
driving them into the cell cycle (Andersson et al., 1972). Polyclonal 
activators excite a large proportion of all resting B cells irrespective of their 
MHC haplotype. LPS drives about 25% of resting B cells to enter the cell 
cycle. To determine the responsiveness of B cells to LPS at various times 
after addition and the most effective concentration of LPS, resting B 
lymphocytes were cultured with 0, 2.5,5, 10 and 20 fig/ml LPS for 24,48, 
72 and 96 hours. Proliferation was measured by the uptake of pH] methyl 
thymidine which was added in the last 6 hours of culture (described in section 
2.8.). The cells were harvested onto nitrocellulose filters and counted.
Figure 21 is a representation of this experiment.
Resting B cells that were cultured in the absence of LPS show a very 
low incorporation of pH] methyl thymidine which indicates virtually no 
proliferation. At 24 hours the level of pH] methyl thymidine incorporation is 
low in response to LPS; the cells are just beginning to enter the cell cycle.
LPS activates B cells asynchronously and therefore at early stages after 
addition of LPS only a small number of cells may show signs of activation 
which would account for the low levels of proliferation observed at 24 hours. 
Wetzel & Kettman (1981) observed a lag in the response of cells to LPS of 
up to 24 hours. Beyond 24 hours, all the cells that can be activated by LPS 
should have entered the cell cycle and this was the case after 48,72 and 96 
hours of culture with LPS. The cells showed the greatest response to LPS 
after 48 hours of culture and this was beginning to fall after 72 hours and was 
reduced to nearly background after 96 hours. After several cell divisions the 
LPS may become rate limiting and the cells can fall back to resting state. LPS 
also induces some B cells to become secrete immunoglobulin which would 
reduce proliferation (Andersson et al., 1972).
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Figure 21 The Mitogenic Effect of Lipopolysaccharide on B 
Lymphocytes Measured by the Uptake of pH]-methyl Thymidine
High density resting B cells isolated from murine spleen were cultured 
in complete medium including 50 pM 2-mercaptoethanol. 
Lipopolysaccharide was added to the cultures at 0, 2.5, 5,10 and 20 
jig/ml. The B cells were cultured for 24,48, 72 and 96 hours and 1 
pCi of pH]-methyl thymidine was added to each well in the last six 
hours of culture (materials & methods 2.8.). The cells were harvested 
onto nitrocellulose filters and counted. The pH] methyl thymidine 
incorporated is presented as counts per minute and is the mean value of 
three determinations, (x = +/- SD, n=3)
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It was observed that at all concentrations of LPS the incorporation of 
[^H] methyl thymidine was similar. The LPS concentration between 2.5 and 
20 |Xg/ml did not seem critical and a concentration of 10 fig/ml LPS was 
chosen for subsequent cultures.
3.5. Characterisation of Plasma Membrane
With the simple procedure for plasma membrane preparation that has 
been employed it was necessary to ensure that there was an enrichment in 
plasma membrane with minimal contamination from other cellular 
compartments. This was accomplished by comparing the SDS-PAGE 
profiles of homogenised whole cells and membranes by silver staining 
(Figure 22) and, more specifically, by evaluating enzyme activities that are 
characteristic of each cellular compartment in both crude homogenates and 
putative cell membrane fraction. Enzyme activities have been compared in B 
cells from BALB/c mouse spleen and cells from the Daudi cell line and are 
summarised in tables 2 and 3.
3.5.1. Visualisation o f Whole Cell and Membrane Profiles by
Silver Staining
Proteins from whole cells and the prepared membranes from both 
BALB/c spleen cells and Daudi cells were separated by gel electrophoresis. 
The proteins were visualised by silver staining described by Wray et al 
(1981). This technique for visualising proteins is very sensitive and can 
detect nanogram levels of proteins. Figure 22 shows a silver stained gel of 
proteins from the whole cell homogenate and plasma membrane from mouse 
B cells and Daudi cells. Comparison of cell homogenate and plasma 
membrane shows that several proteins that are present in the cell homogenate 
are missing or depleted in the plasma membrane. In membranes prepared 
from spleen proteins of molecular weights 94,53,51 and 46 kDa have been 
reduced. Daudi cells show several proteins between 64 and 78 kDa and also
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Figure 22 Silver Stained SDS Gel of B Cell Homogenate and Plasma 
Membrane
25 jig of protein from mouse resting B cell homogenate (lane 2), 
plasma membrane (lane 3) and cell homogenate (lane 4) and plasma 
membrane (lane 5) from Daudi cells were separated on a SDS gel. The 
proteins were visualised by silver staining (section 2.22.). Lane 1 
contains low molecular weight markers.
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proteins of 47,42, 33 and 32 kDa which cannot be detected in the 
membranes prepared from these cells. This would be expected as any 
proteins representative of cellular compartments other than the plasma 
membrane eg. cytosol or golgi should have been removed. In some cases a 
depletion rather than a complete absence is observed which is due to the fact 
that the method of protein detection is veiy sensitive and therefore even the 
smallest amount of contamination can be detected. With other proteins there 
is an enrichment observed in the plasma membrane fraction rather than a 
depletion, for example in membranes from spleen cells there are proteins of 
molecular weight 42,31,27 and 24 kDa which present in a greater amount 
than is observed in whole cells. This enrichment is due to the proteins 
representative of the plasma membrane as there will be more of them per mg 
of protein. The differences observed between the whole cell homogenate and 
plasma membrane in both mouse B cells and Daudi cells suggest that a partial 
purification has been obtained. These differences cannot be assigned to the 
loss or gain of specific proteins only an overall increase or decrease in 
protein. A more specific method of ensuring purified plasma membrane is by 
using marker enzymes.
3.5.2. Lactate Dehydrogenase
Lactate dehydrogenase has been located in two subcellular 
compartments, the mitochondrion and the cytoplasm. The two activities can 
be separated by performing the assay (2.19.1.) in the absence and presence 
of Triton-X-100, a detergent which is needed to disrupt the mitochondria. In 
the absence of Triton-X-100 the activity of the free, cytosolic, lactate 
dehydrogenase can be measured and in the presence of Triton-X-100 the 
latent activity is released and so total lactate dehydrogenase activity is 
measured. If the free activity is subtracted from the total activity a measure of 
the latent activity can be obtained which is mostly due to the mitochondrial 
lactate dehydrogenase.
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The cytosolic lactate dehydrogenase was typically 0.127 units/mg in 
the whole cell homogenate compared to 0.022 units/mg in the membrane of 
splenic mouse B cells, a decrease of 83%, and the mitochondrial lactate 
dehydrogenase also showed a decrease from 0.082 units/mg to 0.046 
units/mg. In Daudi cells there was a 89% decrease in the cytosolic lactate 
dehydrogenase from 0.890 units/mg to 0.097 units/mg and a 75% decrease in 
mitochondrial from 0.223 units/mg to 0.065 units/mg (table 3). These results 
indicate that there was substantially reduced lactate dehydrogenase activity in 
plasma membrane compared to whole cell homogenate in both mouse spleen 
cells and Daudi cells. The activities have been decreased between 70-80% 
and therefore this indicates that the plasma membrane fraction is significantly 
depleted of cytoplasm and mitochondria.
3.5.3. Catalase
Catalase is an enzyme which can be used as a cytoplasmic marker, 
since its activity is specifically found in peroxisomes (Darnell et al., 1986). 
Catalase displays considerable latency and the assay was therefore performed 
in the presence of Triton-X-100 (described in section 2.19.2.). Tables 2 and 
3 show the values obtained for catalase in Daudi and mouse B cells and 
membranes. Daudi cells showed levels of catalase activity of 30.08 units/mg 
which was reduced to 9.28 units/mg in the membranes, a decrease of 69%. 
Mouse B cells had an activity of 4.64 units/mg compared to 1.37 units/mg in 
membranes, a 70% reduction. These results are consistent with those 
obtained for lactate dehydrogenase in that there is minimal contamination in 
the membrane fraction from the cytoplasm.
3.5.4. Fumarase
Fumarase forms part of the Krebs cycle and is, therefore, located in 
the mitochondria. Fumarase activity was measured by following the 
production of fumarate from the dehydration of malate (Hill & Bradshaw 
1969) (described in section 2.19.3.). The assay was performed in the
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presence of Triton-X-100 to allow the release of fumarase from any unbroken 
mitochondria. In the mouse spleen (table 2) the whole cell homogenate had 
0.020 units/mg of fumarase activity and the plasma membrane contained 
0.002 units/mg, a reduction of 90%. Daudi cells (table 3) showed similar 
levels of fumarase activity with 0.015 units/mg in whole cell homogenates 
and 0.005 units/mg in membranes, a decrease of 66%. This showed a 
substantial reduction in mitochondria in the plasma membrane which was 
consistent with the findings for lactate dehydrogenase.
3.5.5. NADPH-Cytochrome C Reductase
NADPH-cytochrome C reductase is an enzyme found in the
endoplasmic reticulum. Cytochrome C acts as an electron acceptor when 
NADPH is oxidised to NADP+. NADPH-cytochrome C reductase was 
assayed by the method of Williams and Kamin (1962) (described in section
2.19.4.). In mouse B cells (table 2) 1.54 x 10~2 units/mg of NADPH- 
cytochrome c activity was detected and 5.29 x 10-3 units/mg in the membrane 
fraction. This represented a 66% depletion of NADPH-cytochrome c 
reductase from the membrane fraction. In Daudi cells (table 3) there was a 
decrease of 100% from 6.97 xlO -4 units/mg in whole cell homogenates to 
no detectable level in the membranes. From these results it was assumed that 
there was a significant depletion of endoplasmic reticulum in the membranes.
3.5.6. 5 r nucleotidase
5' nucleotidase was assayed by the method of Newby et al (1975) 
as described in materials and methods (2.19.5.). 5' nucleotidase has been 
confirmed to be an ectoenzyme present exclusively on the cell surface in 
mouse lymphocytes (Uusitalo & Kamovsky 1977a) and it can therefore be 
used as a marker for plasma membrane. The amount of 5* nucleotidase 
found in homogenate from mouse B cells was 0.013 units/mg and in Daudi 
cells 0.001 units/mg compared to 0.150 units/mg in membranes from mouse 
B cells and 0.008 units/mg in Daudi membranes (tables 2 and 3). The levels
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of 5' nucleotidase indicated that in membrane prepared from mouse B cells 
there was a 12 fold enrichment, and in membranes prepared from Daudi cells, 
an 8 fold enrichment. These increases are consistent with the findings of 
other workers. Ferber et al (1972) saw an enrichment by a factor of 25 in 
lymphocyte plasma membranes, in human thymocyte plasma membrane a 16 
fold increase was reported (Allan & Crumpton 1972) and in plasma 
membrane a 12-16 fold increase in 5’ nucleotidase activity was observed 
(Avruch & Wallach 1971). Although the increases observed in 5' 
nucleotidase activity in plasma membranes are consistent the levels detected 
are variable. It has previously been reported that lymphocytes isolated from 
the spleen have six times the amount of 5' nucleotidase activity than 
lymphocytes isolated from the thymus (Uusitalo & Kamovsky 1977a). It has 
been suggested that there are two populations of lymphocytes with respect to 
5‘ nucleotidase activity, one population with 51 nucleotidase on their surface 
and the other with none (Uusitalo & Kamovsky 1977b). The proportion of 
positive cells changes within a population and this suggests the reason why 
results are variable giving high standard deviations. The reason for the 
different populations is unknown.
From the results shown in tables 2 and 3 it is evident that there has 
been a 90% increase in the amount of 5' nucleotidase in the membranes 
compared to the whole cell homogenate thus suggesting that there has been a 
substantial enrichment in plasma membrane.
3.5.7. Leucylaminopeptidase
Leucylaminopeptidase is an enzyme located on the plasma 
membrane. It was measured as described in materials and methods (2.19.6.) 
by a modification of the method of Wachsmith et al (1966). The amount of 
pmoles of 2 napthylamide liberated was calibrated from a standard curve 
prepared by measuring the fluorescence of known amounts of 4 
methylumbelliferone. In mouse B cells an average value of 128 pmoles/mg
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of protein was obtained which was increased to 172 pmoles/mg in 
membranes. This only represents an increase of 25% which could be 
explained by the fact that small high density B cells already have a high 
plasma membrane to cytoplasmic ratio and therefore the increase may not be 
as significant as would be expected with cells that have a smaller plasma 
membrane to cytoplasmic ratio. In Daudi cells the amount of napthylamide 
liberated was 27 pmoles/mg in whole cell homogenate and 60 pmoles/mg in 
membranes which represents an increase of 55%. It has been reported by 
Evans (1978) that the amounts of leucylaminopeptidase vaiy in different 
plasma membranes which would explain the different amounts detected here. 
The results show a small but significant increase in leucylaminopeptidase in 
the membrane preparation, therefore, there is an enrichment for plasma 
membrane.
3.5.8. p N  Acetlyglucosaminidase and p  Galactosidase
P N acetlyglucosaminidase and P galactosidase are the most active of 
the P glycosidases. They are found in the lysosomes which are cytoplasmic 
particles involved in acid hydrolysis, p N acetylglucosaminidase and p 
galactosidase were assayed by the method of Peters et al (1972) (described 
in section 2.19.7.). In the assay 4-methylumbelliferyl-a-D-galactoside and 
4-methylumbellifeiyl-N-acetyl-p-D-glucosaminide are hydrolysed by P 
galactosidase and p N acetylglucosaminidase, respectively, to yield 4- 
methylumbelliferone which can be measured fluorimetrically. A standard 
curve of the fluorescence of 4-methylumbelliferone was prepared and the 
values for the whole cell homogenate and membrane were determined from 
this (tables 2 and 3). The amount of P galactosidase found in B cells from 
mouse spleen was 5053 pmoles/mg of protein and this was reduced to 4308 
pmoles/mg in membranes. In Daudi cells 2875 pmoles/mg were found and 
1532 pmoles/mg in membranes prepared from these cells. These values only 
represent depletions of 15% and 47% in mouse B cells and Daudi cells 
respectively. Looking at the levels of P N acetyl glucosamine, tables 2 and 3,
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again the membranes still have a lot of activity. Mouse B cells recorded 
amounts of 5266 pmoles/mg in the whole cell homogenate and 5000 
pmoles/mg in membranes and Daudi cells 2406 pmoles/mg and 1234 
pmoles/mg in the membranes. This only represents depletions of 5% and 
49%. There may therefore be some contamination in the membranes from 
lysosomes. The contamination is contradicatory to the results obtained from 
the other enzymes assayed. Lysosomes are cytoplasmic particles and lactate 
dehydrogenase and catalase indicated that there was minimal contamination 
from the cytoplasm. It could be that as the assay is sensitive and the (3 
glycosidases are very active that the values indicated for (3 galactosidase and 
P N acetyl glucosamine are therefore, an over estimation.
3.5.9. Galactosyl Transferase
Galactosyl transferase has been found to be concentrated in the golgi 
(Fleischer et al 1969). Galactosyl transferase activity was measured by 
using ovalbumin as an acceptor for galactose (described in materials and 
methods 2.19.8.). The transfer of galactose from UDP-galactose to 
ovalbumin has been found to be proportional to the concentration of 
galactosyl transferase (Beaufay et al 1974). The plasma membrane has a 
galactosidase activity which can hydrolyse the galactose from UDP giving 
false results but the assay cocktail is such that it does not promote the activity 
of this enzyme. In membrane prepared from mouse B cells, the activity of 
galactosyl transferase was 0.09 units/mg, a decrease of 53%, compared to the 
levels in the whole cell homogenate, 0.19 units/mg. In Daudi cells a value of 
0.032 units/mg was detected compared to 0.009 units/mg in the membrane, a 
decrease of 72%. From these results the putative plasma membrane is 
substantially free from golgi membrane. This is particuarly important as 
golgi and plasma membrane have similar densities in sucrose gradients which 
may have resulted in copurification (Evans 1978).
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Table 2 Enzyme Marker Activities in Murine B Lymphocytes
Table 2 represents the amounts of each enzyme found in homogenates 
of mouse B cells and the putative plasma membranes (materials and 
methods 2.19.1.-2.19.8.). The values shown are averages of values 
obtained over several experiments. Values are expressed as specific 
activities (units/mg) except for leucylaminopeptidase, p N 
acetylglucosamine and P galactosidase which are expressed as pmoles 
product/mg protein.
TABLE 2 Enzyme Marker Activities in Murine B Lymphocytes
Enzyme Specific Activities (units/mg protein)
Homogenate Membrane
Lactate Dehydrogenase
cytoplasmic 0.127 0.022
mitochondrial 0.082 0.046
Catalase 4.64 1.37
Fumarase 0.020 0.002
NADPH-Cytochrome C reductase 0.0154 0.00529
5'Nucleotidase 0.013 0.150
Galactosyl transferase 0.190 0.090
Leucylaminopeptidase (pmoles/mg) 128 172
p galactosidase (pmoles/mg) 5053 4308
P N acetylglucosaminidase 5266 5000
(pmoles/mg)
Table 3 Enzyme Marker Activities in Daudi Cells
Table 2 represents the amounts of each enzyme found in homogenates 
of Daudi cells and the putative plasma membranes (materials and 
methods 2.19.1.-2.19.8.). The values shown are averages of values 
obtained over several experiments. Values are expressed as specific 
activities (units/mg) except for leucylaminopeptidase, P N 
acetylglucosamine and p galactosidase which are expressed as pmoles 
product/mg protein.
TABLE 3 Enzyme Marker Activities in Daudi Cells
Enzyme Specific Activities (units/mg protein)
Homogenate Membrane
Lactate Dehydrogenase
cytoplasmic 0.890 0.097
mitochondrial 0.223 0.065
Catalase 30.08 9.28
Fumarase 0.015 0.005
NADPH-Cytochrome C reductase 0.000697 0
5'Nucleotidase 0.001 0.008
Galactosyl transferase 0.032 0.009
Leucylaminopeptidase (pmoles/mg) 27 60
P galactosidase (pmoles/mg) 2875 1532
P N acetylglucosaminidase 
(pmoles/mg)
2406 1234
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3.5. Evaluation of Plasma Membrane
Comparison of enzyme activities in cellular homogenate and the 
putative plasma membrane fraction indicate that a high purity of plasma 
membrane has been attained. In both Daudi and mouse spleen cells a 
minimum of 70% reduction in contaminating cellular compartments has been 
achieved whereas there has been a substantial enrichment in plasma 
membrane as determined by leucylaminopeptidase and 5' nucleotidase. 
Protein profiles of homogenised whole cells and plasma membranes indicated 
several differences with reductions of some proteins and enrichment of 
others.
The protein profiles of splenic B cells and Daudi cells show several 
differences as determined by SDS-PAGE. These differences are 
substantiated by the enzyme activities found in the different cell types. Daudi 
cells have higher levels of the cytosolic and mitochondrial enzymes and lower 
levels of plasma membrane enzymes. This is consistent with the fact that 
resting B cells, such as those from mouse spleen, are small and, therefore, 
have a high surface area to cell volume ratio. Resting B cells are therefore a 
good source of plasma membrane and contamination should be minimal 
because of the small amount of cytoplasm. Daudi cells because they are B 
cell lymphomas are continually proliferating and, therefore, contain more 
cytoplasm consequently more mitochondrial and cytoplasmic associated 
enzymes. The evidence however, suggests that in both Daudi and splenic 
resting B cells the plasma membrane has been substantially purified.
3.6. Discussion
The data from chapter three indicate that the methods employed to 
obtain a 'purified' B cell population from a 'mixed' lymphocyte population 
were sucessful. In the separation of B cells from murine spleen this was 
demonstrated by the use of antibodies against molecules on the T cell surface 
in conjunction with flow cytometry and secondly by the response of the cells
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to T and B cell specific mitogens. The efficiency of human B cell separation 
from tonsils and peripheral blood was demonstrated by simultaneous two 
colour immunofluorescence using antibodies against CD3 on T cells and 
CD19 on B cells. This method indicated that a substantial enrichment in B 
cells had been obtained. Anti-immunoglobulin studies on both murine and 
human ’purified' B cells further demonstrated that the population of cells was 
greater than 90% B cells. Both murine and human B cells were assessed for 
their response to the lymphokine IL-4. Murine B cells demonstrated 
proliferation in a costimulator assay with anti-IgM and showed a 17 fold 
increase in MHC class II expression after 24 hours in culture with IL-4. The 
effect of IL-4 on human B cells was demonstrated by an increase in CD23 
expression after culture with IL-4. Human B cells were also shown to 
express la but this was at a high level even in the absence of ligand in the 
culture medium. Culturing human B cells with IL-4 increased the expression 
of the IL-2 receptor.
Insulin receptors were expressed on both murine and human B cells. 
Transferrin receptor expression was low and this was possibly due to using 
FITC labelled transferrin to detect the receptor.
The purity of the plasma membrane prepared from the B cells was 
analysed by silver staining of SDS-PAGE gels showing a comparison of 
whole cell proteins and plasma membrane protein. This technique showed an 
enrichment in some proteins in the plasma membrane and a depletion in 
others. The plasma membrane was further analysed for purity by measuring 
enzyme activities that are specific to cellular compartments. These enzyme 
assays indicated that the ’putative' plasma membrane contained very little 
contamination from other cellular compartments.
127
4. RESULTS.
THE EFFECTS OF IL-4 ON 
PROTEIN KINASE 
ACTIVITIES IN RESTING 
AND MITOGEN-ACTIVATED 
B CELLS
CHAPTER 4
THE EFFECTS OF EL-4 ON PROTEIN KINASE ACTIVITIES IN 
RESTING AND MITOGEN ACTIVATED B CELLS
4.1. TC A Precipitation of Total Phosphorylated Membrane
Protein from Resting Murine B Lymphocytes 
Membranes prepared from high density resting murine B 
lymphocytes were phosphorylated with y-[32p] ATP in the presence or 
absence of IL-4. After termination of the kinase reaction, three 5 pi aliquots 
were removed from each reaction for TCA precipitation (described in 2.13.). 
A comparison of the total membrane protein phosphorylation in the presence 
and absence of IL-4 in seven independent experiments is given in table 4.
In five out of seven of the experiments represented there is an increase in total 
membrane phosphorylation when IL-4 is present in the kinase assay. The 
increase in [^^P]-phosphate incorporation in the presence of EL-4 is variable 
ranging from 6-42% greater than when IL-4 was absent from the assay. In 
the other two experiments represented there is a decrease in total phosphate 
incorporation in the presence of IL-4. It appears therefore that there is some 
variability in the incorporation of phosphate into membrane proteins between 
experiments. In the majority of experiments an increase in phosphate 
incorporation is observed in the presence of IL-4 but this increase is variable. 
Technically, the efficiency in washing of the filter papers may account for 
part of the discrepancy. In this experiment the effect of IL-4 on total 
membrane protein is quantitated rather than the effect on individual proteins.
It is therefore a combined effect that is being observed which may involve the 
phosphorylation of some proteins and the dephosphorylation of others. In 
individual experiments, this may cause a variation in total phosphorylation.
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Table 4 Total Incorporation of Phosphate into Membrane 
Proteins
Membranes from high density resting murine B cells were 
phosphorylated in the absence and presence of 10 units of IL-4 (section 
2.12.). Three 5 |il samples were removed from the terminated reaction 
and spotted onto filter discs. The proteins were precipated with 10% 
ice cold TCA (section 2.13.) and the [32p]-phosphate incorporated into 
the proteins determined by liquid scintillation counting. Table 4 
displays the results of seven representative experiments expressed in 
cpm (x +/- SD, n=3).
TABLE 4:- Total incorporation of phosphate into membrane proteins.
NqIL-4
8047 ± 720 
5898 ± 1313 
9259 ± 126 
15516 ± 2241 
2413 ± 52 
7265 ± 1135 
24064 ± 1636
±-JL-4
13950 ±  3299 
7244 ±1378  
9850 ± 51 
15248 ±  2633 
3164 ±  725 
6572 ± 617 
28715 ±  3707
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4.2. Thin layer electrophoresis of total phosphorylated
membrane protein 
To try and identify if phosphorylation of a particular amino acid was 
responsible for the changes in total phosphorylation of membrane proteins 
observed in the presence of IL-4, phosphorylated membrane proteins from 
resting murine B cells were subjected to acid hydrolysis (section 2.16.) and 
the resulting phosphoamino acids separated by two dimensional thin layer 
electrophoresis (section 2.17.) (figure 23). Phosphorylation of the 
membrane proteins were performed in the presence (B) and absence (A) of 
IL-4. Three phosphoamino acids could be identified by the use of standard 
phosphoamino acids, phosphoserine, phosphothreonine and 
phosphotyrosine. From the autoradiograph of the thin layer plates it appears 
that incorporation into all three phosphoamino acids is increased in the 
presence of IL-4. The phosphoamino acids were quantified by scraping each 
amino acid from the thin layer plate and counting the radioactivity. Table 5 
shows the results from three experiments. This confimed that there was an 
increase in all three phosphoamino acids in the presence of IL-4. In the first 
of the experiments it appears that phosphorylation of tyrosine increased 75% 
compared to increases of 44% and 33% for serine and threonine respectively. 
This would suggest that IL-4 causes the greatest increase in tyrosine 
phosphorylation. This observation is not supported by the second two 
experiments where the phosphate incorporation into all three amino acids is 
approximately equivalent. Phosphotyrosine, however, accounts for the 
smallest percentage of total acid stable phosphate in proteins, only 0.05%, 
whereas phosphoserine and phosphothreonine account for 90% and 10%, 
respectively (Sefton et al., 1980). An increase in phosphotyrosine is 
therefore more significant as this phosphoamino acid is less abundant in cells.
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Figure 23 Incorporation of Phosphate into Phosphoamino Adds
Membrane proteins from resting murine B cells were phosphorylated in 
the absence (A) and presence (B) of 10 units of IL-4 (section 2.12.). 
The reaction was terminated by protein precipitation and the proteins 
were then acid hydrolysed (materials & methods 2.16.). The 
hydrolysed proteins were mixed with a mixture of three standard 
phosphoamino acids and subjected to two dimensional thin layer 
electrophoresis (section 2.17.) to allow separation of phosphoamino 
acids. The standard phosphoamino acids were visualised.by ninhydrin 
staining and the labelled phosphoamino acids were visualised by 
autoradiography.
Y = phosphotyrosine 
T = phosphothreonine 
S = phosphoserine 
P = free phosphate
A. Rest ing B c e l l  membrane
0 ^  0
^  1 s t  d imens ion  w
B. R e s t i n g  B c e l l  membrane + IL-4
 T7~h~ : ©1st  dimension
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Table 5 Incorporation of Phosphate into Phospho Serine, Threonine 
and Tyrosine
The incorporation of phosphate into serine, threonine and tyrosine was 
determined by excising the separated phosphoamino acids from TLE 
plates such as that described in figure 23. Each individual 
phosphoamino acid was then counted in 3 ml ecoscint in a Beckman 
scintillation counter. Table 5 represents the results of three individual 
experiments expressed in cpm.
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TABLE 
5. Incorporation 
of phosphate into phospho-serine, threonine and 
tyrosine.
,4.3. Effect of Interleukin 4 on Membrane Phosphorylation in
Resting Murine B Lymphocytes
High density resting B cells from BALB/c mouse splenocytes were 
isolated from the 1.08/1.09 g/ml interface of a percoll gradient (described in 
materials & methods 2.3.1.& 2.3.3.). Membranes were prepared from these 
cells and the proteins were phosphoiylated in kinase assays (Figure 24) in the 
presence (track b) and absence (track a) of recombinant murine IL-4 (10 
units/assay). The membrane phosphoproteins were separated by SDS PAGE 
and visualised by autoradiography.
An overall enhancement of phosphate incorporation was observed in 
the presence of IL-4. This enhancement is consistent with the increase in 
phosphate incorporation observed in TCA insoluble material in the presence 
of IL-4 and in the increase in [^^P]-phosphate uptake into serine, threonine 
and tyrosine observed with thin layer electrophoresis. There is however a 
specific increase in phosphorylation of a protein marked by the arrow on 
figure 24 in the presence of IL-4. In a number of independent experiments 
the molecular weight of this protein consistently fell within the range of 40-44 
kDa. It is thought that this phosphoprotein is identical to the 42 kDa protein 
previously described by Justement et al (1986) and was therefore termed 42 
kDa. To determine the increase in intensity of phosphorylation of the 42 kDa 
protein the autoradiograph was analysed by linear laser densitometry. Figure 
25 illustrates the intensity of the phosphorylated proteins in the presence and 
absence of IL-4 as determined by densitometry of the autoradiograph. The 
intensity of three proteins, 62 kDa, 51 kDa and 42 kDa observed on the 
autoradiograph have increased in the presence of IL-4. There is a low level 
of phosphorylation of the 42 kDa protein in the absence of IL-4 constituting 
3.75% of the total area under the graph. This was increased to 7.15% in the 
presence of IL-4. The two higher molecular weight proteins constitute 7.8% 
and 9.4% respectively of the total area under the graph in the absence of EL-4.
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Figure 24 Membrane Phosphoprotein profiles from Murine Resting B 
Lymphocytes
Aliquots of 50 fig of membrane protein prepared from high density 
resting B cells were incubated on ice for 3 minutes with 10 pCi y- 
[32p]-ATP in the absence (track a) or the presence (track b) of 10 units 
rmIL-4 (described in materials & methods 2.12.). The reactions were 
terminated by the addition of SDS-PAGE sample buffer and the 
proteins separated by gel electrophoresis and visualised by 
autoradiography. Low molecular weight markers were run on the gel 
and visualised by coomassie blue staining. The arrow indicates a 
phosphoprotein of 42 kDa.
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Figure 25 Laser Densitometry of Autoradiographs of Phosphoprotein 
Profiles
The autoradiograph of figure 24 was subjected to densitometry using 
the Bio-Rad 620 system. The profiles shown were obtained with 
background subtraction but without filtering, enhancement or boosting. 
The data were resolved by automatic integration on the Olivetti M24 
system. The top panel illustrates the trace for unstimulated membrane 
phosphoproteins and the lower panel shows the equivalent data for the 
IL-4 stimulated samples. The positions of the origins and the dye front 
correspond to those indicated on the original autoradiograph (figure
23), and the position of the 42 kDa protein is also indicated. The x axis 
of the figures represent migration (mm), while the y axis represent 
optical density.
Dye f rontOrigin
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In the presence of IL-4 this is increased to 10.8% and 10.7% respectively. 
The results from densitometiy are consistent with the fact that IL-4 is 
inducing protein phosphorylation in high density resting murine B 
lymphocytes. An attempt was made to determine which amino acid was 
phosphorylated on the 42 kDa protein. This was performed by eluting the 42 
kDa protein from the gel, hydrolysing it and separating the phosphoamino 
acids by thin layer electrophoresis, as described in materials and methods
2.16.1.-2.17. Due to the low incorporation of [^^P]-phosphate into the 42 
kDa protein, possibly due to the low numbers of IL-4 receptors on resting B 
cells, no phosphoamino acids were visualised on autoradiography of the TLE 
plate. The phosphoamino acid(s) in the 42 kDa protein, therefore, remain(s) 
unidentified.
4.4. Effect of Purified and Recombinant IL-4 on Membrane
Phosphoproteins on LPS Activated Murine B Cells
Resting murine B cells express only low numbers of receptors for 
IL-4 (Park et al., 1987a; Ohara & Paul, 1987). The number of receptors for 
IL-4 can be increased 5-10 fold on activation of the B cells with LPS. To 
determine if an increase in the number of IL-4 receptors per B cell increased 
the intensity of phosphorylation of the 42 kDa protein membranes were 
prepared from low density 'activated' cells after 24 and 48 hours of culture 
with LPS. The membrane proteins were phosphorylated with y-[32p]_ATP 
in the absence of ligand or the presence of purified IL-4 or recombinant IL-4. 
Three 5 |il aliquots of terminated reaction mix were taken for determination of 
total protein phosphorylation by TCA precipitation (table 6).
Phosphoproteins were separated by gel electrophoresis and 
visualised by autoradiography (figure 26).
Table 6 represents the total incorporation of [32p] -phosphate into
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Table 6 Total [32pj-Phosphate Incorporation into Membranes from 
Mitogen Activated B Cells
Membranes were prepared from high density resting murine B cells and 
low density 'activated' B cells after culture with LPS for 24 or 48 
hours. Each type of membrane was incubated with 10 jiCi y-[32p]. 
ATP in the presence or absence of 10 units of IL-4 and the reaction was 
terminated by the addition of 55°C sample buffer. Three 5 pi aliquots 
were removed from the terminated reaction mix and spotted onto filter 
discs. The discs were washed four times in 10% TCA and 10 mM 
sodium pyrophosphate and then counted in 3 ml ecoscint in a Beckman 
LS 6800 scintillation counter. Table 6 illustrates the results of three 
experiments expressed in cpm (x +/- SD, n = 3)
TABLE 6. Total r&PI-phosphate incorporation into membranes 
from mitogen activated B cells.
Resting Cells
-IL-4 +IL-4
19367 ±1541 25459 ±  1893
3638 ±197 4175 ± 4 1 5
8470 ±1470 9792 ±1222
LPS f24Hrs^
-IL-4 +EL-4
22979 ± 494 17422 ±1059
3476 ±  147 3755 ± 397
5925 ± 1219 8341 ±  1183
LPS (48HTS)
-EL-4 
22131 ± 2936 
3843 ±  507 
9600 ±  3913
+IL-4
26022 ± 2095 
3687 ± 385 
7814 ±  718
137
Figure 26 Phosphoprotein Profiles of LPS Activated Murine B 
Lymphocytes
High density resting B cells were prepared as described in materials 
and methods 2.3.1. & 2.3.3. and cultured for 24 hours, panel A, or 48 
hours, panel B, with 10 pg/ml LPS. After culture the B cells were 
separated on percoll gradients and membranes were prepared from the 
low density 'activated1 cells (1.065/1.055 g/ml percoll interface). 
Membrane proteins were exposed to 10 jiCi y-[32p]-ATP in the 
absence of ligand (lane a) the presence of 10 units affinity purified IL-4 
(lane b) or 10 units recombinant IL-4 (lane c). The proteins were 
separated by SDS-PAGE and visualised by autoradiography. Low 
molecular weight markers were run on the gel and visualised by 
coomassie blue staining.
a b c a b c
\
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membrane proteins from resting cells, 24 hour LPS cultured cells and 48 
hour LPS cultured cells in the presence or absence of rmEL-4. In resting 
cells, in all three experiments shown, there is an increase in phosphate 
incorporation in the presence of EL-4. This is the same in two out of the three 
cases for the membranes prepared from B cells cultured with LPS for 24 
hours. Membranes prepared from B cells cultured for 48 hours show a 
decrease in phosphate incorporation when IL-4 is included in the 
phosphorylation assay in two out of the three examples given. As before 
these results illustrate that the total phosphate incorporation into membrane 
proteins is variable. There does not appear to be a consistent pattern for the 
incorporation of [^^p]-phosphate into membrane prepared from each type of 
B cell in fact the [^^P]-phosphate into all three appears very similar within 
each experiment.
The profiles of membrane phosphoproteins are identical with the 
purified and the recombinant form of the IL-4 (Figure 26, tracks b and c).
The purified IL-4 was isolated from supernatants of EL4 cells, which had 
been stimulated with PMA, using immobilised IIBII, an antibody to IL-4. 
Residual PMA present in the purified IL-4 could be increasing protein 
phosphorylation via protein kinase C. This possibility can be excluded as the 
recombinant EL-4 is produced by microbial expression of plasmid vectors 
containing the gene for murine IL-4 and, therefore, has no PMA present
In membranes prepared from low density "activated" cells after 
culture with LPS for 24 hours there was an increase in phosphorylation of the 
42 kDa protein in the presence of IL-4 (figure 26, panel A).
Phosphoproteins of higher molecular weights, 105,90,77 and 71 kDa were 
also starting to appear in the membranes from cells cultured with LPS that 
were absent in the phosphoprotein profiles resting B cell membranes (figure
24). These higher molecular weight phosphoproteins were present in the 
presence and absence of EL-4 and, therefore, were not a specific effect of the
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IL-4. Membranes prepared from low density cells after 48 hours of culture 
with LPS indicated an increase in intensity of these higher molecular weight 
phosphoproteins (figure 26, panel B). Phosphorylation of these proteins is 
probably a reflection of activation of the B cells by LPS. LPS has been 
shown to activate protein kinase C (Chen et al., 1986) which phosphorylates 
proteins on serine and threonine residues.
There was no evidence of phosphorylation of the 42 kDa protein in 
the membranes of cells cultured with LPS for 48 hours in the presence of 
either purified (track b) or recombinant (track c) 3L-4. Lipopolysaccharide is 
a mitogen for B cells driving them into the cell cycle. Figure 21 illustrates the 
effect of LPS on B cells by measuring the uptake of [^H]-methyl thymidine. 
At 24 hours after addition of LPS the cells are just beginning to enter the cell 
cycle as B cells are activated asynchronously from resting and show a lag in 
the response to LPS of up to 24 hours (Wetzel & Kettman, 1981). By 48 
hours all LPS responsive cells have entered the cell cycle and are proliferating 
as determined by the uptake of [^H]-methyl thymidine. The IL-4 stimulated 
phosphoiylation of the 42 kDa protein is observed only in membranes 
prepared from high density resting B cells and "activated" B cells at early 
stages of the cell cycle but is not present in B cells at later stages in the cell 
cycle even though there are more IL-4 receptors on these cells. This suggests 
that the IL-4 induced phosphorylation of the 42 kDa protein is an early event 
in B cell activation.
4.5. Membrane Phosphoprotein Profiles of a Murine Cell
Line
Membranes were prepared from the cell line, P388Di. P388D^ is a 
mouse macrophage-like cell line, derived from DBA/2 mice, possessing 
greater than 1100 IL-4 receptors/cell (Ohara & Paul, 1987; Lowenthal et al., 
1988). The membrane proteins from this cell line were phosphorylated by J- 
[32p]_ATP in the presence and absence of IL-4. The phosphoproteins were
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Figure 27 Phosphoprotein Profiles of Membranes from P388Dj Cells
Membranes were prepared from P388Dj cells and subjected to y- 
[32p]-ATP in the presence (track b) or the absence (track a) of 10 units 
rmIL-4. The proteins were separated by SDS-PAGE and the 
phosphoproteins were visualised by autoradiography.
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separated by SDS-PAGE and visualised by autoradiography.
Figure 27 shows the phosphoprotein profiles of P388D} in the presence 
and absence of IL-4. The profile shows that there has been incorporation of 
[32p]-phosphate into several proteins. There does not, however, appear to 
be any difference in the phosphoprotein profiles in P388Dj cells with and 
without IL-4 as a stimulatoiy ligand. P388D^ cells are continuously 
proliferating and, therefore, the need for the 42 kDa phosphorylation event 
may have been passed. This is consistent with observations in LPS activated 
cells where 42kDa phosphoiylation was shown to be an early event in signal 
transduction.
The phosphoprotein profiles of P388Dj are quite different from the 
profiles observed from BALB/c spleen cells. There are several higher 
molecular weight proteins in membranes from P388Dj cells, as was seen in 
the LPS cultured cells, which are probably a reflection of cell activation.
4.6. ATP Binding Proteins in Resting Murine B Lymphocytes
Several receptors for mitogenic growth factors possess protein 
kinases which are capable of autophosphoiylation. The possibility that the 42 
kDa protein possessed intrinsic phosphotransferase activity was investigated. 
Membranes were prepared from high density resting B cells and binding of 
ATP to the membrane proteins was estimated by using the photoaffinity label 
8 - a z i d o - y -  [32p] - ATP, which binds to ATP binding proteins irreversibly in 
the presence of UV light ATP binding assays were performed as described 
in materials and methods 2.14. and labelled proteins were separated by gel 
electrophoresis and visualised by autoradiography.
In the presence of UV light only one major band was seen on the 
autoradiograph (Figure 28, track b). This ATP binding protein had a 
molecular weight of 50 kDa averaged over several experiments. In the
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Figure 28 ATP Binding Proteins in Resting B Lymphocytes Plasma 
Membranes
Membrane proteins from resting murine B lymphocytes were incubated 
with 3 jiCi of the photoaffinity label 8-azido-y- [3 2p] - ATP (materials 
and methods section 2.14.). The assay was performed on microscope 
slides and illuminated with UV light for 60 seconds at room 
temperature. The reaction was terminated by the addition of SDS- 
PAGE sample buffer and the proteins separated by SDS-PAGE and 
visualised by autoradiography. Where indicated rmIL-4 was present at 
10 units per assay and unlabelled ATP at a concentration of 50 mM. 
Low molecular weight markers were run on the gel and visualised by 
coomassie blue staining. Arrows represent molecular weights of 94, 
67, 43, 30, 20.1 and 14.4 kDa.
f r o n t
absence of UV light, there were no A T P  binding proteins identified (tracks a 
and c) indicating that binding of 8-azido y - [3 2 p j_ A T P  is dependent on the 
presence of UV light. There were no other A T P  binding proteins identified 
when the experiment was carried out in the presence of IL-4, in fact, there 
was no change in the labelling of the 50 kDa protein (track d ) . IL-4 does not 
appear to affect the binding of A T P  to the 50 kDa protein. In the presence of 
excess unlabelled A T P  the majority of photoaffinity labelling could be 
abolished indicating that the label was specifically identifying A T P  binding 
proteins (tracks e-h).
With longer exposures of the autoradiograph there was evidence of 
some labelled proteins of higher molecular weights which were also present 
in the absence of light These proteins may be phosphorylated by protein 
kinases using the 8-azido y-[32p]-ATP as a substrate as it is the y-phosphate 
that is radioactive. This could have been overcome using 8 - a z i d o - o c - [ 3 2 p ] -  
ATP which could not have been used as a substrate for phosphorylation.
The only major ATP binding protein in high density resting B 
lymphocytes identified from this experiment was a protein with a molecular 
weight of 50 kDa. The phosphoprotein identified in membranes from resting 
B cells in the presence of IL-4 was 42 kDa. The molecular weights of both 
proteins have been determined over several experiments and the difference is 
consistently observed. Membrane proteins phosphorylated by y-[32p]-ATP 
have been run on SDS gels parallel to 8 -azido y-[32p]-ATP labelled proteins 
and the proteins have different mobilities (chapter 5, figure 38). Other 
evidence for the proteins being different is that phosphorylation of the 42 kDa 
protein is enhanced in the presence of IL-4 whereas IL-4 does not appear to 
affect the labelling of the 50 kDa protein. This suggests that the 42 kDa 
phosphoprotein is not a protein kinase itself but is a protein kinase substrate.
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4.7. Effect of Interleukin 4 on Membrane Protein Phosphorylation in
Resting Human Tonsillar B Lymphocytes
Membrane phosphoproteins from human tonsillar B cells were 
analysed to determine if murine and human B cells had similar protein kinase 
mediated signal transduction pathways for IL-4. Membranes were prepared 
from high density resting B cells isolated from human tonsils (section 2.3.2. 
& 2.3.3.) and phosphorylated using y-[32p]-ATP. The membrane proteins 
were separated by SDS-PAGE and visualised by autoradiography (figure 
29).
Membrane proteins were phosphorylated in the presence (tracks b & 
d) and absence (tracks a & c) of rhIL-4 (100 units/assay). Although several 
phosphoproteins are evident there are no apparent differences in the profiles 
in the presence of IL-4. Figure 29, panel B represents gels which have been 
soaked in 1M KOH for 90 minutes at 55°C. This procedure hydrolyses 
aliphatic but not aromatic phosphate ester bonds and therefore the alkali 
resistant phosphoproteins indicate the presence of phosphotyrosine (Cooper 
and Hunter., 1982). This gives a good preliminary estimate of the 
phosphotyrosine containing proteins, but is not unequivocal since some 
serine and threonine phosphoproteins may be alkali resistant. Treatment of 
the gels with alkali has greatly reduced the number of phosphoproteins 
detectable but again no differences can be observed between proteins 
phosphorylated in the presence and absence of IL-4. This suggests that the 
binding of IL-4 to its complementaiy receptor in the human system does not 
involve the phosphorylation of a 42 kDa protein. It must of course be noted 
that the murine and human B lymphocytes come from different anatomical 
sources, spleen and tonsils, respectively.
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Figure 29 Membrane Phosphoprotein Profiles of Human Tonsillar B 
Lymphocytes
Membrane from high density resting human tonsillar B lymphocytes 
were subjected to in vitro phosphorylation as described in materials 
and methods 2.12. IL-4 where indicated was present at 100 units per 
assay of rhIL-4. The assays were performed in the presence of 30 mM 
MgCl2  or 5 mM MnCl2  as indicated on the gel. The proteins were 
separated by SDS gel electrophoresis and phosphoproteins visualised 
by autoradiography (panel A). An identical gel was run and soaked in 
alkali at 55°C for 90 minutes prior to autoradiography (panel B). 
Molecular weight markers are indicated on the gel.
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Figure 30 Membrane Phosphoprotein Profiles of Human B Cells from 
Peripheral Blood
Membranes were prepared from high density resting B cells isolated 
from peripheral blood(section 2.3.2. & 2.3.3.). The membrane 
proteins were incubated with y-[32p]-ATP in the presence (track a) or 
absence (track b) of 100 units of rhIL-4. The phosphoproteins were 
separated by SDS-PAGE and visualised by autoradiography (panel A). 
An identical gel was run and treated with 1M KOH at 55°C for 90 
minutes prior to autoradiography (panel B). This experiment was 
performed in conjunction with Miss A. Wood in the laboratory.
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4.8. Membrane Phosphoprotein Profiles of Resting Human B
Lymphocytes Isolated from Peripheral Blood
As a comparison to tonsillar B cells, membranes were also prepared 
from human B cells isolated from peripheral blood. These membranes were 
exposed to y-[^^P]-ATP in the presence or absence of IL-4 and the 
phosphoproteins separated by gel electrophoresis and visualised by 
autoradiography (figure 30).
Figure 30 illustrates that, again, although several phosphoproteins 
were evident there was no difference in the profiles when IL-4 was present in 
the kinase assay. Panel B represents the equivalent gel treated with KOH and 
this shows that the profiles in the presence and absence of IL-4 are similar. 
This experiment substantiates the finding in human tonsillar B cells that the 
signals transduced when IL-4 binds to its receptor are different in the mouse 
and human system.
4.9. Membrane Phosphoproteins in Human B cell lines
Membranes were prepared from cells of two human B lymphoma
cell lines, Daudi and Raji. Both cell lines have been reported to express high 
numbers of IL-4 receptors (Park et al., 1987b). The phosphoprotein 
profiles from both cell lines are complex, exhibiting a large number of 
phosphoproteins, particularly at higher molecular weights (figure 31). 
Phosphorylation of these proteins is possibly due to the activity of protein 
kinase C as these cells are continuously proliferating. There does not appear 
to be any differences in the phosphoprotein profiles of samples treated with 
(track a) or without (track b) IL-4. Gels treated with KOH (panel B) indicate 
a reduction in the the number of phosphoproteins but no differences are 
observed between membranes phosphorylated in the presence or absence of 
IL-4. This again illustrates the absence of enhanced phosphorylation of the 
42 kDa protein in human cells and in continuously proliferating cells.
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Figure 31 Membrane Phosphoprotein Profiles of Human B Cell Lines 
Membranes prepared from Daudi and Raji cells were subjected to in 
vitro phosphorylation in the presence or absence of 100 units per 
assay of rhIL-4 (described in materials & methods 2.12.). In vitro 
phosphorylation was performed in the presence of either 30 mM 
MgCl2  or 5 mM MnCl2  as indicated on the gel. Molecular weight 
markers are indicated on the gel.
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4.10. Discussion
The work detailed in this chapter suggests that the binding of both 
purified and recombinant IL-4 to isolated murine B cell membranes enhances 
the phosphorylation of a protein with a molecular weight of 42 kDa. It is 
thought that this protein is identical to that previously described (Justement et 
a l , 1986). The phosphorylation of this protein appears to be restricted to 
membranes prepared from resting B cells and B cells that are in early stages 
of activation. Phosphorylation of the protein was not observed in membranes 
from B cells which had entered the cell cycle due to stimulation with LPS for 
48 hours or in cell lines which were continuously proliferating even though 
these cells possess 5 to 10 times more IL-4 receptors per cell than resting 
cells (Park et al., 1987a; Ohara & Paul, 1987). This may mean that 
phosphorylation of the 42 kDa protein is an early event in B cell activation 
and B cells that are in the cell cycle do not require this event The signals 
transduced by LPS to activate the B cell may be through a different pathway 
which by-passes phosphorylation of the 42 kDa protein and the later action of 
IL-4 does not require i t  Indeed LPS has been reported to activate protein 
kinase C whereas in the mouse the activation of PKC has been shown not to 
be involved in the signals transduced by IL-4 (Justement et al., 1986; 
Mizuguchi et al., 1986). Alternatively the 42 kDa protein may already be 
phosphorylated and is therefore unable to be labelled with y - [3 2 p ]-A T P .
IL-4 has several different biological effects on B cells and appears to 
act differently on resting and activated cells, in one case as a competence 
factor and in the other as a differentiation factor. IL-4 acts as a competence 
factor on resting B cells to enhance their response to antigen (Howard et al., 
1982). B cells that have been treated with LPS are committed to the cell cycle 
and therefore do not require a competence signal. The presence of IL-4 in 
this case promotes immunoglobulin isotype switching to IgGl and IgE and 
is, therefore, acting as a differentiation factor (Vitteta et al., 1985; Sideras et
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al., 1985; Noma et al., 1986; Isakson, 1986). It may be, therefore, that the 
signal IL-4 gives to the cell when acting as a competence factor differs to the 
signal given when it is acting as a differentiation factor. In this respect a 
second set of EL-4 receptors may exist that are of lower affinity than those 
described previously (Ix>wenthal et al., 1988; Park et al., 1987a; Ohara & 
Paul, 1987). The competence signal may be delivered to resting B cells 
through the high affinity receptors involving the phosphorylation of a 42 kDa 
membrane protein as part of the signal transduction pathway. The later 
differentiation signal may be delivered to the B cells through lower affinity 
receptors whose signal transduction pathway is different or the 
phosphorylation of the 42kDa protein is by-passed.
No equivalent phosphoprotein was detected in human B cells either 
from peripheral blood, tonsils or cell lines. This may be due to the different 
anatomical sources of the B cells in mouse and human ie. spleen compared to 
tonsils or peripheral blood. The human B cells may be in a pre-activated state 
having already encountered antigen in vivo. The other explanation could be 
that the signals transduced when IL-4 binds to its receptor are distinct in the 
mouse and human. Several differences have been observed in the biological 
activities of IL-4 between species and the lymphokine does not act across the 
species barrier (Mosmann et al., 1986). The amino acid sequence of mouse 
and human IL-4 is 50% homologous and therefore, the differences between 
species may exist in the IL-4 receptors. The published estimated molecular 
weight for the binding components of the IL-4 receptor are 75 kDa in the 
mouse (Park et al., 1987a; Ohara & Paul, 1987) and 139 kDa in the human 
(Park et al., 1987b). A second IL-4 binding component has now been 
identified in human burkitt lymphoma Jijoye cells with a molecular weight of 
70 kDa (Galizzi et al., 1988). Recently the murine IL-4 receptor has been 
cloned and sequenced and the mature receptor estimated to have a molecular 
weight of some 140 kDa (Drs D. Cosman and S. Gillis, Immunex 
Corporation, personal communication to W. Cushley). The molecular
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weights for human and murine IL-4 receptors may not therefore be so 
different although the human receptor still remains to be sequenced. Recent 
studies with human B cells have shown that the signals transduced when 
human EL-4 binds to its receptor include phosphoinositide hydrolysis, 
elevation of cAMP levels and the activation of protein kinase C (Finney et 
a l, 1989). In the mouse, it has been reported that binding of murine IL-4 
does not involve any of these events (Justement etal., 1986; Mizuguchi et 
a l, 1986).
The phosphoamino acids in the 42 kDa protein are so far undefined. 
The use of thin layer electrophoresis and other biochemical procedures has 
failed to yield any definitive data. The question of the identity of the 42 kDa 
protein remains unclear although several candidates may be proposed. In 
several systems ligand binding to plasma membrane associated receptors 
stimulates an intrinsic tyrosine kinase activity which undergoes 
autophosphorylation. Experiments with the photoaffinity label 8-azido-y- 
[32p]-ATP suggested that the 42 kDa protein did not bind ATP and was 
therefore unlikely to possess intrinsic phosphotransferase activity. This does 
not prevent the 42 kDa protein being a substrate for a tyrosine kinase that is 
associated with the receptor. A tyrosine kinase substrate of between 40 kDa 
and 45 kDa, now termed 42 kDa, has been found with various mitogens, 
including EGF, TPA, PDGF, and IGF-1, in a number of cells (Hunter & 
Cooper 1985). This protein is highly conserved and represents only 0.001% 
of total cell protein which would account for the low level of phosphate 
incorporation observed.
A second possibility is that the 42 kDa phosphoprotein represents 
the low affinity receptor for IgE. One of the biological effects of IL-4 is to 
increase the expression of the low affinity receptor for IgE, FcRe in the 
mouse (Hudak et al., 1987) and CD23 in the human (Defrance et al.,
1987a). IL-4 also induces the release of the soluble form of this molecule
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from the membrane bound form (Bonnefoy et al., 1988). The molecular 
weight of the membrane form of FcRe/CD23 is 45 kDa and is a single 
glycosylated polypeptide. This molecule is expressed at low levels in resting 
B cells which would be consistent with the weak phosphorylation signal 
observed on the 42 kDa phosphoprotein. Prediction of the primary protein 
structure of human FcRe/CD23 from the nucleotide sequence reveals that a 
sequence exists in the cytoplasmic tail region of the molecule that may serve 
as a potential phosphate acceptor site (Ludin et a/., 1987). The arguement 
against this molecule being a candidate for the 42 kDa phosphoprotein is that 
it is found in both mouse and human and as yet the phosphorylation of the 42 
kDa protein has not been observed in human B cell plasma membranes.
A further possibility is that the the 42 kDa phosphoprotein is the 
heavy chain of the major histocompatibility complex class 1. This molecule 
is expressed on the surface of all nucleated cells and erythrocytes and the 
heavy chain is a 45 kDa glycosylated polypeptide (Benacerraf, 1981). The 
arguements against this protein being the 42 kDa phosphoprotein are that 
there has been no reported effect of a direct action of IL-4 on MHC class 1. 
The MHC class I antigen has also been reported to be phosphorylated on ser 
335 by protein kinase C (Shackelford & Trowbridge, 1986) and binding of 
IL-4 to its receptor on murine resting B cells does not appear to activate PKC 
or effect its translocation to the plasma membrane (Justement et al., 1986). 
This does not rule out the possibility that the MHC class 1 could be a 
substrate for other protein kinases.
Another candidate for the 42 kDa phosphoprotein is a guanine 
nucleotide binding (G) protein. These are a family of proteins which are 
similar in structure and are essential to a variety of signal transducing 
reactions that occur at cell membranes (for a review see Neer and Clapham,
1988). Many cell surface recptors which act through adenylate cyclase have
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been shown to do so through two G proteins. One of these G proteins has a 
stimulatory effect and the other an inhibitory. A second family of receptors 
which transmit messages by activating a phosphoinositidase that hydrolysis 
polyphosphoinositides producing two second messengers, DAG and 
has been reported to act via a G protein. G proteins have also been found 
associated with the insulin receptor tyrosine kinase (O'Brien et al., 1987). 
The P subunit of the insulin receptor has been shown to possess an intrinsic 
tyrosine kinase activity (Kasuga et al., 1983). It has now been reported that 
this kinase activity is capable of phosphorylating the a  subunits of Gi and Go 
when they are in a holomeric form (O'Brien et a l, 1987). This suggests that 
when insulin binds to its receptor signals may be transduced through G 
proteins which are activated by the phosphoiylation of a tyrosine residue on 
the a  subunit.
G proteins are characterised by a heterotrimeric structure consisting 
of a, P and y subunits (Neer and Clapham, 1988). The P and y subunits are 
35-36 kDa and 8 kDa respectively and are highly conserved. The a  subunit 
with a molecular weight between 39-52 kDa has some highly conserved 
regions (regions for the binding and hydrolysis of GTP) and others that are 
more diverse (the receptor and effector recognition sites). Interaction of 
GDP-aPy with an activated receptor results in the binding of GTP to the a  
subunit. This GTP-a subunit then dissociates from the P and y and binds to 
the effector molecule resulting in a modification in the activity of this 
molecule. Activation is terminated by the endogenous GTPase activity of the 
a  subunit which converts the GTP to GDP (Harnett and Klaus, 1988a). The 
GDP-a can then recombine with the P and y subunits and then interaction of 
GDP-aPy with the receptor initiates another round of G protein activation.
G proteins have been found in a wide variety of systems and there 
have been reports of the involvement of G proteins in the regulation of B 
lymphocytes. As discussed in the introduction (section 1.12.) binding of
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antigen to slg results in the generation of the second messengers IP3 and 
DAG and it has been shown that both slgM and slgD receptors are coupled to 
the phosphoinositide system by a G protein (Gold et al., 1987; Harnett & 
Klaus, 1988a). Recently it has been shown that the inhibition of proliferation 
observed when intact Ig binds to Fc receptors is due to the uncoupling of the 
antigen receptor from the G protein (Harnett & Klaus, 1988b; Rigley etal.,
1989). This negative signal can be overcome by IL-4 allowing B cells to 
proliferate (O'Garra et al., 1987). It is interesting therefore to speculate that 
EL-4 may be overcoming the uncoupling of the antigen receptor from the G 
protein by either activating its own G protein or the uncoupled G protein eg. 
by phosphorylation of the a  subunit. Figure 32 shows a schematic 
representation of how this might occur.
In order to determine if a G protein was involved in the signal 
transduction of EL-4 on binding to its receptor preliminary experiments were 
performed assessing the GTPase activity in membrane from resting B cells in 
the presence and absence of IL-4 (in conjunction with Dr G. Milligan, 
Department of Biochemistry, University of Glasgow). The results indicated 
that there was no significant increase in GTPase activity in the presence of 
EL-4. This does not eliminate the possibility of the involvement of a G 
protein in EL-4 signalling as only a small change in the GTPase activity may 
occur in the presence of EL-4 due to the low number of EL-4 receptors on 
resting cells. There are several other methods for identifying a G protein 
which include the use of antibodies raised against G proteins either to 
individual subunits or synthetic peptides. Sensitivity to cholera and pertussis 
toxin has also been used to identify G proteins. Cholera toxin results in ADP 
ribosylation of the G protein and therefore if ADP ribosylation and 
phosphorylation could be correlated on the 42 kDa protein this would provide 
evidence for the 42 kDa phosphoprotein belonging to the family of G 
proteins. The observation that the 42 kDa protein is not phosphorylated in 
human B cells does not eliminate the possibility that it is a G protein as this
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Figure 32 Interplay of Three Cell Surface Receptors in Murine B Cells
The signals transduced when antigen binds to its receptor, membrane 
immunoglobulin, involve the activation of a G proten, Gp. When 
intact immunoglobulin G binds to FRjj this results in a negative signal 
which prevents the signals transduced by the antigren receptor. This 
negative signalling is accomplished by the uncoupling of Gp from 
membrane immunoglobulin (Rigley et al., 1989), panel A. Interleukin 
4 has been shown to be capable of overcoming this negative signal 
(OGarra et al., 1987). The results from this thesis suggest that part 
of the signalling when murine EL-4 binds to its receptor involve the 
phosphorylation of a 42 kDa membrane protein. A candidate for this 
phosphoprotein is the a  subunit of a G protein. It is, therefore, 
tempting to speculate that EL-4 overcomes the negative effect of FRjj 
on antigen receptor by phosphorylating the antigen receptor associated 
G protein and thereby activating it and allowing subsequent PtdInsP2 
hydrolysis to ocurr, panel B.
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would be consistent with the existence of distinct second messenger systems 
activated by IL-4 in the two species.
The final possibility is that the 42 kDa phosphoprotein represents a 
unique component of the murine IL-4 receptor which is distinct from the 75 
kDa protein, which has been shown to bind IL-4, and the sequenced 140 kDa 
protein.
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5. RESULTS.
INDUCTION OF A NOVEL 
PLASMA MEMBRANE 
PHOSPHOPROTEIN FOLLOWING 
CULTURE OF RESTING B CELLS 
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CHAPTER 5
INDUCTION OF A NOVEL PLASMA MEMBRANE PHOSPHOPROTEIN 
FOLLOWING CULTURE OF RESTING B CELLS WITH EL- 4.
5.1. Membrane Phosphoprotein Profiles from Murine B Cells
Cultured with LPS or EL-4
The data of chapter 4 suggest that exposure of membranes from high 
density resting murine B lymphocytes to EL-4 in the presence of y-[^^P]-ATP 
promotes the phosphorylation of a 42 kDa protein. Phosphorylation of this 
protein could only be detected in membranes from resting murine B cells and 
B cells in early stages of activation but not in cycling cells or cell lines, even 
though these latter cells possess more IL-4 receptors per cell (Ohara and Paul, 
1987). Culturing B cells with IL-4 has been shown to increase the 
expression of the IL-4 receptor (Ohara & Paul, 1987). B cells that have been 
cultured with IL-4 have a greater number of receptors per cell, but the cells 
are not in the cell cycle as IL-4 alone is an insufficient stimulus to drive 
resting B cells into S phase. The membrane phosphoprotein profiles from B 
cells Cultured in the presence of IL-4 for 24 hours were analysed for 
enhanced phosphorylation of the 42 kDa protein.
Figure 33 represents the membrane phosphoprotein profiles from 
freshly prepared resting murine B cells (lanes a & b), low density B cells after 
culture with LPS for 24 hours (lanes c & d) or 48 hours (lanes e & f) and 
resting B cells cultured with 100 units/ml rmIL-4 for 24 hours (lanes g & h). 
In vitro phosphorylation assays were performed in the presence and absence 
of 10 units/assay rmIL-4 (section 2.12.). The phosphoprotein profiles of 
membranes prepared from freshly isolated high density resting B cells (lanes 
a and b) indicated that the presence of IL-4 in the kinase assay promotes the 
phosphorylation of a protein in the 42 kDa molecular weight range; this is 
consistent with the data of figure 24. The enhanced phosphorylation of the
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42 kDa protein was also evident in membranes prepared from low density B 
cells cultured with LPS for 24 hours (lanes c and d). The phosphoprotein 
profiles of membranes from low density B cells cultured for 48 hours with 
LPS (lanes e and f) were faint but on prolonged exposures of the gel there 
was no evidence of phosphorylation of a 42 kDa protein. Phosphorylation of 
a 42 kDa protein was evident in the profiles of membranes from B cells that 
had been cultured with IL-4 for 24 hours (lanes g and h). In this case 
phosphorylation of the protein did not depend on the presence of IL-4 in the 
phosphorylation assay as the intensity of the band appeared equivalent in the 
absence (lane g) or presence (lane h) of IL-4 in the assay. The membrane 
phosphoprotein profiles from B cells cultured in the presence of IL-4 also 
showed phosphorylation of a novel protein. This protein represented the 
major band in the profiles and had a molecular weight in the range 72-76 kDa, 
as determined over several experiments. The 75 kDa protein was 
phosphorylated to the same extent whether IL-4 was included in the 
phosphorylation assay or not.
Figure 34 represents the autoradiographs of two gels, one gel was 
treated with 1M KOH in phosphate buffer at 55°C for 90 minutes (panel A) 
while the other was in phosphate buffer alone (panel B) prior to 
autoradiography. The phosphate ester linkage of phosphotyrosine is more 
stable to alkaline hydrolysis than those of phosphoserine and 
phosphothreonine (Cooper and Hunter, 1981b). This means that treatment of 
SDS gels with alkali allows preliminary estimation of the number of 
phosphoproteins which contain phosphotyrosine. In this case, treatment of 
the SDS gel with alkali substantially reduced the number of phosphoproteins 
visible. The majority of high molecular weight membrane phosphoproteins 
from LPS cultured cells have been removed which is consistent with the idea 
that they may be protein kinase C substrates. The 75 kDa protein, however, 
remains as a major autoradiographic signal in alkali treated gels (panel A, 
lanes g and h) which suggests that this protein may contain phosphotyrosine.
159
Figure 33 Membrane Phosphoprotein Profiles of B Lymphocytes After 
Culture with LPS or IL-4
High density resting B cells were isolated from B ALB/c mouse spleen 
(materials and methods 2.3.1. and 2.3.3.). Membranes were prepared 
from an aliquot of resting cells (tracks a and b) and the remaining cells 
were divided into three aliquots and either cultured with 10 pg/ml LPS 
for 24 hours (tracks c and d) or 48 hours (tracks e and f) or with 100 
units/ml IL-4 for 24 hours (tracks g and h) prior to membrane 
preparation. The cells cultured with LPS were separated on percoll 
gradients and low density 'activated' cells from the 1.065/1.055 g/ml 
were used for preparation of membranes. In vitro phosphorylation 
assays were performed using 10 pCi y-[32p]-ATP in the presence or 
absence of 10 units/assay of IL-4 as indicated on the figure. Proteins 
were separated by SDS-Page and phosphoproteins were visualised by 
autoradiography.
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Figure 34 Total and Alkali Resistant Phosphoprotein Profiles 
This experiment was identical to that described in figure 33. Proteins 
were separated on two identical gels. After electrophoresis one gel was 
soaked in phosphate buffer (RHS) and the other in phosphate buffer 
containing 1M KOH (LHS). Both gels were incubated at 55°C for 90 
minutes before being dried and autoradiographed (materials and 
methods 2.18.7.).
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5.2. The Effect of Anti-EL-4 Antibody on the 75 kDa
Phosphoprotein
Figure 33 suggests that the phosphorylation of the 75 kDa protein is 
specific to the presence of IL-4 in the culture. Culturing the B cells with LPS 
fails to induce the phosphorylation of this protein which may be due to the 
fact that LPS drives the B cells directly into the cell cycle, by-passing the 
activated state which IL-4 alone induces. To ensure that the induction of 
phosphorylation of the 75 kDa protein was a specific effect of culturing the B 
cells with IL-4 and not an effect induced solely by culturing the cells, 
particuarly in the presence of serum, two experiments were performed 
(Figure 35). High density murine B cells were cultured in medium alone 
(tracks a and b), in the presence of 100 units/ml rmIL-4 (tracks c and d) or in 
the presence of rmIL-4 and 1 IB 11 (tracks e and f) and membrane proteins 
from these cells were subjected to in vitro phosphorylation in the presence or 
absence of 10 units/assay rmIL-4 (Figure 35). The total and alkali resistant 
phosphoprotein profiles are represented in panels A and B, respectively.
1 IB 11 is an antibody which neutralises the effects of IL-4 (Ohara et al., 
1985). It has been shown to inhibit the biological effects of IL-4, and 
prevents the binding of IL-4 to its receptor (Park et al., 1987a). Membrane 
phosphoprotein profiles for cells cultured in the absence of ligand show a 
major phosphorylated species of 82,64,53 and 19 kDa but there is no 
evidence of the 75 kDa protein either in the presence or absence of IL-4 in the 
phosphoiylation assay. Figure 35, panel B, tracks a and b, indicated that 
only the 64 kDa phosphoprotein showed any alkali resistence. The 
membrane phosphoprotein profiles of cells cultured in the presence of IL-4 
show similar phosphoproteins to those cultured in the absence of ligand with 
the exception of a phosphoprotein at 75 kDa, which was not present in the 
control membranes. The 75 kDa protein was alkali resistant (panel B, tracks 
c and d) and also a protein of slightly higher mobility corresponding to a 
molecular weight of 64 kDa. The 75 kDa phosphoprotein was observed in
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Figure 35 Effect of Anti-IL4 Antibody on Membrane Phosphoprotein 
Profiles
High density resting B cells from B ALB/c mouse spleen were cultured 
(in a total volume of 10 ml) for 24 hours in complete medium in the 
absence of ligand (tracks a and b) or the presence of 100 units/ml 
rmIL-4 (tracks c and d) or in the presence of 100 units/ml rmIL-4 and 
20% (v/v) supernatant of the 1 IB 11 hybridoma. Membranes were 
prepared from these cells and they were subjected to in vitro 
phosphorylation with 10 |iCi g-[32p]-ATP in the presence and absence 
of 10 units/assay rmIL-4 as indicated on the figure. The proteins were 
separated by gel electrophoresis on two identical gels. One gel was 
soaked in the presence of alkali (panel B) and the other in the absence 
(panel A) and the gels then autoradiographed. The arrow indicates the 
75 kDa phosphoprotein.
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both the presence and absence of EL-4 in the in vitro assay although in this 
case there is evidence of a slight enhancement in phosphorylation when IL-4 
is included in the in vitro phosphorylation assay. Membranes from cells 
cultured with IL-4 and 1 IB 11 have similar phosphoprotein profiles to 
membranes from cells cultured in the absence of ligand. This is particuarly 
noticable in the alkali-treated gel (panel B, tracks e and f) where there is no 
band at 75 kDa. The inclusion of IL-4 in the phosphorylation assay does not 
appear to influence, either positively or negatively, the phosphorylation of the 
75 kDa protein.
The data are consistent with the hypothesis that the appearance of the 
75 kDa membrane phosphoprotein is specifically induced by the presence of 
IL-4 in a 24 hour culture and that culture in serum-containing medium alone 
is insufficient to induce this event
5.3. Effect of Interferon-y on the Appearance of the 75 kDa
Phosphoprotein
Culturing murine B cells with IL-4 for 24 hours induces the 
appearance of an alkali resistant 75 kDa phosphoprotein. Inclusion of the 
1 IB 11 antibody in the culture inhibits this effect. 1 IB 11 prevents the binding 
of IL-4 to its receptor, which suggests, therefore, that binding of IL-4 to its 
receptor results in induction of the 75 kDa protein. Ifn-y is an inhibitor of the 
biological effects of IL-4 (Rabin et al., 1986b; Mond et al., 1986) but it 
does not bind to the IL-4 receptor or prevent binding of IL-4 itself to the 
receptor (Park et al., 1987a; Park et al., 1987b). It was, therefore, 
interesting to study the effects of Ifn-y on the IL-4 induced appearance of the 
75 kDa protein. Resting B cells were cultured in the absence of ligand, in the 
presence of 100 units/ml rmIL-4 alone, 1000 units/ml rmlfh-y alone or with 
1000 units/ml rmlfn-y and 100 units/ml rmIL-4 together, in vitro 
phosphorylation assays were then performed on the membranes from these 
cells in the presence and absence of 10 units/assay rmIL-4 or 100 units/assay
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imlfn-y as stimulatory ligands. Figure 36 is a representation of such an 
experiment.
The phosphoprotein profiles of membranes from cells cultured for 
24 hours in medium alone (tracks a, b and c) show phosphorylation of 
proteins at 84, 70, 64, 59,55, 49,45 and 22 kDa. There was no evidence of 
the 75 kDa protein, which is consistent with the data of figure 35. The 
membrane phosphoprotein profiles from B cells cultured with IL-4 show 
similar phosphoproteins to control membranes (tracks d, e and f) with the 
exception of a protein of 55 kDa, which is not phosphoiylated in membranes 
from B cells cultured with IL-4. Two additional phosphoproteins are present 
in membranes from B cells cultured in the presence of IL-4 and these are a.75 
kDa protein and a 30 kDa protein. The membrane phosphoprotein profiles 
from B cells cultured in the presence of Ifn-y (tracks g,h and i) appeared to be 
identical to the profiles from B cells cultured in the presence of IL-4.
Phosphorylation of both the 75 and 30 kDa phosphoproteins were 
evident in the profiles from B cells cultured in the presence of Ifn-y. The 
profiles were not altered by inclusion of either cytokine as stimulatory ligand 
in the in vitro phosphorylation assay. The membrane phosphoprotein 
profiles of cells cultured in the presence of both IL-4 and Ifn-y (tracks j, k and 
1) were very similar to that of control cells (tracks a, b and c). There was no 
evidence of phosphorylation of the 75 kDa protein or the 30 kDa protein in 
these tracks. As in the profiles of control cells, a 55 kDa protein was 
phosphorylated. An equivalent gel to figure 36 was treated with 1 M KOH 
prior to autoradiography to determine which of the phosphoproteins might 
contain phosphotyrosine (figure 37). The major alkali resistant 
phosphoproteins were a 84 kDa prtotein, present in all tracks, and a 75 kDa 
protein, present only in the profiles from B cells cultured in the presence of 
either IL-4 (tracks d, e and f) or Ifn-y (tracks g, h and j). The 
phosphorylation of the 75 kDa protein is partially obscured by the heavy
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Figure 36 Effect of Ifn-y on Membrane Phosphoprotein Profiles
Resting B cells were cultured for 24 hours in complete medium alone 
(tracks a, b and c) or with 100 units/ml rmIL-4 (tracks d, e and f) or 
with 1000 units/ml rmlfn-y (tracks g, h and i) or with both rmIL-4 (100 
units/ml) and rmlfn-y (1000 units/ml) together (tracks j, k and 1). 
Membranes were prepared from these cells and they were subjected to 
in vitro phosphorylation assays as described in materials and methods 
2.12. in the absence of ligand or the presence of 10 units/assay rmIL-4 
or 100 units/assay rmlfn-y (as indicated under each track). The 
membrane proteins were separated by SDS-PAGE and the 
phosphoproteins visualised by autoradiography. The molecular weight 
markers indicated on the figure represent 94, 67,43, 30,20.1 and 14.4 
kDa.
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Figure 37 Alkali Resistant Phosphoproteins
The samples for gel electrophoresis were prepared exactly as described 
in the legend to figure 36. The gel was soaked in 1M KOH at 55°C for 
90 minutes prior to autoradiography. The arrows represent molecular 
weight markers of 94, 67, 43, 30, 20.1 and 14.4 kDa.
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phosphorylation of the 84 kDa protein and appears as a shadow in figure 37, 
but comparison with control cells (figure 37, tracks a, b and c) provides 
support for its presence.
It appears, therefore, that the binding of IL-4 or Ifn-y to their 
respective receptors can induce the appearance of a 75 kDa and a 30 kDa 
phosphoprotein. The fact that both lymphokines together abolish this effect is 
indicative of their ability to mutually inhibit each others activity.
5.4. Determination of the Ability of the 75 kDa Phosphoprotein to Bind
ATP
Membranes were prepared from high density resting murine B cells 
and from B cells that had been cultured with IL-4 for 24 hours. Aliquots of 
these membranes were exposed to the photoaffinity label 8 - a z i d o - y - [ 3 2 p ] -  
ATP. The reaction was initiated by illumination with UV light for one minute 
(section 2.14.). After termination of the reaction, sample buffer was added 
and the proteins were separated by SDS-PAGE. The proteins capable of 
binding ATP were visualised by autoradiography (figure 38). ATP binding 
proteins were determined in membranes from both freshly prepared resting B 
cells and B cells cultured with IL-4 in the presence or absence of IL-4 (as 
indicated on figure 38). To determine the specificity of binding, excess 
unlabelled ATP was added to equivalent samples (as indicated on figure 38). 
Aliquots of membrane from both resting B cells and B cells cultured in the 
presence of IL-4 were also subjected to kinase assays (lanes 1, 6, 7 and 12 
from the left). The membrane proteins were incubated with y-[32P]-ATP in 
the presence or absence of 10 units/assay rmIL-4 and the proteins separated 
by gel electrophoresis and visualised by autoradiography (section 2.12).
An ATP binding protein with a molecular weight of approximately 
50 kDa was observed in membranes from both resting B cells and B cells that 
had been cultured with IL-4. The intensity of labelling of this protein was
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similar in the presence and absence of IL-4 in the assay, and the majority of 
binding of the labelled ATP was abolished in the presence of unlabelled ATP. 
This protein is likely to be identical to that observed in resting murine B cell 
membranes (chapter 4, figure 28).
There was also evidence of another ATP binding protein of a lower 
intensity on the autoradiograph. This protein was only evident when IL-4 
was present in the assay and had a molecular weight of 78 kDa. The 78 kDa 
ATP binding protein was found in membranes from resting B cells and B 
cells that had been cultured with IL-4. The presence of unlabelled ATP 
reduced the binding of labelled ATP to the protein but did not appear to totally 
abolish it. It may be that the higher affinity or more abundant 50 kDa protein 
is binding the cold ATP, thereby permitting continued labelling of the lower 
affinity 78 kDa protein. Comparison of the membrane phosphoprotein 
profiles from B cells cultured in the presence of IL-4 shows that the 75 kDa 
phosphoprotein identified in figures 33 and 35 has a slightly higher mobility 
to the 78 kDa ATP binding protein. It is most tempting to speculate that these 
two proteins may be identical and that the observed difference in molecular 
weight is due to the binding of ATP. However, the arguement against the 
two proteins being identical is that the 78 kDa ATP binding protein is also 
observed in membranes from high density resting B cells and the 75 kDa 
phosphoprotein cannot be detected in these membranes. It may be that in 
resting membranes the 78 kDa protein can bind ATP, but the substrate 
phosphorylation site or protein is not available until culture with IL-4. More 
probably, the 75 kDa protein may be present in low amounts in membranes 
from resting cells and although the assay for the detection of ATP binding 
proteins is sensitive enough to detect these low amounts, the assay for the 
detection of protein kinase substrates may have a higher threshold which 
results in an apparently negative result
The data from figure 38 suggest that two B lymphocyte plasma
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Figure 38 ATP Binding Proteins in Membranes from Resting B Cells 
and B Cells Cultured with IL-4
Membranes were prepared from resting murine B cells and B cells 
cultured for 24 hours with 100 units/ml rmIL-4. Membrane proteins, 
were incubated with 3 jiCi of the photoaffinity label 8-azido-y-[32p]- 
ATP (materials and methods section 2.14.). The assay was performed 
on microscope slides and illuminated with UV light for 60 seconds at 
room temperature. The reaction was terminated by the addition of 
SDS-PAGE sample buffer and the proteins separated by SDS-PAGE 
and visualised by autoradiography. Where indicated rmIL-4 was 
present at 10 units per assay and unlabelled ATP at a concentration of 
50 mM. Membrane proteins were also subjected to in vitro 
phosphorylation (2.12) in the presence or absence of 10 units/assay 
rmIL-4. The proteins were separated on the same gel as the ATP 
binding proteins (lane 1, 6,7 and 12 from the left).
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membrane proteins are capable of binding ATP, a 50 kDa protein and a 78 
kDa protein. The 50 kDa ATP binding protein has an equivalent molecular 
weight to a phosphoprotein observed in membranes from resting B cells, and 
the level of labelling of this protein does not appear to be affected by the 
presence or absence of IL-4 as a stimulatory ligand. The 78 kDa ATP 
binding protein may be equivalent to the 75 kDa phosphoprotein uniquely 
observed in B cells cultured in the presence of IL-4. If these proteins are 
indeed equivalent it may be that IL-4 activates a putative protein tyrosine 
kinase which undergoes an autophosphoiylation reaction.
5.5. Synthetic Peptide Substrates for Murine B Cell
Membrane Kinases
A large number of protein kinases have now been identified and an 
important factor has been the striking sequence similarity in their catalytic 
domains. There are several short, highly conserved sequences (Hunter, 
1987). At the N terminal the sequence Gly - X -Gly - X - Gly. followed by 
Lys, 15-20 residues downstream are conserved and both form part of the 
binding site. At a distance of between 80-180 residues there is a sixty amino 
acid region containing the conserved sequences Arg - Asp - Leu., Asp - Phe- 
Gly , and Ala - Pro - Glu (Hunter and Cooper, 1985).
Cyclic AMP-dependent protein kinases recognise substrates partly 
on the basis of their primaiy amino acid sequence. The serine residue 
phosphoiylated by the kinase usually has one or two basic amino acids on the 
N-terminal side (Hunter, 1982). Tyrosine protein kinases are characterised 
by a lysine or arginine seven residues to the N-terminal side of the 
phosphorylated tyrosine and one or more acidic residue around the tyrosine 
(Hunter, 1982; Hunter, 1987).
These conserved sequences in the catalytic site of protein kinases 
allow short peptide sequences to be constructed that can act as exogenous
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substrates for protein kinases. Short peptides, RR-src, [Val^J-angiotensin II 
and phosphate acceptor peptide (figure 4), were used as exogenous substrates 
in in vitro phosphorylation assays to determine if the protein kinases in 
resting B cell membranes were capable of phosphorylation of exogenous 
substrates (section 2.15.). The phosphorylation assays were carried out in 
the presence or absence of 3 units/assay rmIL-4. The reactions were 
terminated by the addition of TCA at 0 ,1 ,2 ,5  and 10 minutes, and three 20 
pi aliquots were spotted onto 2 x 2cm squaes of Whatman P81 paper. This 
paper has negative charges and, therefore, the positively charged amino acids 
at the N terminal of the peptides can bind to the paper. The papers were 
washed throughly and then counted by liquid scintillation.
The results from this experiment were plotted on graphs of assay 
time versus incorporation of phosphate into the peptides (figure 39). In each 
case the incorporation in the absence of peptide, the presence of peptide and 
the presence of peptide plus IL-4 are shown. In each case it can be seen that 
there are counts bound to the paper even in the absence of peptide. This can 
either be due to phosphoiylated membrane proteins binding to the papers or 
perhaps free [^^PJ-phosphate or y-[32p]-ATP. In this system it is a range of 
protein kinases that are present in the membrane rather than a single purified 
kinase and, secondly, membrane proteins that act as protein kinase substrates 
will compete with the peptide substrates for phosphorylation. Panel A 
represents the incorporation of phosphate into RR-src. In the presence of 
RR-src there is an increase in phosphate incorporation above that measured 
with membrane alone. This suggests that phosphorylation of RR-src is being 
detected. The presence of IL-4 enhances incorporation of [3?P] into RR-src, 
showing an increase in phosphate incorporation up to 5 minutes and then a 
slight decrease. Panel B represents the incorporation of phosphate into 
[Val5]-Angiotensin n. The data showed a similar general trend to that 
reported for RR-src. In the presence of the peptide there was 
phosphorylation above that detected with membrane alone. The addition of
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Figure 39 Incorporation of [32p]-Phosphate into Peptide Subtrates
Membranes were prepared from resting B lymphocytes and in vitro 
phosphorylation assays were performed using RRsrc (2mM), [Val^]- 
angiotensin II (2mM) and Phosphate acceptor peptide (0.2mM) as 
substrates. The assays were performed as described in materials and 
methods 2.15. and were terminated with TCA at 0 ,1 ,2 ,5  and 10 
minutes. Figure 39 shows the results from these experiments 
Panel A RRsrc
Panel B Ang
Panel C PAP
In each case the assay was performed with B cell plasma membrane 
alone, B cell plasma membrane in the presence of 3 units/assay rmIL-4, 
B cell plasma membrane and peptide and B cell plasma membrane, 
peptide and 3 units/assay rmIL-4 as indicated on each graph.
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IL-4 to the assay resulted in a sharp increase in incorporation suggesting that 
the presence of IL-4 is activating one or more kinases. Panel C represents 
phosphate incorporation into phosphate acceptor peptide (PAP). In the 
absence of peptide some background phosphorylation can be detected. When 
PAP is added there is a higher level of incorporation, suggesting that PAP is 
acting as a protein kinase substrate. As previously, in the presence of IL-4, 
there is an increase in [32p] -phosphate incorporation over time which is 
above the level in the absence of IL-4. In each case, to determine whether IL- 
4 was enhancing peptide phosphorylation or background membrane protein 
phosphorylation, assays were performed with membrane and IL-4 alone in 
the absence of peptide. The increase in incorporation was not significant, 
suggesting that a specific increase in phosphorylation of the peptide was 
being detected in the presence of IL-4.
It appears that all three peptides can act as exogenous substrates for 
B cell plasma membrane protein kinases and that the activity of these protein - 
kinases is increased when IL-4 is present. It cannot, however, be determined 
which kinase is responsible for the phosphorylation as several kinases may 
exist in the plasma membrane. The fact that both tyrosine (RR-src and 
Angiotensin) and serine (PAP) residues were phosphorylated suggests that at 
least two different classes of protein kinase are present.
5.6. The Affinity for ATP of B Lymphocyte Plasma
Membrane Protein Kinase(s)
The use of peptides as exogenous substrates allows the 
determination of some kinetic parameters. In this case, definitive values 
cannot be obtained as it is not a purified kinase preparation which is being 
assayed, but rather an effect of multiple protein kinases. The affinity of the 
plasma membrane protein kinases from resting B cells and B cells cultured in 
the presence of 100 units/ml rmIL-4 for ATP was determined in the presence 
and absence of IL-4 as a stimulatory ligand. The assays illustrated were
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performed in the presence of 30 mM MgCl2 . In vitro kinase assays were 
performed using RR-src as an exogenous substrate at various concentrations 
of y-[32p]-ATP (0, 2.5, 5,10, 25 and 50 |iM). Three 20 fll aliquots from 
the terminated reaction were spotted onto P81 paper which was washed and 
counted. The results obtained were converted into pmoles/min/mg and 
graphs of 1/V (pmoles/min/mg) against 1/[ATP] were plotted (figures 40 and 
41), and are summarised in table 7.
The Km for ATP and Vmax parameters for IL-4-stimulated and 
control assays were estimated from the appropriate intercepts (Table 7). The 
data suggest that, in the case of resting cell membranes, addition of IL-4 as 
stimulatory ligand causes a small decrease in Vmax, and also altered the Km 
value for ATP from 50 |iM to 25 [iM. A similar trend of data was obtained 
when assays were performed using membranes prepared from B lymphocytes 
which had been cultured for 24hrs with EL-4. In this instance, the Vmax 
value was again slightly reduced (by an almost identical magnitude to that 
observed with control membranes), but the value was altered some 25 
fold, from 100 |iM to 4 jiM. Thus, addition of IL-4 to B cell membranes has 
very little effect upon the rate of phosphorylation of the peptide substrate 
(consistently in the range of 100 pmoles / minute/ mg membrane protein), but 
had the effect of increasing the affinity of IL-4-driven protein kinases for ATP 
in the presence of Mg2+ as cation. This effect is most striking in the 
membranes which have been prepared from cells cultured with the 
lymphokine for 24hrs. This would not be inconsistent with a long-term mode 
outcome of IL-4 action being increased levels of expression of its receptor 
and associated protein kinases. Indeed, given the low level of receptor present 
at resting cell membranes, it may be that the data obtained from the 
membranes derived from cells cultured overnight with the cytokine are a more 
accurate reflection of the kinetic parameters relating to IL-4-driven 
phosphorylation of the RR-src peptide substrate. Overall, however, the data 
are consistent with the hypothesis that IL-4 does influence the activities of
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Figure 40 Phosphorylation of RRsrc by Resting B Cell Plasma 
Membrane Protein Kinases
In vitro phosphorylation assays were performed with plasma 
membrane from resting B cells in the presence of RRsrc (2mM) as 
described in section 2.15. The assays were performed in the presence 
or absence of 3 units/assay rmIL-4 at y-[^P]-ATP concentrations of 
0, 2.5, 5,10,25 and 50 |±M. The reactions were terminated by the 
addition of TCA and three 20 pi aliquots were spotted onto P81 paper. 
The papers were washed and counted and the counts incorporated into 
RRsrc determined. The pmoles of [32p]-phosphate/min/mg protein 
were calculated and graphs of 1/pmoles/min/mg against l/[y-[32pj- 
ATP] (pM~l). The data points were fitted to a simple linear curve, and 
x  and y axis intercepts extrapolated from this line.
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Figure 41 Phosphorylation of RRsrc by Plasma Membrane Protein 
Kinases from B cells cultured with IL-4.
In vitro phosphorylation assays were performed with plasma 
membrane from B cells culutred overnight with IL-4. Assays were 
performed in the presence of RRsrc (2mM) as described in section 
2.15, andthe data plotted and handled as detailed in the legend to figure 
40.
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Table 7 Km and Vmax values for B Lymphocyte Plasma Membrane 
Protein Kinases
The Km and Vmax values for B lymphocyte plasma membrane kinases 
were calculated from the intercepts on the appropriate axis from the 
graphs in figures 40 and 41.
TABLE 7. Km and Vmax Values for B Lymphocyte
Plasma Membrane Protein Kinases.
Resting Cells
Vmax Km
(pmol/min/mg) (fiM)
-IL-4 100 50
+EL-4 67 25
Cells after Overnight Culture with IL-4
Vmax Km
(pmol/min/mg) (jiM)
-DL-4 125 100
+IL-4 100 4
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protein kinases associated with the B cell plasma membrane, and that it 
mediates its effect by increasing the affinities of such kinases for the Mg^+- 
ATP substrate complex. Whether such kinases are part of the 1L-4 receptor 
itself or are associated molecules activiated at a later stage following the initial 
ligand binding event remains to be clarified.
5.7. Membrane Phosphoprotein Profiles of Human Tonsillar
B Cells After Culture
The question as to whether the 75 kDa phosphoprotein was unique 
to the murine system was answered by performing similar experiments with 
membranes prepared from B cells isolated from human peripheral blood and 
tonsils. High density resting B cells were isolated from human tonsils and 
cultured in medium alone, in the presence of 1000 units/ml rhIL-4 or in the 
presence of 10 ng/ml PMA and 1 pM calcium ionophore. PMA activates 
protein kinase C and calcium ionophore increases intracellular calcium 
mimicing the two second messengers, DAG and respectively.
Membrane proteins were phosphorylated in the presence of y-[^^P]-ATP, and 
the resulting phosphoproteins separated by gel electrophoresis and visualised 
by autoradiography. The membrane phosphoprotein profiles from these cells 
are shown in figure 42.
The profiles from control cells (figure 42, tracks a-d) are similar 
whether IL-4 is included as stimulatory ligand in the assay or not The sole 
exception is that of an enhancement in phosphorylation of a 72kDa protein 
when IL-4 is included in the in vitro assay. The autoradiographic signal 
from this phosphoprotein is resistant to alkali (figure 43, tracks a-d). The 
major band in the membrane phosphoprotein profiles of control cells is at 64 
kDa with a faint band below this at 60 kDa, and the phosphorylation of both 
is independent of the inclusion of IL-4 in the assay. The membrane profiles 
from cells cultured with IL-4 (figure 42, tracks e-h) and PMA plus calcium
it.-. i
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Figure 42 Membrane Phosphoprotein Profiles of Human Tonsil B 
Lymphocytes After Culture
Resting B cells were isolated from human tonsils and cultured for 24 
hours in complete medium (tracks a-d), or with 1000 units/ml rhIL-4 
(tracks e-h) or PMA (10 ng/ml) and calcium ionophore (1 |iM) (tracks 
i-1). After culture membranes were prepared from the cells and 
subjected to in vitro phosphorylation with 10 |iCi y-[32p]_ATP in the 
presence or absence of 100 units/assay rhIL-4. The assay was carried 
out in the presence of either 30mM MgCl2 (tracks a, b, e, f, i and j) or 
5mM MnCl2 (tracks c, d, g, h, k and 1). Proteins were separated by 
gel electrophoresis and phosphoproteins were visualised by 
autoradiography.
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Figure 43 Alkali Resistant Membrane Phosphoproteins From Human 
B Lymphocytes After Culture
This experiment was identical to that described in the legend to figure 
39. The gel was treated with 1M KOH at 55°C for 90 minutes prior to 
autoradiography.
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ionophore (figure 42, tracks i-1) show an enhancement in phosphorylation of 
this doublet, with an apparent preference for the lower of the two bands, i.e., 
the 60 kDa species. From figure 43, the data suggest that only the higher, 64 
kDa, band of this doublet is resistant to alkali.
The membrane phosphoprotein profiles from B cells cultured with 
IL-4 show two distinct changes when IL-4 is included in the phosphorylation 
assay. Phosphorylation of a protein of 88 kDa disappears when IL-4 is 
included in the assay (figure 42, tracks e and f). This 88  kDa phosphoprotein 
was present in the membrane phosphoprotein profiles of control cells whether 
IL-4 was included in the assay or not, but the effect of culturing the cells with 
IL-4 then exposing the membranes from these cells to IL-4 as stimulatory 
ligand results in a loss of this phosphorylation event. Membrane 
phosphoprotein profiles from B cells cultured with PMA and calcium 
ionophore also show a disappearence of the 88 kDa band when IL-4 is 
included in the assay. The 88 kDa protein was alkali resistant (figure 43). 
Secondly, in the membrane phosphoprotein profiles from cells which have 
been cultured with IL-4 there is phosphorylation of a protein of apparent 
molecular weight 72 kDa which is considerably enhanced when IL-4 is 
included in the assay. In the membrane phosphoprotein profiles from cells 
that have been cultured with PMA plus calcium ionophore, the 72 kDa protein 
appears to be present whether IL-4 is included in the assay or not. The 72 
kDa protein is also resistant to alkali (figure 43).
5.8. Membrane Phosphoprotein Profiles of B cells from
Human Peripheral Blood After Culture
Resting B cells were isolated from human peripheral blood and 
cultured for 24 hours in medium alone, in the presence of 1000 units/ml rhEL- 
4 or in the presence of 10 ng/ml PMA and 1 |iM calcium ionophore. The 
membrane proteins from these cells were phosphoiylated with y-[32p]-ATP
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Figure 44 Membrane Phosphoprotein Profiles of Human Peripheral 
Blood B Lymphocytes After Culture
Resting B cells were isolated from human peripheral blood and cultured 
for 24 hours in complete medium (tracks a-d) or with 1000 units/ml 
rhIL-4 (tracks e-h) or PMA (10 ng/ml) and calcium ionophore (1 |iM) 
(tracks i-1). After culture membranes were prepared from the cells and 
subjected to in vitro phosphorylation with 10 |iCi y-[32p]-ATP in the 
presence or absence of 100 units/assay rhIL-4. The assay was carried 
out in the presence of either 30mM MgCl2  (tracks a, b, e, f, i and j) or 
5mM MnCl2  (tracks c, d, g, h, k and 1). Proteins were separated by 
gel electrophoresis and phosphoproteins were visualised by 
autoradiography.
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in the presence or absence of 100 units/assay rhIL-4 (section 2.12.). The 
membrane phosphoprotein profiles of B cells from peripheral blood were 
similar to those isolated from tonsils. Phosphoprotein profiles of membranes 
from control cells (figure 44, tracks a-d) showed no differences, regardless of 
whether IL-4 was included in the kinase assay or not. The membrane 
phosphoprotein profiles of B cells cultured in the presence of IL-4 were faint 
and, as a result, little information could be deduced from them. The 
membrane phosphoprotein profiles from B cells cultured with PMA plus 
calcium ionophore showed an enhancement in phosphorylation of a protein of 
72 kDa relative to control cells. The intensity of labelling of this 
phosphoprotein was independent of the inclusion of IL-4 in the in vitro 
phosphorylation assay.
The membrane phosphoprotein profiles of human B cells suggest 
that culture with IL-4 or PMA plus calcium ionophore induces the appearance 
of a 72 kDa phosphoprotein which is alkali resistant A low level of 
phosphorylation of this protein is also observed in the membrane profiles 
from control cells, but only when IL-4 is included in the in vitro kinase 
assay. It is possible that the 72 kDa phosphoprotein observed in membranes 
from human B cells is similar to the 75 kDa protein found in membranes from 
murine B cells. This question could be addressed, in the first instance, by 
two-dimensional gel electrophoretic analyses or by high resolution tryptic 
phosphopeptide mapping.
5.9. The Requirement for Metal Ions in the Phosphorylation
Assay
The hydrolysis of ATP requires the presence of metal ions, usually 
Mg2+ or Mn^+ The metal ion can exist at high concentrations in neutral 
solutions and acts as a superacid, complexing with ATP to weaken the bond 
of the leaving group. The literature documents the use of both Mg2+ and
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Mn2+ as divalent cations in phosphorylation assays. Carpenter et al (1979) 
studied the effect of EGF on phosphorylation of A431 membranes by 
determining the incorporation of [^^P]-phosphate into total membrane protein 
over various concentrations of Mg^+ and Mn^+ The requirement for metal 
ions was obligatory and EGF-stimulated protein phosphorylation was 
detected at all concentrations of metal ions. The half maximal incorporation 
of [32p] into protein was achieved at a Mg^+ concentration of 50 mM, 
whereas a lower concentration of Mn^+, 10 mM, was required. A higher 
incorporation of [-^^P]-phosphate was obtained with 50 mM Mg^+ than 10 
mM Mn^+. A tyrosine protein kinase activity in LSTRA cells phosphoiylates 
a protein of molecular weight 58 kDa, p58 (Casnellie et al., 1982). This 
protein was heavily labelled when either Mn^+ or Mg^+ were employed as 
divalent cation cofactor. However, approximately 5 times more radioactivity 
was incorporated into the 58 kDa protein in the presence of Mn^+ than Mg^+ 
when both were used at 10 mM. In phosphorylation reactions with higher 
initial levels of ATP (28 |iM) it was found that the initial velocity of 
phosphorylation was higher in the presence of MgCl2 than M nC ^ but as the 
ATP was depleted dephosphorylation was more prominent in the presence of 
MgCl2 - This indicated that the tyrosine kinase either had a lower Km for 
ATP in the presence of MnCl2  or that MnCl2  was inhibiting an endogenous 
phosphoprotein phosphatase. A tyrosine kinase in the detergent extract of the 
LSTRA cell line was assesed for its ability to phosphorylate exogenous 
peptides and it was determined that the kinase had a five-fold greater activity 
(Vmax) in the presence of Mg^+ than Mn^+ (Casnellie et al., 1982). These 
experiments indicate that the preferred metal ion is dependent on the kinase 
under study. The protein kinase activities associated with human B cell 
plasma membranes were investigated in the presence of MgCl2  or MnCl2  
(figures 29, 31, 42, 43 and 44). Phosphorylation assays (section 2.12.) 
were performed in the presence of 30 mM MgCl2 or 5 mM MnCl2  and the 
phosphoproteins were separated by SDS-PAGE and visualised by 
autoradiography. In figure 29 the proteins in tracks a and b were
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phosphorylated in the presence of 30 mM MgCl2  and, in tracks c and d, in 
the presence of 5 mM MnCl2 . The phosphoprotein profiles are similar in all 
four tracks but greater [32p]-phosphate incorporation has been achieved in 
the presence of MgCl2  with the exception of one protein of 19 kDa which is 
only present with MnCl2  as cation. The phosphoprotein profiles in figure 44 
also indicate a greater [32p]-phosphate incorporation in the presence of 
MgCl2 - In figures 42 and 43 in the presence of MnCl2  no phosphoproteins 
can be detected at this autoradiographic exposure. The phosphoprotein 
profiles from Daudi and Raji cells (figure 31) appear to be approximately 
equivalent in the presence of MgCl2  or MnCl2 . Comparison of the 
membrane phosphoprotein profiles in the presence of Mg^+ or Mn^+ 
indicated that Mg^+ was the preferred metal ion of kinases associated with 
human B cell membranes at the concentrations used.
5.10. DISCUSSION
The main finding from the experiments described in this chapter is 
that culturing resting murine and human B cells with recombinant IL-4 
induces the phosphorylation of a 75 kDa membrane protein. This protein is 
resistant to alkali suggesting that it may be phosphorylated on tyrosine 
residues. Ligand binding appears to be essential for the appearance of the 
phosphoprotein. Culture in complete, serum-containing medium in the 
absence of IL-4 did not induce this event. Furthermore, the inclusion of 
11B11, anti-IL-4 antibody, in the culture prevented phosphorylation of the 75 
kDa protein presumably by binding to IL-4 and hence preventing the binding 
of the cytokine to its receptor. Interestingly, the 75 kDa phosphoprotein 
appears in the profiles of membranes phosphorylated in the presence or 
absence of IL-4 in the assay. An explanation for this may come from the fact 
that IL-4 binds to its receptor with high affinity and, even after washing the 
cells, some IL-4 from the culture medium may still remain bound to the 
plasma membrane receptor (Ohara and Paul, 1987; Park et al., 1987a; Park
186
etal.y 1987b).
Phosphorylation of the 75 kDa protein is not evident in the 
membrane profiles from resting cells even when IL-4 is included in the 
phosphorylation assay. This observation is consistent with the presence of 
IL-4 in the culture medium being essential for the appearance of this 
phosphoprotein. This suggests that culturing the B cells with IL-4 either 
induces the appearance of the 75 kDa protein at the plasma membrane or 
causes a conformational change of an existing 75 kDa membrane protein 
which allows the protein to be phosphorylated on subsequent exposure to y- 
[3 2 p ] -A T P . Perhaps the requirement for culture in the presence of IL-4 
reflects the capacity of the lymphokine to up-regulate the expression of its 
own receptor (Ohara and Paul, 1987). In contradiction to this, culturing 
murine B cells with LPS has also been shown to increase expression of IL-4 
receptors and yet there is no there is no evidence of a 75 kDa protein in the 
membrane phosphoprotein profiles from such cells. There are, however, 
several differences in the action of IL-4 and LPS on B cells. Culturing the B 
cells with LPS drives them into the cell cycle and to antibody secretion 
(Andersson et al., 1972) whereas culturing with IL-4 alone induces only an 
activated state and the cells do not enter the cell cycle (Howard et al., 1982). 
Regarding the signalling mechanisms of the two ligands, LPS has been 
shown to activate protein kinase C (Chen et al., 1986) whereas other reports 
indicate that the signals transduced when IL-4 binds to its receptor do not 
include the activation of protein kinase C, at least in the murine system 
(Justement et al., 1986; Mizuguchi et al., 1986). Further evidence for their 
different actions on B cells comes from their regulation of immunoglobulin 
isotype switching. IL-4 promotes the secretion of IgGl from LPS treated B 
cells (Vitetta et al., 1985; Sideras et al., 1985; Noma et al., 1986; Isakson, 
1986). Although both ligands are required to enhance IgGl secretion, the 
two ligands act independently of each (Snapper et al., 1987). When resting 
murine B cells were cultured with IL-4 for 48 hours then washed and LPS
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added, IgGl secretion was enhanced. This suggests, then, that LPS is acting 
on B cells by a different mechanism from IL-4 and that this LPS-activated 
pathway does not involve the phosphorylation of a 75 kDa protein, even 
when IL-4 is included in the phosphorylation assay.
In contrast to the murine system, the 75 kDa phosphoprotein is 
present in membrane profiles from human B cells cultured with PMA plus 
calcium ionophore and its phosphorylation is independent of IL-4 in the in 
vitro phosphorylation assay. PMA and calcium ionophore mimic DAG and 
respectively, to activate protein kinase C. Recent reports on human B 
cells indicated that binding of IL-4 to its receptor induced an increase in IP3 
followed by an increase in calcium (Finney et al., 1989). It was suggested 
that the signals transduced by IL-4 in the human system may involve 
PtdInsP2  hydrolysis. This signal alone is insufficient to induce CD23 
expression on B cells, an event which also requires an increase in cAMP 
(Finney, et.al., 1989). The results suggest that the activation of the B cells 
by PMA plus calcium ionophore, which induce protein kinase C, result in 
phosphorylation of a 72 kDa membrane protein. In contradiction to this is the 
fact that protein kinase C phosphorylates proteins on serine and threonine 
residues and preliminary results suggest that the 75 kDa protein is 
phosphorylated on tyrosine residues. This does not rule out the possibility 
that the 75 kDa protein can be phosphorylated on more than one amino acid. 
In the insulin and the EGF systems binding of ligand to the homologous 
receptor activates a receptor associated tyrosine kinase which promotes an 
autophosphorylation reaction (Cohen etal., 1982; Kasuga et al., 1983). It 
has, however, been demonstrated that the receptor can also be phosphorylated 
on threonine residues by protein kinase C (Hunter et al., 1984). The binding 
of the ligand to the receptor activates PtdInsP2 hydrolysis which results in the 
activation of PKC (Sawyer and Cohen, 1981; Takayama, 1984). There is 
also evidence that that the tyrosine kinases encoded by src, pp60v-iS,rc 
(Sugimoto et al., 1984) and ros, pp6 8v_ras (Macara et al., 1984) can
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phosphorylate PI, PIP and DAG. The fact that activation of two distinct 
kinases has been shown in other systems which involve cell growth, suggests 
perhaps that two kinases may be involved in the signals transduced by IL-4 in 
the human system.
The finding that interferon-y causes similar, if not identical, 
alterations in the membrane phosphoprotein profiles of murine B lymphocytes 
to those observed with the same cells cultured with IL-4 is particuarly 
interesting in view of the antagonistic effects of the lymphokines in many 
biological assays (Rabin et al., 1986b; Mond et al., 1986). Although the 
lymphokines are antagonistic towards each other, they have many similar 
effects on B cells. Both lymphokines promote directed immunoglobulin 
isotype switching in B cells in the presence of LPS: IL-4 drives switching to 
IgGl or IgE (Vitetta et al., 1985; Sideras et al., 1985; Noma et al., 1986; 
Isakson, 1986) and Ifn-y to IgG2a (Snapper et al., 1988c). This has been 
shown to be accomplished by a similar molecular mechanism in both cases. 
Hence, the induction of similar protein kinases by IL-4 and Ifn-y may be 
accounted for in terms of their effect on similar genes required for isotype 
switching. IL-4 and Ifn-y again have similar effects on MHC class II 
expression. Ifn-y is inhibitory to the increase in MHC class II antigens seen 
on culture of B cells with IL-4, but Ifn-y itself increases MHC class II 
antigens on macrophages, B cell tumours and immature B cells (Mond et al., 
1986). IL-4 has been shown to influence the level of a DNA binding protein 
which binds to a sequence in the MHC class II genes resulting in enhanced 
gene transcription (Boothby et al., 1988). Ifn-y has also been shown to 
exert its effect at the level of gene transcription by a trans acting protein 
(Amaldi et al., 1989). This is further evidence of the two ligands using a 
similar protein kinase in order to activate similar genes.
The simultaneous exposure of B cells to EL-4 and Ifn-y abolishes the 
effects on membrane phosphoprotein profiles observed with either ligand
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alone. This is consistent with the capacity of the lymphokines to mutually 
inhibit each others biological effects.
The molecular identity of the 75 kDa phosphoprotein remains 
undefined. One possibilty is that the phosphoprotein represents the binding 
component of the IL-4 receptor which has been previously identified as 
having a molecular weight of 75 kDa in the mouse (Park et al., 1987a) and 
139 kDa and 70 kDa in the human (Park et al., 1987b; Galizzi et al., 1988). 
In this respect the IL-4 receptor may be similar to other ligand receptor 
systems ie. insulin, EGF, PDGF etc. whose receptors possess an intrinsic 
tyrosine protein kinase activity which result in an autophosphorylation. The 
results of experiments employing 8-azido-y- [32p] - ATP are not entirely 
inconsistent with this possibility as a protein of 75 kDa can be identified as 
binding ATP although not as strongly as the 50 kDa protein, whether this 
protein is identical to the 75 KDa phosphoprotein remains to be unequivocally 
defined. The alkali resistance of the 75 kDa phosphoprotein suggests that it 
may be phosphorylated on tyrosine but the use of other biochemical 
techniques have been unable to confirm this. Antibodies raised against 
tyrosine phosphate or azobenzylphosphonate, an analogue of tyrosine 
phosphate, although specific for tyrosine residues, did not bind to any 
membrane phosphoproteins as analysed by immunoblotting. It may be that 
the membrane proteins were of insufficient quantities and the antibodies of 
such low affinity that tyrosine phosphate was unable to be detected. 
Techniques employing two dimensional thin layer electrophoresis showed an 
increase in [32p]-phosphate incorporation into serine, threonine and tyrosine 
phosphate in total membrane protein analyses (figure 23). The 
phosphoamino acids present in the 75 kDa protein could not be detected by 
this method due to the low incorporation of [32p] -phosphate. The protein 
kinase activity of membrane proteins from resting B cells and B cells cultured 
with IL-4 was also analaysed by the use of exogenous peptide substrates 
containing one potential phosphorylation site but the results were
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inconclusive. The most compelling data against the hypothesis that the 75 
kDa phosphoprotein is part of the IL-4 receptor is that the murine IL-4 
receptor has now been identified by cloning and nucleotide sequencing to be 
140 kDa in the mature, fully glycosylated form (Drs D. Cosman and S.
Gillis, Immunex Corporation, personal communication to Dr. W. Cushley). 
This does not rule out the possibility that the 75 kDa protein is a result of 
protease activity as protease inhibitors were not included in the 
phosphorylation experiments. Secondly, Ifn-y promotes the appearance of 
the 75 kDa protein and reports suggest that it does not bind to the IL-4 
receptor. Ifn-y binding to its receptor may activate a protein kinase which 
phosphoiylates the IL-4 receptor preventing signal transduction perhaps by 
decreasing the affinity of the receptor for ligand. Although binding studies 
suggest that Ifn-g has no effect on the binding of IL-4 to its receptor. 
Alternatively the 75 kDa phosphoprotein induced by Ifn-y may be of a similar 
molecular weight but a different phosphoprotein to that induced by IL-4. The 
fact that IL-4 and Ifn-y together inhibit the appearance of the 75 kDa protein 
suggests that the inhibition occurs before the phosphorylation event. It is 
possible that Ifn-y inhibits the induction of the 75 kDa to the membrane.
The 75 kDa phosphoprotein may be a component of the IL-4 
receptor distinct from the binding component or a protein distinct from but 
associated with the receptor.
Another candidate structure for the 75 kDa phosphoprotein based on 
the molecular weight is the P subunit of the high affinity receptor for IL-2 
(Smith, 1988). This structure is particuarly interesting in light of the data in 
chapter 3 and also subsequent two-colour flow cytometric studies which have 
been performed (R. Butcher and W. Cushley, Department of Biochemistiy, 
University of Glasgow) indicating that culturing human B cells with IL-4 
increases the expression of the CD25 antigen. The high affinity IL-2 receptor 
consists of a 55 kDa protein, CD25 and a 75 kDa protein. The IL-2 receptor
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is also found to be similar on both human and mouse B cells.
It is also interesting to consider the mechanism by which the 75 kDa 
protein appears in the membrane as it is not detected in membranes from 
resting B cells. The 75 kDa protein may be a result of de novo gene 
expression stimulated by culturing the cells with IL-4 or alternatively it may 
exist in a cytoplasmic location and be translocated to the plasma membrane. 
The 75 kDa protein may, of course, already exist in the plasma membrane and 
the phosphorylation event may represent the translocation of a protein kinase 
of which the 75 kDa protein is a substrate. A final possibility is that the 75 
kDa protein or its associated kinase activity are present in resting cell 
membranes but are either not active or are below the sensitivity limits of the 
in vitro kinase assay.
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6. GENERAL 
CONCLUSIONS.
6 . GENERAL CONCLUSIONS
Control of B lymphocyte activation and differentiation by 
lymphokines involves the interplay of several molecules. The interaction of 
these molecules with their receptors induces a variety of biological effects in 
the cell. Numerous biological effects of IL-4 have been reported, but the 
signals transduced when IL-4 binds to its receptor to elicit these effects are 
poorly understood. Comparison with other systems shows that protein 
phosphorylation and dephosphoiylation is frequently involved in the control 
of cell function. Experiments in this thesis, employing plasma membranes 
isolated from B , have identified two membrane associated phosphoproteins 
which respond to the binding of IL-4 to its receptor.
The 42 kDa phosphoprotein is specific to the murine system. 
Phosphorylation of this protein was only evident in membranes from resting 
B cells and B cells at early stages in the cell cycle. Phosphorylation of the 
42 kDa protein is perhaps a signal transduced by the interaction of IL-4 with 
its receptor on resting B cells to potentiate their subsequent response 
antigen. The 42 kDa phosphoprotein was not evident in membranes isolated 
from human B cells. The human B cells were isolated from peripheral blood 
and tonsils whereas the mouse B cells were from spleen. The distinct 
anatomical sources of the B cells may be an explanation for the differences 
in protein phosphorylation observed between species. It may be that the 
human B cells, although in the resting state, had already encountered antigen 
in vivo and, hence, were in an activated state that did not require the 42 kDa 
phosphorylation signal. Alternatively the biochemical mechanism of action 
of IL-4 may vary between the two species. ATP binding experiments have 
indicated that the 42 kDa phosphoprotein does not bind ATP, which 
suggests that it is a protein kinase substrate.
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Culturing high density resting murine B cells in the presence of IL-4 
results in the appearance of a 75 kDa signal in the membrane phosphoprotein 
profiles of these cells. Ligand binding is apparently required for the 
appearance of this phosphoprotein since culture in medium alone or in the 
presence of 1 IB 11, anti IL-4, fails to induce the alteration in membrane 
phosphoprotein profile. The 75 kDa phosphoprotein was not evident in the 
membrane profiles from B cells cultured with LPS. The 75 kDa signal was 
present in the membrane profiles of B cells cultured in the presence of Ifn-y, 
which inhibits many of the biological effects of IL-4. However, the 75 kDa 
signal was not present in the membrane phosphoprotein profiles of B cells 
cultured with IL-4 and Ifn-y simultaneously. The 75 kDa protein was alkali 
resistant and ATP binding experiments suggested that it may bind ATP. The 
membrane phosphoprotein profiles from human B cells cultured in the 
presence of human IL-4 indicated the phosphorylation of a 72 kDa protein 
which was alkali resistant Culturing B cells in the presence of PMA plus 
calcium ionophore also induced phosphorylation of the 72 kDa protein in 
human B cell plasma membranes. Whether the murine and human proteins 
are identical remains to be unequivocally determined.
The data from this study suggest that in the murine system IL-4 
influences the phosphorylation of two membrane-associated proteins, a 42 
kDa protein and a 75 kDa protein. The 42 kDa signal can be detected in 
membranes from resting B cells and this suggests that the location of the 
protein is in the plasma membrane and it is the interaction of IL-4 with its 
receptor that results in phosphorylation of the protein. The murine 75 kDa 
phosphoprotein and the human 72 kDa phosphoprotein cannot be detected in 
membranes prepared from resting B cells but only in membranes prepared 
from B cells that have been cultured with IL-4 or, in the human system,
PMA plus calcium ionophore. This suggests that perhaps the 75 kDa 
protein is not present in the plasma membrane of resting B cells but that
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culturing with IL-4 either induces the translocation of this protein from 
another location to the plasma membrane or induces the transcription of the 
gene encoding this protein. These competing possibilities could be resolved 
by culturing B cells with IL-4 for different times and subjecting the 
membranes to in vitro phosphoiylation to determine the appearance of the 
75 kDa phosphoprotein. Rapid appearance would indicate a translocation 
event whereas a longer lag would suggest that gene transcription was 
involved. It is also possible that the 75 kDa is located in the plasma 
membrane of resting cells, but at levels below the sensitivity of the kinase 
assay. The presence of IL-4 may increase the amount of the 75 kDa protein 
available for phosphorylation. This is consistent with the fact that IL-4 
increases expression of the IL-4 and IL-2 receptors, both of which are 
candidates for the 75 kDa phosphoprotein.
The question as to the identity of these proteins remains to be 
answered although several candidate structures have been suggested. One 
suggestion is that the 75 kDa protein is an IL-4 receptor associated tyrosine 
kinase which is activated upon IL-4 binding resulting in an 
autophosphoiylation reaction. The action of IL-4 would therefore be 
analogous to other growth factor receptor systems. The binding of PDGF 
(Frackelton et al., 1983), EGF (Cohen et al., 1982) and insulin (Kasuga 
et al., 1983) to their respective receptors has been shown to induce a 
receptor associated tyrosine kinase which results in autophosphorylation of 
the receptor. Phosphorylation of proteins on tyrosine residues has 
previously been reported for both T and B lymphocytes (Earp et al., 1984; 
Casnellie et al., 1982) including the T cell antigen receptor (Klausner et 
al., 19867; Samelson et al., 1986). It has been hypothesised that the 42 
kDa phosphoprotein may be the a  subunit of a guanine nucleotide (G) 
binding protein. If this were the case then the IL-4 receptor system may be 
analogous to the insulin receptor system. The P subunit of the insulin 
receptor has been shown to possess an intrinsic tyrosine kinase activity
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which is capable of phosphoiylating the a  subunits of Gi and Go (O'Brien 
et al., 1987). Binding of IL-4 to its receptor may, therefore, activate a 75 
kDa receptor associated tyrosine kinase, resulting in both 
autophosphorylation and phosphorylation the a  subunit of a 42 kDa G 
protein. Methods for identifying the involvement of a G protein in signal 
transduction have already been discussed in chapter four. If the 75 kDa 
phosphoprotein is part of the IL-4 receptor then antibodies which have been 
raised against the receptor may be able to immunoblot and/or 
immunoprecipitate the protein. The 75 kDa protein is the same molecular 
weight as the IL-4 binding component identified in the murine system (Park 
et al., 1987a). If the 75 kDa phosphoprotein does indeed represent the 
binding component of the IL-4 receptor, then crosslinking of [125l]-IL-4 to 
IL-4 receptors present on plasma membranes isolated from B cells cultured 
with IL-4 should isolate a 75 kDa IL-4 binding component which is capable 
of autophosphorylation in an in vitro kinase assay.
Alternatively the 42 kDa phosphoprotein may be a protein kinase C 
substrate. There have been reports of the activation of two independent 
kinases in other ligand receptor systems. Both EGF and insulin binding to 
their respective receptors have been shown to enhance phosphatidylinositol 
turnover which leads to the activation of protein kinase C (Sawyer and 
Cohen, 1981; Takayama, 1984). Further evidence of the involvement of 
two independent kinases in signal transduction comes from RNA tumour 
viruses. In vitro, the tyrosine kinases encoded by src, pp60v"iSTC 
(Sugimoto et al., 1984) and ros, pp68v"r<9iS (Macara et al., 1984) have 
been shown to phosphorylate phosphatidyl inositol, phosphatidyl inositol 4 
phosphate and 1,2 diacylglycerol which results in the activation of protein 
kinase C. Binding of IL-4 to its receptor may, therefore, activate a 75 kDa 
receptor associated tyrosine kinase which is capable of enhancing 
polyphosphoinositol hydrolysis resulting in the activation of protein kinase
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C of which the 42 kDa protein is a substrate. The involvement of protein 
kinase C in IL-4 signal transduction could be confirmed or eliminated by 
performing the in vitro phosphorylation assay in the presence of protein 
kinase C inhibitors. Data from two groups suggest that the 42 kDa protein 
is not a protein kinase C substrate (Justement et al., 1986; Mizuguchi et 
a l, 1986).
An alternative possibity is that IL-4 binding to its receptor results in 
the activation of one or more protein kinases of which the 42 kDa and 75 
kDa proteins are substrates. The 42 kDa and 75 kDa phosphoproteins, 
although both involved in the signal transduction by IL-4, may be 
functionally unrelated.
The other candidate structure for the 75 kDa phosphoprotein based 
on molecular weight is the |3 subunit of the IL-2 receptor (Smith, 1988). 
The expression of CD25 of human B cells has been shown to be enhanced 
after culture of the cells with IL-4. This could, potentially, enhance the 
ability of the B cell to respond to IL-2. IL-2 has been shown to be capable 
of stimulating the proliferation and differentiation of large bouyant B cells 
(Mond et al., 1985) and can also act as a costimulant with antigen in the 
activation of resting B cells (Pike e ta l, 1984). Moreover, IL-2 has been 
shown to increase tyrosine phosphorylation (Salzman et al., 1988). The 
question as to whether the 75 kDa phosphoprotein is the IL-2 receptor could 
be investigated by immunoblotting membrane phosphoprotein profiles from 
IL-4 cultured B cells with antibody specific for the (3 subunit. Alternatively 
cross-linking experiments could be performed using [^^l]-JL-2, similar to 
those detailed above for IL-4.
The membrane phosphoprotein profiles from B cells cultured with 
IL-4 and Ifn-y simultaneously do not show the 75 kDa phosphoprotein,
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which is consistent with the ability of Ifn-y to inhibit the activity of IL-4. 
Interestingly, membrane phosphoprotein profiles from B cells cultured with 
Ifn-y alone did show a 75 kDa signal. It is tempting to speculate that this 75 
kDa phosphoprotein is identical to that induced by IL-4. If IL-4 and Ifn-y 
induce phosphoiylation of the same protein this could suggest two 
possibilities. If the 75 kDa protein is a component of the IL-4 receptor then 
phosphorylation of the protein by Ifn-y may be on a different phosphoamino 
acid, or on the same type of phosphoamino acid at a different site in the 
protein. Phosphorylation of the 75 kDa protein by Ifn-y may, therefore, 
result in a reduced or abolished protein kinase activity. Phosphoiylation of 
the EGF.receptor tyrosine kinase on serine and threonine was shown to 
result in a loss of EGF binding, which was due to a decrease in the affinity 
of the receptor for EGF (Hunter et al., 1984). The arguement against this 
situation for Ifn-y is that Ifn-y does not inhibit the binding of IL-4 to its 
receptor, at least to the high affinity receptor identified by Park et al (1987a) 
and Ohara and Paul (1987). If the 75 kDa phosphoprotein is a component 
of the IL-2 receptor, phosphorylation of it by Ifn-y would not account for 
the inhibitory effects of the action of IL-4 on resting B cells.
It could be that EL-4 and Ifn-y inhibit each others effects at the level 
of gene transcription. In this case, if culturing B cells with IL-4 induces 
transcription of the 75 kDa phosphoprotein Ifh-y may inhibit this 
transcription event. This hypothesis would also hold for the inhibition of 
Ifn-y induced gene transcription by IL-4. The exact nature of the interaction 
of IL-4 and Ifn-y, with regard to the 75 kDa phosphoprotein, cannot be 
established until the identity of the 75 kDa phosphoprotein is determined.
In the human system the 72 kda phosphoprotein may be identical to 
the murine 75 kDa phosphoprotein. In this case, all the candidates for the 
75 kDa phosphoprotein are relevant for the human 72 kDa phosphoprotein.
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In the human system, the appearance and phosphoiylation of the 72 kDa 
phosphoprotein can be induced by PMA plus calcium ionophore which 
suggests that PMA plus calcium ionophore are mimicing the effect of 
culturing B cells with IL-4. In the murine system, culturing B cells with 
LPS does not result in the appearance of the 75 kDa phosphoprotein. This 
is perhaps an arguement for suggesting that the phosphoproteins are 
different in the two systems. The signals transduced by IL-4 binding to its 
receptor on human B cells do not appear to include phosphorylation of a 42 
kDa protein. It is, therefore, tempting to speculate that the biochemical 
mechanism of action is distinct in the two species.
The two IL-4 induced phosphoproteins identified in this study were 
from in vitro phosphoiylation of B lymphocyte plasma membranes. The 
effects of IL-4 on phosphoiylation should also be demonstrated in whole B 
cells or permeabilised B cells using [32p]-orthophosphate in order to 
correlate these results with relevance in vivo. The difficulties with this is 
that a veiy small signal is involved due to the low numbers of IL-4 receptors 
per cell and, therefore, it is difficult to detect a phosphoiylation signal. 
Analysis of protein kinase events in detegent-permeabilised cells may 
provide an useful experimental system for in vivo resolution of the 
questions posed by the data of this thesis.
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